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This thesis consists of five chapters describing the bay-annulation of the planar hexa-peri-
hexabenzocoronene towards a bowl-shaped hexa-peri-hexabenzocoronene where all six bay 
sites are annulated. 
Chapter one provides an overview of polycyclic aromatic hydrocarbons and their fundamental 
properties, along with a review on the synthesis of hexa-peri-hexabenzocoronene and the 
bowl-shaped polycyclic aromatic hydrocarbons corannulene and sumanene. 
Chapter two describes the extension of research previously undertaken on synthesising 
cyclopenta-incorporated hexa-peri-hexabenzocoronene where fluorene is utilised as a pre-
formed source of five-membered rings. Improvements made in the synthesis of key 
precursors, exploration of conditions facilitating the unexpected chlorination previously 
observed during cyclodehydrogenation, and utilisation of this functionality is discussed. 
Chapter three describes the extension of the methodology discussed in chapter two towards 
multiple annulations of hexa-peri-hexabenzocoronenes where fluorene is utilised as a pre-
formed source of five-membered rings. A number of different topologies containing the 
fluorene moiety were investigated, with the synthesis and subsequent oxidative 
cyclodehydrogenation reactions outlined. 
Chapter four describes bay-annulation of hexa-peri-hexabenzocoronenes post-
cyclodehydrogenation, and product reactivity. Due to limited examples of post-
cyclodehydrogenative functionalisation of hexa-peri-hexabenzocoronenes, the development 
of synthetic methods to achieve annulation is discussed.  
Chapter five describes an extension of chapter four where alternative annulation reactions at 
the periphery of hexa-peri-hexabenzocoronene were explored. In particular, annulation from 
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1.1 Polycyclic Aromatic Hydrocarbons (PAHs) 
Polycyclic aromatic hydrocarbons (PAHs) are a family of compounds that predominantly 
consist of sp2 hybridised carbon and hydrogen atoms, with the carbon atoms arranged in a 
number of fused rings.1 As this definition is broad, there are many possible structures that this 
applies to;2 however, the archetypical PAH consists entirely of sp2 carbon atoms with 
hydrogen atoms at the periphery, of which many examples are found in nature. Outside of the 
lab, PAHs are commonly formed by the incomplete combustion of carbon-containing 
materials, such as forest fires or by grilling food on barbeques.3 Small PAHs such as 
anthracene, triphenylene and fluorene (Figure 1.1) have been isolated from oil and tar 
deposits,4 whilst numerous PAHs have been detected in interstellar bodies.5 
 
 
Figure 1.1: Examples of PAHs: (a) anthracene; (b) phenanthrene; (c) triphenylene; (d) coronene; (e) fluorene. 
A major avenue of small PAH research is the qualitative and quantitative study of their effect 
on the environment, particularly those produced in the incomplete combustion of fossil fuels.6 
The most prominent example is benzo[a]pyrene, an organic contaminant found to be 
carcinogenic, mutagenic and a main contributor of chimney sweeps’ carcinoma.7 Due to 
compounds like benzo[a]pyrene, concern over the impact of many PAHs on the environment 
has spurred numerous studies.8-9 Larger, naturally scarce/unknown and typically non-volatile 
PAHs have gained attention as they can be considered to be nanoscale graphene sheets.10 
Many of these studies revolve around discovering and utilising their physical properties.11-13  
1.1.1 Properties 
An inherent property of most PAHs is their chemical and thermal stability. In 1972, Erich Clar, 
considered the father of PAH chemistry, proposed a qualitative rule to estimate the relative 
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stability of PAHs, amongst other properties.14 This rule states that all available π-electrons 
should be placed in discrete sextets, much like benzene, if possible. The more discrete sextets 
able to be formed, the more stable the compound. Rings that have sextets can be 
differentiated by depicting them as Robinson rings. Exemplifying this rule are the structural 
isomers anthracene and phenanthrene (Figure 1.2).15 These both consist of three fused phenyl 
rings, arranged in a linear combination for anthracene (a) and bent for phenanthrene (b). 
Anthracene is less stable than phenanthrene and Clar’s rule illustrates this. As can be seen 
with Robinson ring notation, phenanthrene has two sextets as opposed to anthracene’s one, 
and from this can be predicted to be more stable, agreeing with the observed properties.14  
 
Figure 1.2: PAHs with sextets depicted as Robinson rings: (a) anthracene; (b) phenanthrene; (c) triphenylene. 
Clar’s rule extends further for those PAHs where all π-electrons can be located in discrete 
sextets. These are referred to as fully-benzenoid Clar PAHs and are vastly more stable than 
their structural isomers. The smallest fully-benzenoid PAH is triphenylene (Figure 1.2 (c)).15 
PAHs also exhibit liquid crystalline properties if appropriately substituted at the periphery. The 
liquid crystalline phase is a phase with properties both of a solid and a liquid, such as long 
range orientational order (like a solid) whilst also retaining some freedom of movement (like 
a liquid).16 As a result of this orientational order, many of a liquid crystalline compound’s 
(mesogen) properties can be anisotropic which allows for a host of applications.17 
A mesogen has a generalised structure consisting of a rigid core with long, flexible alkyl chains 
at the periphery. The rigid cores tend to be composed of fused rings and can be a multitude 
of shapes such as rods (calamatic liquid crystals) or discs (discotic liquid crystals). These shapes 
exhibit different types of mesophases with various amounts of order.17  
PAHs typically are thermotropic discotic liquid crystals with two main mesophases: the 
nematic and the columnar arrangements (Figure 1.3). In the nematic mesophase the 
molecules have orientational order but have random positional order. In the columnar 
mesophase, however, they retain this orientational order whilst arranging into columns. The 
column positional order varies resulting in the different types of columnar mesophases.18 The 
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driving force of this columnar stacking is due to the favourable intermolecular interactions 
between rings.10  
 
Figure 1.3: Nematic and columnar mesophases of discotic liquid crystals with discs representing the core only. 
The interactions, known as π-stacking, largely arise from the electrostatic attraction between 
the electron rich aromatic ring and the electron poor hydrogen atoms on an adjacent ring. 
This attraction can arise in two main configurations: edge-to-face or face-to-face (Figure 1.4).19 
In edge-to-face interactions, the two rings are approximately perpendicular to each other 
while face-to-face their planes are parallel with an offset. The offset is dependent on many 
factors including size of the core and degree of alkyl substitution, with larger cores resulting 
in a smaller offset.10  
 
Figure 1.4: Edge-to-face and face-to-face stacking of benzene. 
1.1.2 Hexa-peri-hexabenzocoronene (HBC) 
One heavily studied PAH is hexa-peri-hexabenzocoronene (HBC, Figure 1.5).10, 20-21 It is a 




Figure 1.5: Hexa-peri-hexabenzocoronene and numbering. 
Underivatised HBC, like many large PAHs, is sparingly soluble due to strong π-stacking 
interactions between molecules resulting in aggregation in a distinctive herringbone 
arrangement (Figure 1.6).22 Incorporation of bulky substituents that sterically hinder 
aggregation, or long alkyl chains which dilute the aromatic contributions, can be appended to 
help mitigate this undesirable property. Whilst smaller PAHs are often harvested from nature, 
larger PAHs like HBC must be synthesised.  
 
Figure 1.6: X-ray crystal structure showing the herringbone arrangement of unsubstituted HBC.22 
1.1.3 Historical Syntheses of HBC 
The initial synthesis of HBC, published in 1958 by Clar and Ironside, revolved around the 
intermolecular fusion of two molecules of 8H-benzo[fg]tetracene (Scheme 1.1).23-24 The 
authors found that under brominating conditions, a tribromo derivative was synthesized 
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which, upon melting, gave the fusion of two molecules of the hydrocarbon and the 
corresponding loss of HBr. The fusion product, hexabenzo[a,cd,f,j,lm,o]perylene, was then 
melted in an evacuated capillary and found to solidify at 482 °C with the evolution of 
hydrogen. This resultant solid formed did not melt again below 700 °C and was unable to be 
dissolved in conc. H2SO4, with only slight solubility reported in trichlorobenzene. The unknown 
PAH was able to be crystallised from boiling pyrene and found to be hexa-peri--
hexabenzocoronene.  
 
Scheme 1.1: First synthesis of hexa-peri-hexabenzocoronene by Clar, Ironside and Zander.23-24 
That same year, two alternative methods to HBC by Halleux et al. were reported (Scheme 
1.2).25 Of note in one synthesis is the transformation of a hexaarylbenzene to hexa-peri-
hexabenzocoronene mediated by a Lewis acid which, although modified, is essentially the 
same methodology currently utilised to HBCs. In this work treatment of hexaphenylbenzene 
with molten AlCl3/NaCl resulted in the formation of HBC in yields around 3%.    
 
Scheme 1.2: Synthesis of hexa-peri-hexabenzocoronene by Halleux, Martin and King from hexaphenylbenzene 
or 8H-benzo[fg]tetracene-8-one.25 
Alternate synthetic pathways to HBCs were left undiscovered until 30 years later, when 
Hendel et al. published a new methodology whilst looking at potential molecular sources for 
the astronomical absorption features known as diffuse interstellar bands,26 which have long 
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been postulated to arise from interstellar PAHs.5, 27-28 Here, the reaction of phenanthro[9,10-
b]triphenylene-9,18-dione with phenyllithium gave a diol which, upon treatment with an 
AlCl3/NaCl melt, followed by heating with copper at 400 °C afforded HBC (Scheme 1.3). The 
desired HBC was obtained in a mixture with a phenyl eliminated side product, which were 
then able to be separated by fractional sublimation followed by fractional crystallisation from 
1,2,4-trichlorobenzene. Overall, 3.6 mg of pure HBC was obtained from the initial 9.42 g of 
diol (a yield of ~ 0.4%) which, although poor, was stated to be competitive with Clar’s method 
due to the ease in formation of the precursors.  
 
Scheme 1.3: Synthesis of hexa-peri-hexabenzocoronene by Hendel, Khan and Schmidt.26 
1.1.4 Modern Synthesis of HBCs  
Modern synthetic methods towards HBC were primarily developed by the Müllen group from 
the 1990s.10, 20-21, 29 From the improvements made, two distinct stages are able to be 
distinguished: formation of an oligophenylene or hexaphenylbenzene precursor containing all 
the required aromatic rings, which is then followed by an intramolecular oxidative 
cyclodehydrogenation to fuse the rings together (Scheme 1.4).29 An important development 
made in the synthesis of the precursors was the ability to include peripheral functional groups 
which, most importantly, enabled the incorporation of solubilising groups to the periphery. 
Additionally, development of less harsh cyclodehydrogenative conditions than those used by 




Scheme 1.4: General overview of retrosynthetic pathways to HBCs primarily by the Müllen group.10, 20-21, 29 
1.1.5 Cyclodehydrogenation 
The intramolecular cyclodehydrogenation (commonly referred to as the Scholl reaction, 
graphitisation, planarization or dehydrogenative coupling) is an efficient reaction to form new 
aryl-aryl bonds in carbon rich polyphenylenes. In the case of hexaphenylbenzene, six new 
carbon-carbon bonds between neighbouring peripheral phenyl rings are formed with the loss 
of 12 hydrogen atoms, resulting in the planarization of the molecule to HBC (Scheme 1.5).  This 
effective reaction is mediated by a Lewis acid, often in combination with an oxidant, with 
typical combinations consisting of molten AlCl3/NaCl,25 AlCl3/CuCl2 or AlCl3/Cu(OTf)2 in CS2,29-
30





Scheme 1.5: Dehydrogenative coupling of hexaphenylbenzene or a tris(biphenyl)benzene to form hexa-peri-
hexabenzocoronene.29 
Dehydrogenative coupling reactions can proceed via an oxidative aromatic coupling (radical 
cation mechanism) or via the Scholl reaction (arenium cation mechanism, Scheme 1.6). In both 
mechanisms an aryl cation is formed, with the key bond forming step proceeding via different 
paths. In the case of the radical cation mechanism, new bond formation occurs when the 
formed radical is transferred from the initially oxidised ring to a neighbouring one. The cationic 
intermediate then eliminates H+ to reform a neutral ring, followed by oxidation of the radical 
to another cation then another H+ elimination. For the arenium cation mechanism, new bond 
formation occurs in a manner similar to electrophilic aromatic substitution, where the 
arenium cation is the electrophile. When using FeCl3, either of these mechanisms are possible, 
due to the ability of FeCl3 to be both an oxidant and a Lewis acid, although an oxidative 





Scheme 1.6: Proposed mechanisms for the first C-C bond formation in the oxidative aromatic coupling of 
hexaphenylbenzene 
Calculations by Rathore et al. and King et al. have extensively modelled both pathways.31, 33-36 
One notable observation was that the rate determining step is the formation of the new 
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carbon-carbon bond which where the aromaticity of the neighbouring ring is broken. 
Additionally, the bonds are formed in a stepwise manner, with the first being the slowest, 
resulting in the partially-fused intermediates proceeding through to the final product. This 
observation can be shown experimentally, where incomplete reactions typically contain the 
starting material and the fully-fused product without partially-fused intermediates.  
1.1.6 Synthesis of Hexaphenylbenzene Precursors 
The precursors utilised in a cyclodehydrogenation, a substituted HPB, can be formed via a few 
main pathways to give either a highly symmetrical or unsymmetrical HBCs, with the pathway 
used dependent on the geometry desired.  
The synthetic pathway to either a C6 or C3 symmetric HBC involves the cyclotrimerisation of a 
diaryl acetylene catalysed with a dinuclear cobalt complex (Scheme 1.7).29 If a C6 symmetric 
HBC is desired, a symmetric acetylene is utilised; alternatively, unsymmetrical acetylenes are 
able to be used in the same manner to give lower symmetry HPBs. In the latter case, two 
regioisomers (C3 and C1 symmetric) are produced which cannot be readily separated without 
appended polar groups. These acetylenes are produced by the Pd-catalysed Sonogashira 
cross-coupling, a coupling between an aryl halide and an arylacetylene.37 Statistically, the 
desired C3-symmetric HPB is produced in a maximum yield of 25% leading to alternate 




Scheme 1.7: The isomeric mixture of products produced by cobalt catalysed cyclotrimerisation. Each colour 
represents a differently substituted ring. 
An alternative route commonly used towards a C3 symmetric HBC begins with the acid 
catalysed cyclotrimerization of 2’-bromoacetophenone (Scheme 1.8). The resultant 
halogenated triphenylbenzene can be extended with aromatic rings through Pd catalysed 
cross-couplings to yield an tris(biphenyl)benzene.  
 
Scheme 1.8: Synthesis of an tris(biphenyl)benzene suitable for the formation of a C3 symmetric HBC. Each 
colour represents a differently substituted ring. 
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This framework can typically be fused together under cyclodehydrogenative conditions in the 
same manner as HPBs. One notable example where the reactivity of the HPB is different to 
the tris(biphenyl)benzene is outlined in a study by Wadumethrige and Rathore towards a 
hexaalkoxy HBC.38 In this case, the alkoxy HPB did not form the desired HBC, instead an 
indenofluorene moiety was afforded through formation of new carbon-carbon bonds para to 
the methoxy on the neighbouring ring instead of the desired meta positions (Scheme 1.9). To 
work around this, the tris(biphenyl)benzene analogue was synthesised which afforded the 
desired HBC upon subjection to cyclodehydrogenative conditions.  
 
Scheme 1.9: Synthesis of hexamethoxy HBC by Wadumethrige and Rathore.38 
For less symmetric HBCs, a method revolving around the Diels-Alder cycloaddition of a 
diarylacetylene and a tetraphenylcyclopentadienone is often utilised (Scheme 1.10). These 
reactants, when heated between 140 and 260 °C, form the central six-membered ring which, 
upon the extrusion of CO, becomes aromatic. This method allows for a large variety of 
substituents to be incorporated into the product, with up to four different substituents being 
able to be placed on one molecule in a controlled arrangement, without regioisomers being 
able to form. Many of these substituents are used for increasing solubility of the system, so 




Scheme 1.10: Synthesis of a HPB via Diels-Alder cycloaddition. Each colour represents a differently substituted 
ring. 
More recently, a method by Jux and co-workers was reported for the formation of HPBs with 
up to five differently substituted rings without regioisomers.39 This synthesis revolved around 
a series of regioselective halogenations followed by Pd-catalysed cross-couplings to build up 
the HPB one ring at a time from para-nitroaniline (Scheme 1.11). Although featuring a number 
of steps, the synthesis was proven to function on the decagram scale in an overall yield of 
40%. 
  
Scheme 1.11: Synthetic method by Jux and co-workers to a HPB containing five differently substituted rings.39 
Each colour represents a differently substituted ring. 
1.2 Non-planar PAHs 
Although PAHs are often thought of as planar fragments of graphene, distortions in the 
honeycomb framework can occur, resulting in a twisting of the structure out of plane. These 
distortions can arise in several ways, the most prominent being through steric repulsion 
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between peripheral substituents, or by inclusion of non-six-membered rings. Structural 
distortions can manifest in three different ways: helicenes, saddle-shaped PAHs and bowl-
shaped PAHs.   
Helicenes arise from ortho-fused (also known as cata-fused) polyphenylenes which curl upon 
themselves, resulting in steric congestion that is alleviated by a distortion out of plane. Despite 
the lack of a stereogenic centre, helicenes are chiral with helical chirality exhibited about an 
axis.40 A clockwise helix is designated P and an anticlockwise helix designated M (Figure 1.7). 
Current research in this class is focussed on synthesising larger helicenes as well as improving 
non-racemic syntheses of enantiopure helicenes.41-42  
 
Figure 1.7: X-ray crystal structures of P-[7]helicene (left) and its isomer M-[7]helicene (right).43-44 Hydrogens 
omitted for clarity. 
Saddle shaped PAHs can arise either through steric repulsion, such as that seen for the other 
possible HBC isomer, hexa-cata-hexabenzocoronene (Figure 1.8), or by inclusion of rings 
larger than six-members, such as a heptagon-containing PAH related to HBC reported by Luo 





     
Figure 1.8: X-ray crystal structure of hexa-cata-hexabenzocoronene (left),47 and a heptagon-containing PAH 
reported by Luo et al.45 Hydrogens and hexyl chains omitted for clarity. 
When five-membered rings are incorporated into a PAH, bowl-shaped PAHs can arise. 
1.2.1 Bowl-shaped PAHs 
Bowl-shaped PAHs (also referred to as open geodesic polyarenes, buckybowls or π-bowls)48-50 
have been known since the synthesis of corannulene by Barth and Lawton in 1966.51-52 The 
arduous 12 step synthesis begins with 3-methoxycarbonyl-4H-cyclopenta[def]phenanthrene 
(Scheme 1.12) and sequentially added additional non-aromatic six-membered rings around 
the periphery, which were then aromatised in the final step to give corannulene in an overall 
yield of 0.4%. Due to this low yield, little was able to be studied about this remarkable 
compound. However, a 1H NMR spectrum and crystal structure were obtained, proving 




Scheme 1.12: Transformations undertaken in the original synthesis of corannulene.51 
Despite the novelty of this structure, little more synthetic work was undertaken in this area 
until the discovery of buckminsterfullerene (C60).53 Due to its structural similarities with C60, 
corannulene was seen as a plausible precursor for the rational synthesis of fullerenes. From 
this point, it was a further 25 years before a synthetic method was developed that could 
produce corannulene in any appreciable quantity.54  
More recently, the synthesis of sumanene, also a carbon fragment of C60, was achieved by 
Sakurai et al.55 In contrast to corannulene, this hydrocarbon contains five-membered rings at 
18 
 
the periphery, leading to some edge carbons being sp3 hybridised. The increased number of 
five-membered rings in sumanene results in it being more curved than corannulene. Of note 
is the resemblance to triphenylene, an all-benzenoid PAH without the five-membered rings.  
 
Figure 1.9: Sumanene, a bowl-shaped PAH. 
As a result of the curvature, buckybowls have different attributes at the concave (endo) and 
convex (exo) faces (Figure 1.10). The exo face is electronically different to the endo face due 
to the orientation of the p-orbitals, with them angling away from each other on the exo side, 
leading to an electron-poor face, and the converse for the endo side. The anisotropy extends 
to the peripheral groups, with the benzylic positions in sumanene being non-equivalent. This 
regioselectivity was shown by deprotonating and reacting with chlorotrimethylsilane. The 
equatorial (exo) position was preferentially substituted three times to give 
tris(trimethylsilyl)sumanene.55  This preference was stated to be due to steric hindrance 
between axially substituted positions rendering this orientation unfavourable. 
 
Figure 1.10: Side-on view of sumanene depicting endo and exo faces. 
Due to the differences in electron density within the π-system, a change in the solid-state 
packing arises, where instead of the offset face-to-face stacking associated with planar-PAHs, 
the electron-rich face is attracted to the electron-poor face, giving a convex in concave 





Figure 1.11: X-ray crystal structure showing the solid state arrangement of unsubstituted sumanene.55 
1.2.2 Applications of Non-planar PAHs 
Many applications envisioned for curved-PAHs utilise their unique shape in combination with 
the properties of PAHs; for instance, in supramolecular chemistry they can be utilised as 
buckycatchers (Figure 1.12).56 This is where a curved PAH, via intermolecular interactions, 
coordinates to buckminsterfullerene in a 1:1 arrangement. In an example by Sygula et al. the 
electron-rich face of the corannulene moieties coordinate to the electron-poor outer face of 
C60 to such an extent that the two components crystallise together.57  This architecture can be 
extended further by the addition of a second buckycatcher (a 2:1 adduct) yielding a molecular 




Figure 1.12: Buckycatcher based on two corannulene units bound to C60. Reproduced with permission.56 
Another application that is pursued, particularly by the Scott group, is the formation of 
buckybowls that can be sequentially extended to form carbon nanotube (CNT) fragments 
(Figure 1.13).58 CNTs are heavily studied for their structural and electronic properties;59 
however, isolation of discrete CNTs from the mixtures produced is a current challenge in the 
field. Bottom-up synthesis from buckybowls could circumvent the troublesome separation of 
CNTs by providing control over the diameter of the CNT produced, where the diameter is 
determined by the size of the buckybowl.  
 
Figure 1.13: Schematic of the formation of CNTs. Reproduced with permission.58 
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Metal complexation of buckybowls is also of interest, due to the inequivalent faces, especially 
whether complexation occurs with the endo or exo side and the effect of complexation on the 
curvature. For transition metals, ferrocene and ruthenocene as sources of MCp have been 
reacted with sumanene to form η6-sandwich complexes, with the metal bound to a benzenoid 
ring on sumanene.60-62 Of note with these complexes is that the ruthenocene complex shows 
no facial preference, with bowl inversion able to occur, contrasting with the ferrocene 
complex which only formed the endo complex.  
1.2.3 Synthesis of Buckybowls 
As can be imagined, non-planar PAHs are much higher in energy than their planar 
counterparts. Due to this, there have been a limited number of methods published that induce 
curvature in the structure. The source of this curvature is generally from the incorporation of 
five-membered rings into the structure. Synthesis of these compounds is similar to planar-
PAHs, excluding the strain-inducing ring formation.  
Flash vacuum pyrolysis (FVP) is the methodology of choice for many, notably the Scott 
research group, initially utilised in the synthesis of corannulene (Scheme 1.13);63-64 however, 
it has since been applied to form a whole host of curved architectures.65 This technique 
involves heating gaseous reagents to high temperature (up to 1100 °C) under high vacuum for 
a brief amount of time. High temperatures provide sufficient energy to overcome the ring 
strain inherent in the product, whilst intermolecular reactions are minimised in the gas phase. 
Due to these requirements, this reaction is limited in its scope, with only small scales possible 
(up to a gram at a time) and very limited functional group tolerance due to the high 
temperatures. Despite this, FVP was almost exclusively utilised in the synthesis of corannulene 
until improved wet chemical methods were developed, which recently have been further 
developed to the kilogram-scale production of corannulene.66  
 
Scheme 1.13: Flash vacuum pyrolysis formation of corannulene.63-64 
Solution phase synthetic approaches to buckybowls utilise two approaches, either forming 
benzo-rings around a pre-formed five-membered ring (exemplified by corannulene), or the 
formation of the five-membered rings late in the synthesis (exemplified by sumanene). 
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Excluding the original Barth and Lawton method,51-52 the solution phase synthesis of 
corannulene utilises transition metal-mediated ring formation as developed by Siegel et al. 
(Scheme 1.14).67 This method employs a modified McMurry coupling to form the carbon-
carbon bonds before oxidisation yielding the desired corannulene core. The success of this 
reaction was attributed to the high energy organotitanium intermediate allowing for the 
strained product to be formed. 
 
Scheme 1.14: Synthesis of corannulene first published by Siegel et al.67 
Methodology was then improved by both the Siegel and Sygula groups independently,68-69 
where additional bromo functionality was appended (Scheme 1.15). After undergoing the 
McMurry coupling, the extra halo functionality is presumed to be rapidly eliminated as HBr to 
give the aromatic product, circumventing the oxidation step previously required and affording 
a higher overall yield. 
 
Scheme 1.15: Improved synthesis of corannulene, utilising transition metal catalysed ring formation.68-69 
The method by Sakurai et al. to sumanene followed the same holistic approach as the Siegel’s 
first synthesis of corannulene:67, 70 formation of the carbon framework before oxidative 
aromatisation. In a series of studies, a tandem ring-opening metathesis and ring closing 
metathesis was utilised with a Ru catalyst (Scheme 1.16). The ring closing metathesis only 
proceeds with the syn isomer, which was calculated to be highly exothermic, allowing for the 
strain in the compound to be overcome, whereas with the anti the reaction was calculated to 
be highly endothermic. The bridged product was then oxidised with DDQ to form the 




Scheme 1.16: Ring formation utilised by Sakurai et al.70 
1.3 Research Goals and Thesis Outline 
The ultimate goal of this research is to incorporate five-membered rings around the periphery 
of the benzenoid PAH hexa-peri-hexabenzocoronene in all six bay-sites, for the formation of a 
large, curved polycyclic aromatic hydrocarbon (Figure 1.14). Despite being a highly studied 
polycyclic aromatic hydrocarbon,10, 20, 71 reported synthetic methods functionalising the bay 
sites on the periphery of a HBC are few,72-77 with only one sulfur-containing five-membered 
ring reported.78 Therefore, methodology towards the sequential addition of five-membered 
rings onto HBC must be developed. Two approaches are proposed to accomplish this goal: 
five-membered rings either being formed before generation of the HBC core (pre-
cyclodehydrogenation) or formation of five-membered rings at the periphery of an HBC (post-
cyclodehydrogenation).  
 
Figure 1.14: Hexa-peri-hexabenzocoronene (top left); proposed hexa-bridged HBC with added annulative 
functionality highlighted in red (top right); molecular model of HBC (bottom left); molecular model of hexa-
bridged HBC (bottom right). 
1.3.1 Pre-cyclodehydrogenation Bridging 
Previous work by Larsen,79 Hoggard80-81 and the author82 established a valid synthetic pathway 
to a mono-bridged HBC, beginning with the bridge pre-formed as a 4-functionalised fluorene 
(Scheme 1.17). Extension of previous research to elaborate the unusual activity observed in 
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the formation of mono-bridged HBC is explored in Chapter 2. Utilisation of this methodology 
towards more highly bridged examples is examined in Chapter 3.  
 
Scheme 1.17: Incorporation of a fluorenyl group into an HBC. 
1.3.2 Post-cyclodehydrogenation Bridging 
Following difficulties encountered during cyclodehydrogenation in Chapter 3, incorporation 
of bridging substituents post-cyclodehydrogenation was also investigated. This would proceed 
from a bay substituted HBC, of which few examples are known. These could then be 
functionalised such that ring formation by an intramolecular Friedel-Crafts could be examined 
(Scheme 1.18). Development of bay substituted HBCs, functionalisation of these peripheral 
groups and proof-of-concept bridging post-cyclodehydrogenation are explored in Chapter 4. 
Extension of this work with alternate bridging groups is examined in Chapter 5. 
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This chapter describes the extension of research undertaken by Larsen,1 Hoggard2-3 and the 
author4 previously on synthesising cyclopenta-incorporated hexa-peri-hexabenzocoronene. 
Improvements made in the synthesis of key precursors, exploration of conditions facilitating 
the unexpected chlorination previously observed1-3 during cyclodehydrogenation, and 
utilisation of this functionality will be discussed. 
Results in this chapter have been published: 
Thomas B. J. Hall, Bryce R. Hoggard, Christopher B. Larsen and Nigel T. Lucas, Chem. Asian J. 
2019, 14, 1106-1110 
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2.1 Previous Research  
Previous attempts at synthesising cyclopenta-HBC revolved around the pre-
cyclodehydrogenative incorporation of the methylene bridge within the fluorene moiety 
(Scheme 2.1). This fluorenyl moiety (2-1) could be coupled to the remaining oligophenylene 
framework by the well-established method, developed by the Müllen group, utilising a Diels-
Alder reaction with a tetraaryl cyclopentadienone 2-2, followed by a rearrangement with 
extrusion of carbon monoxide, to form the central benzene ring of 2-3.5-7 Annulative 
planarisation via oxidative cyclodehydrogenation would then allow for the formation of the 
desired HBC 2-4.  
 
Scheme 2.1: Key starting materials and reactions to an annulated HBC. The fluorene moiety represented in 
blue. 
Two key steps of contention for this proposed pathway were the formation of the fluorene 
starting material, and whether this moiety could survive the cyclodehydrogenative conditions 
required. Although fluorenes are widely synthesised for applications such as conjugated 
polymers,8-9 substitution is most frequently at the 2 and 7 positions which are readily utilised 
in electrophilic aromatic substitution reactions (Figure 2.1). At the time of Larsen’s initial 
study, only one method had been reported by Kajigaeshi et al. to yield a 4-bromofluorene, an 
essential requirement for the addition of an alkyne to the system.10-11 Thus, initial work 





Figure 2.1: Numbering scheme for 9H-fluorene. 
The methodology by Kajigaeshi et al. consisted of blocking the more reactive 2 and 7 positions 
with bulky tert-butyl groups via Friedel-Crafts alkylation, allowing subsequent electrophilic 
aromatic bromination to occur at the accessible 4/5 position (Scheme 2.2). The tert-butyl 
groups could then be removed via a retro Friedel-Crafts alkylation giving the desired 
bromofluorene 2-8. Larsen, when following this procedure, discovered problems whilst 
attempting the retro Friedel-Crafts step, with formation of 2-8 being unreliable; conditions 
forcing enough to remove tert-butyl groups were found to also remove the desired bromo 
functionality in the majority of attempts tried. In more recent studies, the author has found 
using identical conditions and starting materials, that the product was obtained in ca 20 % of 
attempts. As this reaction is unreliable, the method was abandoned for further studies; 
however, a small amount was able to be synthesised for further test reactions. 
 
Scheme 2.2: Synthesis of ethynylfluorene 2-1 by Larsen.1 
An alternative method was developed by Hoggard to circumvent this unreliable step (Scheme 
2.3).3 Instead of starting with fluorene, synthesis began with the formation of a biphenyl from 
which halogen functionality could be incorporated early on. After halogen incorporation, the 
formation of fluorenone 2-14 could occur which later could be reduced to give fluorene. 
Triflate groups with halogen-like reactivity were used, to allow for selective cross-coupling in 
the first step. An issue with this procedure was due to the moderate heat tolerance of triflate 
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under basic conditions, resulting in oxidation being pursued at lower temperatures than 
typically used, otherwise de-triflation would occur. This resulted in a lower yielding reaction 
that varied in the yields obtained each time. However, despite this flaw, the method provided 
a route to 4-ethynylfluorenone 2-16, with the other steps proceeding in high yields. 
 
Scheme 2.3: Synthesis by Hoggard towards ethynylfluorenone.3 
Alkyne 2-16 was then subjected to a Diels-Alder cycloaddition with cyclopentadienone 2-2 
followed by extrusion of CO to give the fluorenoyl-substituted benzene 2-17 in high yields 
(Scheme 2.4). The ketone functionality was then reduced via hydrogenation (1 atm) with 





Scheme 2.4: Diels-Alder reactions used by Larsen and Hoggard.  
In work by Larsen, fluorene 2-3 was used in an oxidative cyclodehydrogenation with FeCl3 
towards the monobridged system 2-4.1 However, instead of a purely intramolecular oxidative 
cyclodehydrogenation occurring, intermolecular bonds were also formed. Dimerisation was 
determined to occur, with the methylene bridge thought to be a contributing factor. In an 
attempt to prevent potential reactions at the methylene site, two methyl groups were 
appended to the methylene bridge to sterically block intermolecular bond formation. When 
the dimethylated 2-18 underwent oxidative cyclodehydrogenation, a regioselective 
dichlorination occurred at what were the 2 and 7 positions of fluorene, along with the desired 
C-C bonds formed to afford 2-19 in high yield with no signs of any other products. This reaction 
was not repeated or investigated further, due to material and time constraints. A 
monomethylated version was later investigated by Hoggard, but did not give a dichlorinated 
product. Instead, a mixture of the desired non-chlorinated 2-21 and monochlorinated 2-22 
was obtained, which could not be separated. A reinvestigation of Larsen’s system during the 
authors Honours project found that on a test scale, chlorination was correlated with the 
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concentration of FeCl3 present in the reaction. However due to time and material constraints, 
this also could not be studied extensively. 
 
Scheme 2.5: Previously studied systems and the products obtained upon cyclodehydrogenation. 
Continuation of this previous body of work had two main goals: to find a reliable synthesis to 
the essential building block, a 4-bromofluorene or -fluorenone which would then allow for the 
second goal of studying the observed chlorination during cyclodehydrogenation, control of 




2.2 Synthesis of Key Precursors 
Previously explored methods to 4-bromofluorene or fluorenone left much to be desired, in 
either reliability or in number of steps and overall yield. A promising method by Thiery et al. 
reported in 2015 was found to have potential but required optimisation (Scheme 2.6).12 This 
method involves coupling two substituted phenyls together via a Suzuki-Miyaura 
cross-coupling followed by formation of fluorenone 2-25 by an intramolecular Friedel-Crafts 
acylation with the ester group. Cross-coupling proved repeatable using the conditions 
reported in good yields. 
 
Scheme 2.6: Synthesis of 4-bromofluorenone by Thiery et al.12 
Repetition of the reported conditions12 for the intramolecular Friedel-Crafts proved 
troublesome, with only the starting material obtained after work up. Increasing reaction times 
from 2 h to 18 h was found to give the desired 2-25 in good yields with complete consumption 
of all of the starting material. Changing of the acid was found to result in no reaction, and an 
increase in temperature above 100 °C was found to give no appreciable increase in yield. 
Optimal conditions in our hands were found by varying the concentration, with the highest 
yield occurring at 0.4 mol L-1 (Table 2.1, volume of acid 8 mL); however, the quantitative yields 
reported could not be attained. Another problem was the formation of an equivalent amount 
of ethyl methanesulfonate as a by-product that was unable to be separated by column 
chromatography. A base wash of the organic mixture with aq. NaOH during separation 
followed by trituration of the residue with hot ethanol was found to remove this impurity, an 
improvement over the literature procedure. 
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Table 2.1: Concentration studies on the formation of 2-25 from 2-24. 
Amount of 2-24 (mmol) 
Volume of conc. 
MeSO3H (mL) 
Time (h) Temp (°C) Yield (%) 
3.33 10 2 100 99a 
3.2 2 18 100 <25 
3.2 4 18 100 28 
3.2 6 18 100 36 
3.2 8 18 100 62 
3.2 10 18 100 56 
a Literature conditions by Thiery et al.12 
Synthesis then proceeded as outlined by Hoggard, with bromo instead of triflate functionality, 
giving similar yields. Improvements in the synthesis of cyclopentadienone 2-2 were also 
achieved, particularly in the synthesis of the benzil precursor (Scheme 2.7). A commonly used 
methodology begins with the formation of a diaryl acetylene 2-26 followed by oxidation of the 
alkyne to the benzil 2-27 in good yields.13 A proposed pathway revolved around a benzoin 
condensation of two equivalents of benzaldehyde yielding benzoin 2-28. This could then be 
readily oxidised to the benzil in good yields. A method utilising this pathway was found by 
Karlsson et al. which was able to be reproduced and scaled up to a multi-gram synthesis.14 The 
advantage of this method over the established alkyne oxidation is a significant decrease in 
cost of precursors (alkynes are generally expensive) and the time required to purify the 
compounds, with column chromatography no longer essential; a recrystallization after the 
completion of the second step yields analytically pure benzil 2-27.  
 
Scheme 2.7: Previous (left) and current method (right) for the formation of benzil 2-28. 
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2.3 Cyclodehydrogenation Studies 
2.3.1 Fluorenoyl Precursor 
To probe the chlorination observed to be occurring, a number of fluorenyl/fluorenoyl-
tetraphenylbenzenes were subjected to cyclodehydrogenative conditions. Electron-poor 
fluorenone 2-18 was first tested, despite conventional knowledge that aromatics with 
electron-withdrawing substituents do not readily undergo fusion, in the hope that the 
carbonyl-containing 2-29 could be synthesised (Scheme 2.8).  
 
Scheme 2.8: Attempted synthesis of 2-29 by the cyclodehydrogenation of 2-18. 
After work up, the starting material was observed by 1H NMR, along with an additional product 
with 18 aromatic signals, many more than the 6 aromatic environments expected for the 
desired symmetrical HBC. An increase in the number of equivalents of FeCl3 from 24 to 72 was 
found to result in complete consumption of the starting material, but also introduced an 
additional trace product which was able to be separated via preparatory TLC. The MALDI-TOF 
MS spectrum of the separated major product (Figure 2.2) contained a single signal consistent 
with the formation of three aryl-aryl bonds and a trace product consistent with four new 




Figure 2.2: MALDI-TOF MS spectra of 2-30 (top) and trace product (bottom, only one possible structure shown).  
Further analysis of the NMR spectra suggested that the fluorenoyl moiety remained at least 
partially unfused, with apparent triplets present in the 1H NMR which were most likely to arise 
from the electron poor fluorenone portion of the precursor (Figure 2.3). Additionally, seven 
deshielded aromatic singlets between 8.8 and 9.3 ppm were present, which suggest the fusion 




Figure 2.3: Aromatic region in the 1H NMR spectrum of 2-30.  
Extension of the reaction time or a further increase in the number of equivalents of FeCl3 did 
not result in additional bonds forming, presumably due to the electron withdrawing effects of 
the carbonyl group deactivating neighbouring rings to further bond formation. Test-scale 
reactions to modify the carbonyl group, and therefore the electronics of the ring, as a cyclic 
ketal or thioketal by the condensation of 2-30 with either 1,3-propandiol or 1,3-propandithiol 
were then attempted. Despite the formation of the desired cyclic protecting groups, 
subjection to cyclodehydrogenative conditions proved unfruitful, with complete cleavage of 
the protecting groups occurring under the required acidic and oxidative conditions, giving back 
2-30 in both cases. 
2.3.2 Fluorenyl Precursor Cyclodehydrogenation 
Replication of the observed cyclodehydrogenation conditions for the unsubstituted bridged 
HBC 2-4 was then attempted. An initial attempt by Larsen resulted in an insoluble solid which 
was found to be a mixture of products by MALDI-TOF MS, consistent with the desired 
compound and some dimeric products (Figure 2.4). These observations were repeated, 
through further treatment of this mixture with FeCl3 resulting in an increase of dimeric 
products with a corresponding decrease in the desired HBC. As the longer treatments resulted 
in more dimeric products, shorter treatments were attempted to try and obtain pure parent 
2-4, resulting in a reduction of dimeric products produced but without elimination, as well as 
incomplete reaction. An increase from 24 eq. to 36 eq. as well as a decrease in reaction time 
from 1 h to 30 min was found to yield the complete conversion of starting material and 
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minimisation of dimeric and chlorinated products, with only trace amounts present by MALDI-
TOF.  
 
Figure 2.4: MALDI-TOF MS spectra of 2-4. 
Additionally, weak 1H and 13C NMR spectra were able to be obtained for the poorly soluble 
compound in a 50:50 mixture of CDCl3 and CS2, further confirming the formation of the desired 




Figure 2.5: 1H NMR (top) and 13C NMR (bottom) spectra of 2-4. 
A reinvestigation of the chlorination of the monomethyl HBC was also undertaken. In this 
study, chlorination was found to correspond with the concentration of FeCl3 in solution for 
the dimethyl example. Using these conditions on the methyl compound, which previously 
gave a mixture of chlorinated and unchlorinated products, it was found to also exhibit 
concentration dependence, with either the mixture or the dichlorinated product able to be 
obtained. To examine if chlorination would occur without the methylene bridge present, a 




Scheme 2.9: Synthesis and cyclodehydrogenation of biphenyl 2-34. 
Synthesis of this compound was straightforward, using an adapted method of those previously 
mentioned. Upon treatment of 2-34 with higher concentrations of FeCl3, no chlorinated 
products were observed; however, the poorly soluble compound obtained was black instead 
of the expected characteristic yellow of HBCs. Examination of the 1H NMR spectrum revealed 
all the expected signals for a single product, with the MALDI-TOF MS spectrum consistent with 
the HBC being formed with no chlorination. Utilising concentrations that provided minimal 
chlorination in the fluorenyl examples, a yellow powder was obtained with spectra consistent 
with the previous sample. Presumably the darkened colour of the high concentration test was 




Figure 2.6: MALDI-TOF MS spectra of 2-34 (top) and 2-35 (bottom). Loss of a CH3 group observed is due to the 
higher laser power required for HPBs. 
From these tests it can be said that the degree of chlorination is influenced by the presence 
of the methylene bridge. Rationalisation of this chlorination could be the electron donating 
effect of the methylene group, activating the ring for electrophilic aromatic substitutions 
combined with the lack of steric hindrance of other substituted HBC; the unsubstituted sites 
meta to the methylene bridge are able to be accessed whereas typical HBC examples only 
contain sterically hindered ortho sites that are unsubstituted (Figure 2.7).  
 
Figure 2.7: Space-filling molecular model of sterically hindered and unhindered sites in a typical HBC and those 
investigated in this work. 
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A summary scheme of the chlorination results is provided (Scheme 2.10). 
 
Scheme 2.10: Summary of previous and current results on cyclodehydrogenation. 
As chlorination could not be entirely prevented, methods to remove this unwanted 
functionality were investigated. In an earlier study,4 the author has shown that lithiation of 
the chloro groups is achieved with tert-butyllithium, followed by quenching with water to 
result in the overall replacement of chloro functionality with a proton. This method, although 
useful, could not be applied to any system other than the dimethyl analogue tested, due to 
the presence of acidic benzylic protons on the bridge; thus, another method would be 
required to obtain pure 2-21. A method by Imamoto et al.15 utilising CeCl3 and LiAlH4 was 
attempted and found to give unchlorinated 2-21 in good yields (Scheme 2.11).  This method 
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was found to also work on all chlorinated HBCs discussed, thus providing a complete solution 
and allows access to all dichlorinated or non-chlorinated products. 
 
Scheme 2.11: Previous method to remove chlorination (top) and current method (bottom). 
To probe the reactivity of 2-37, electrophilic aromatic substitution with elemental bromine 
was investigated. Upon addition of 2 equivalents of bromine at room temperature, a mixture 
of brominated HBCs were obtained within 10 min, including a tribrominated adduct, 
suggesting high susceptibility to electrophilic aromatic substitution, even without catalysts 
added. Cooling the reaction to -20 °C was found to selectively produce the dibrominated 2-
39, even under large excesses of bromine (Scheme 2.12). The comparable reaction of 9,9-
dimethylfluorene resulted in the formation of a mixture of products, which analysis by MALDI-
TOF MS revealed as a mixture of mono- and dibromo-9,9-dimethylfluorene (Figure 2.8). This 
suggests that HBC 2-37 is more reactive to electrophilic aromatic substitutions than the parent 




Scheme 2.12: Bromination and phenylene extension of 2-37.  
 
Figure 2.8: MALDI-TOF spectrum of the product mixture from the bromination of 9,9-dimethylfluorene. 
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The bromo-HBC 2-39 was then subjected to cross-coupling conditions, to see if extension of 
the aromatic core could be achieved after cyclodehydrogenation (Scheme 2.12). Coupling of 
2-39 with 4-tert-butylphenyboronic acid in a Suzuki cross-coupling was successful, albeit in 
low yields, to give a mixture of 2-37 and 2-40 that were able to be separated 
chromatographically. The low yields were ascribed to the sterically demanding positions.  
The phenylene-extended 2-40 was then subjected to cyclodehydrogenative conditions, 
however, the majority of the starting material was recovered. The MALDI spectrum showed 
trace amounts of product with one bond formed, thus the crude mixture was retreated for a 
longer period of time, but with no noticeable change observed upon work up. Treatment with 
a large excess was then attempted; however, complete decomposition of the starting material 
was observed, with no identifiable products appearing in the 1H NMR spectra. 
After this work had been completed, two related papers were published. Ramakrishna et al. 
working on another fluorene-based PAH found that under oxidative cyclodehydrogenative 
conditions with FeCl3, regioselective chlorination was observed (Scheme 2.13).16 This work 
reinforces the supposition that chlorination occurs due to the effects of the fluorenyl moiety 
on the system. Chlorination was prevented by modification of the oxidant and acid, with a 
mixture of DDQ and MeSO3H in DCM providing their desired parent compound in good yields. 
Hu et al. reported the synthesis of a similar spiro-fused bis HBC (Scheme 2.13).17 Chlorination 
was not mentioned as a side-reaction, however a mixture of DDQ and TfOH in DCM was used 




Scheme 2.13: Recently published work by Ramakrishna et al.16 and Hu et al.17  
2.4 Conclusions 
Extension and refinement of research previously undertaken by Larsen, Hoggard and the 
author on synthesising cyclopenta-incorporated hexa-peri-hexabenzocoronene was achieved. 
Improvements were made in the synthesis of key precursors, especially the formation of 4-
bromofluorenone. These improvements allowed for an investigation into the conditions 
influencing chlorination during cyclodehydrogenation. Reproducible conditions were found 
and manipulated to yield clean dichlorinated cyclopenta-HBCs. Efficient removal of this 




2.5 Experimental Section 
2.5.1 General Experimental 
Synthesis 
All reagents and solvents were purchased commercially and were used as received unless 
otherwise stated. Dry solvents were obtained using a Pure-Solv MD-6 solvent purification 
system. If an inert atmosphere is stated, then the reaction was carried out under an argon 
atmosphere and anhydrous conditions using Schlenk techniques. If no conditions are stated 
then reactions were carried out without any precaution against exposure to air or moisture. 
Solvents removed in vacuo were removed by rotary evaporation.  
New and Previously Reported Compounds 
All compounds are new unless referenced. If the experimental data of a compound is 
referenced, then the synthetic method utilised is new, and the data of the newly synthesised 
compound agreed with the literature. 
Characterisation  
1H and 13C NMR spectra were measured on a Varian 400MR or 500AR spectrometer in 5 mm 
diameter NMR tubes at 298 K. The 1H chemical shifts were referenced to the residual 
non-perdeuterated solvent protons (7.26 ppm for CDCl3); for 13C solvent signals were 
referenced (77.16 ppm for CDCl3). The signals for all new compounds were assigned with the 
assistance of 2D spectroscopic techniques (COSY, NOESY, ROESY, 1H-13C HSQC, 1H-13C HMBC) 
using standard pulse sequences. CDCl3/CS2 mixtures were used, as required, to assist with 
solubility. CS2 is observed at ca. 192.8 ppm in 13C NMR spectra, and contains a small benzene 
impurity observed at 7.36 ppm in the 1H NMR spectra.  
High resolution electrospray ionisation time-of-flight mass spectrometry (HR ESI-TOF MS) 
spectra were measured on a Bruker micrOTOF-Q mass spectrometer by Ian Stewart or Jenny 
Pentelow in the Department of Chemistry, University of Otago. Matrix assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) spectra were 
measured on an Applied Biosystems 4800 Tandem TOF mass spectrometer with external 
calibration to m/z ± 0.08 by the author or Assoc. Prof. Nigel Lucas in the Department of 
Chemistry, University of Otago. The solid analyte and TCNQ matrix were blended using a mini 
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mixermill, suspended in petroleum and transferred to the sample plate. GC-EI-MS analyses 
were performed on an Agilent 7890A gas chromatograph with a CTC AnalyticsPAL system 
autosampler and an Agilent 5975C inert XL MSD with triple axis detector (under the control of 
Enhanced ChemStation software). Injections were made onto a 30 m Agilent HP5-ms column 
with a carrier gas flow of 1.5 mL/min. Detection was by FID at 300 °C and mass spectrometry 
over the mass range 35-350. All MS values are stated as m/z ratio (relative intensity).  
Elemental analysis of compounds were determined at the Campbell Microanalytical 
Laboratory, University of Otago, Dunedin, using a Carlo Erba 1108 CHNS combustion analyser 
with the estimated error being ± 0.3%. 
X-ray crystallography data collection, data processing and structure solving were performed 
by Assoc. Prof. Nigel Lucas in the Department of Chemistry, University of Otago. Data were 
collected on an Agilent SuperNova with Atlas CCD using mirror monochromated microfocus 
Cu Κα radiation (λ = 1.54184 Å) or a Bruker Kappa X8 APEXII diffractometer using graphite 
monochromated Mo Κα radiation (λ = 0.71073 Å). Data processing was undertaken within 
CrysAlisPro,18 including a numerical absorption correction over a face-indexed model and 
multiscan empirical correction, or within Bruker SAINT19 including a multiscan empirical 
correction. The structures were solved by direct methods with SHELXT2014 or SHELXS201420-
21 and extended and refined against all F2 data with SHELXL201420 using the X-Seed22 interface. 
The non-hydrogen atoms in the asymmetric unit were modelled with anisotropic 
displacement parameters. Hydrogen atoms were placed in calculated positions and refined 
using a riding model with fixed C-H distances (sp2 CH 0.95 Å, sp3 CH3 0.98 Å, sp3 CH 1.00 Å) and 
isotropic displacement parameters estimated as Uiso(H) = 1.2Ueq(C), except for CH3, where 
Uiso(H) = 1.5Ueq(C). 
2-Ethoxycarbonylbromobiphenyl 2-24,12 di-(tert-butylphenyl)acetylene 2-26,4 bis(4-tert- 
butylphenyl)ethane-1,2-dione 2-274, 14 and tetrakis(4-tert-butylphenyl)cyclopentadienone 
2-214 were synthesised as reported without significant modification. 
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2.5.2 4-Bromo-9H-fluorenone (2-25) 
 
Ester 2-24 (1.00 g, 3.28 mmol) was dissolved in methanesulfonic acid (8 mL) and heated at 
100 °C for 14 h. The hot reaction mixture was poured into ice-cold water and extracted with 
DCM, washed with aq. NaOH (2 M), water, then dried over MgSO4 and the solvent removed 
in vacuo. The yellow solid was recrystallised from EtOH to give 2-25 as yellow powder (0.52 g, 
2.01 mmol, 61%).  
1H NMR (400 MHz, CDCl3):12 δ 8.36 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 7.5 Hz, 1H), 7.63 (t, J = 7.0 
Hz, 2H), 7.56 (t, J = 8.0 Hz, 1H), 7.36 (t, J = 7.5 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H) ppm. 
2.5.3 4-[(Triisopropylsilyl)ethynyl]-9H-fluorenone (2-15) 
 
A solution of 2-25 (1.59 g, 6.14 mmol) in triethylamine (30 mL) was bubbled with argon for 
15 min. Dichlorobis(triphenylphosphine)palladium(II) (130 mg, 0.185 mmol), CuI (35 mg, 0.185 
mmol) and (triisopropylsilyl)acetylene (1.66 mL, 1.35 g, 7.42 mmol) were added and the 
mixture stirred under an argon atmosphere at 55 °C for 24 h. The solution was cooled and the 
solvent removed in vacuo to give crude 2-15 which was purified via preparative column 
chromatography (SiO2, 50:50 DCM/PE) to yield 2-15 as a yellow solid (2.14 g, 5.94 mmol, 97%).  
1H NMR (400 MHz, CDCl3): δ 8.43 (dt, J = 7.6, 0.7 Hz, 1H, H5), 7.68 (ddd, J = 7.4, 1.1, 0.7 Hz, 1H, 
H8), 7.62 (dd, J = 7.3, 1.1 Hz, 1H, H1), 7.56 (dd, J = 7.9, 1.1 Hz, 1H, H3), 7.48 (td, J = 7.5, 1.2 Hz, 




13C NMR (100 MHz, CDCl3): δ 193.17 (C9), 144.37 (C4b), 144.20 (C4a), 139.46 (C3), 134.76 (C6), 
134.53 (C9a), 134.16 (C8a), 129.43 (C7), 128.68 (C2), 124.31 (C8), 124.17 (C1), 123.33 (C5), 117.65 
(C4), 104.40 (C10), 97.78 (C11), 18.85 (CH(CH3)2), 11.52 (CH(CH3)2) ppm.  
ESI-MS: m/z 383.18; calcd for C24H28OSiNa, [M+Na]+ 383.18.  
Anal. calcd for C24H28OSi: C 79.95; H 7.83. Found: C 79.97; H 7.95. 
2.5.4 4-Ethynyl-9H-fluorenone (2-16) 
 
Tetra(n-butyl)ammonium fluoride (1 M in THF, 4.28 mL, 4.28 mmol) was added dropwise to a 
solution of 2-15 (1.03 g, 2.86 mmol) in DCM (20 mL) and the resultant solution was stirred at 
RT for 2 h. The yellow organic mixture was washed with brine, water, then dried over MgSO4 
and the solvent removed in vacuo. The residue was purified via column chromatography (SiO2, 
50:50 DCM/PE) to give a yellow oil that was recrystallised from EtOH to yield 2-16 as yellow 
crystals (0.580 g, 2.84 mmol, 99%).  
1H NMR (500 MHz, CDCl3): δ 8.28 (dt, J = 7.6, 0.8 Hz, 1H, H5), 7.68 (ddd, J = 7.3, 1.2, 0.7 Hz, 1H, 
H8), 7.65 (dd, J = 7.3, 1.1 Hz, 1H, H1), 7.55 (dd, J = 7.8, 1.1 Hz, 1H, H3), 7.51 (td, J = 7.6, 1.3 Hz, 
1H, H6), 7.33 (td, J = 7.4, 0.9 Hz, 1H, H7), 7.25 (dd, J = 7.8, 7.4 Hz, 1H, H2), 3.49 (s, 1H, H11) ppm.  
13C NMR (125 MHz, CDCl3): δ 192.93 (C9), 144.81 (C4a), 143.99 (C4b), 139.18 (C3), 134.98 (C6), 
134.58 (C9a), 134.11 (C8a), 129.61 (C7), 128.76 (C2), 124.60 (C1), 124.33 (C8), 123.20 (C5), 116.27 
(C4), 83.02 (C11), 81.31 (C10) ppm.  
GC-EI-MS: m/z 204 (100, [M]+), 176 (95, [M-CO]+).  




2.5.5 1-(4-9H-Fluorenoyl)-2,3,4,5-tetra(4-tert-butylphenyl)benzene (2-17) 
 
A solution of 2-16 (0.190 g, 0.930 mmol) and 2-2 (0.736 g, 1.21 mmol) in o-xylene (15 mL) was 
heated at reflux under an argon atmosphere for 22 h. The solution was allowed to cool and 
the solvent remove in vacuo. The product was purified via column chromatography (SiO2, 
50:50 DCM/PE) to yield 2-17 as a pale yellow powder (0.694 g, 0.884 mmol, 95%).  
1H NMR (500 MHz, CDCl3): δ 7.62 (d, J = 7.3 Hz, 1H, H8’), 7.53 (s, 1H, H6), 7.48 (d, J = 7.2 Hz, 1H, 
H1’), 7.32 (t, J = 7.6 Hz, 1H, H6’), 7.22 (t, J = 7.4 Hz, 1H, H7’), 7.18-7.11 (m, 3H, Ar), 7.08-7.03 (m, 
3H, Ar), 6.99 (d, J = 7.5 Hz, 1H, Ar), 6.95 (d, J = 8.1 Hz, 2H, Ar), 6.87-6.57 (m, 10H, Ar), 1.24 (s, 
9H, C(CH3)3), 1.18 (s, 9H, C(CH3)3), 1.11 (s, 9H, C(CH3)3), 1.07 (s, 9H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 194.26 (C9’), 149.11, 148.47, 148.43, 147.99, 145.17, 142.96, 
141.92, 140.86, 140.65, 139.96, 138.69, 138.08, 137.70, 137.54, 137.31, 137.11, 136.40, 
134.67, 134.63 (C6’), 134.28, 131.37, 131.14, 130.73 (broad), 130.25 (C6), 129.65, 128.58 (C7’), 
128.07 (C2’), 124.47, 124.08 (C8’), 123.69, 123.0, 123.32 (C5’), 123.29, 122.68 (C1’), 34.46 
(C(CH3)3), 34.34 (C(CH3)3), 34.25 (C(CH3)3), 34.22 (C(CH3)3), 31.42 (C(CH3)3), 31.39 (C(CH3)3), 
31.33 (C(CH3)3), 31.24 (C(CH3)3) ppm.  
ESI-MS: m/z 807.45; calcd for C59H60Ona, [M+Na]+ 807.45.  
Anal. calcd for C59H60O: C 90.26; H 7.70. Found C 90.36; H 7.63. 
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2.5.6 3,6,9,12-Tetra(tert-butyl)-15-(4-9H-fluorenoyl)tribenzo[fg,ij,rst]pentaphene  
(2-30) 
 
A solution of 2-17 (19 mg, 24 μmol) in DCM (10 mL) was bubbled with N2 for 10 min, then FeCl3 
(0.283 g, 1.74 mmol) in nitromethane (1 mL) added dropwise. The resultant dark red solution 
was stirred for 30 min with continuous N2 bubbling. The reaction was quenched with MeOH 
(10 mL), diluted with DCM and washed with water. The organic layer was dried over MgSO4 
and the solvent removed in vacuo. The yellow residue was purified via column 
chromatography (SiO2, 50:50 DCM/PE) to yield 2-30 as a yellow film (13 mg, 17 μmol, 74%).  
1H NMR (500 MHz, CDCl3): δ 9.21-9.19 (m, 2H, H7,8), 9.10 (d, J = 1.3 Hz, 1H, H5), 9.04 (d, J = 1.1 
Hz, 1H, H10), 9.03 (s, 1H, H16), 8.90 (d, J = 1.6 Hz, 1H, H4), 8.81 (d, J = 1.8 Hz, 1H, H11), 8.70 (d, J 
= 8.9 Hz, 1H, H1), 8.18 (d, J = 8.9 Hz, 1H, H14), 7.88 (dd, J = 6.9, 1.6 Hz, 1H, H1’), 7.76 (dd, J = 8.6, 
1.8 Hz, 1H, H2), 7.68 (d, J = 7.3 Hz, 1H, H8’), 7.49-7.43 (m, 2H, H2’,3’), 7.29 (dd, J = 8.9, 2.0 Hz, 
1H, H13), 7.08 (td, J = 7.5, 0.6 Hz, 1H, H7’), 6.81 (td, J = 7.6, 1.1 Hz, 1H, H6’), 6.52 (d, J = 7.8 Hz, 
1H, H5’), 1.77 (s, 9H, C(CH3)3), 1.76 (s, 9H, C(CH3)3), 1.57 (s, 9H, C(CH3)3), 1.46 (s, 9H, C(CH3)3) 
ppm. 
13C NMR (125 MHz, CDCl3): δ 194.26 (C9’), 150.64 (C3), 149.80 (C12), 149.36 (C6/9), 149.32 (C6/9), 
144.79 (C4b’), 142.08 (C4’), 141.42 (C4a’), 137.49 (C3’), 135.60 (C9a’), 134.90 (C6’), 134.67 (C8a’), 
134.03 (C15), 131.19 (C10b), 130.56 (C10a), 130.43 (C7a/7b), 130.32 (C7a/7b), 130.22 (C4a/4b), 130.21 
(C4a/4b), 129.65 (C2’), 128.78 (C14), 128.75 (C7’), 128.18 (C14a), 127.82 (C16b), 126.78 (C16a), 125.97 
(C14b), 125.83 (C2), 125.39 (C14b1), 124.83 (C16), 124.51 (C13), 124.23 (C8’), 123.97 (C1), 123.42 
(C1’), 123.31 (C7b1), 123.20 (C5’), 123.17 (C16b1), 122.81 (C4b1), 119.63 (C11), 119.45 (C4), 119.20 
(C8), 118.92 (C7), 118.72 (C5), 118.54 (C10), 35.83 (C(CH3)3), 35.77 (C(CH3)3), 35.33 (C(CH3)3), 
35.10 (C(CH3)3), 32.09 (C(CH3)3), 32.05 (C(CH3)3), 31.61 (C(CH3)3), 31.45 (C(CH3)3) ppm.  
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MALDI-TOF MS: m/z 778.39; calcd for C59H54O, [M]+ 778.42. 
2.5.7 1-(9H-Fluoren-4-yl)-2,3,4,5-tetra(4-tert-butylphenyl)benzene (2-3) 
 
Aq. HCl (2 M) was added dropwise to a solution of 2-17 (0.212 g, 0.270 mmol) in THF (20 mL) 
until the solution became cloudy. Palladium on charcoal (10 %, 0.100 g) was added, and the 
flask evacuated and backfilled with H2 from a balloon (x3). The mixture was heated at 55 °C 
for 4 h, then cooled, residual H2 removed by vacuum evacuation, and the mixture filtered 
through Celite. The filtrate was extracted with DCM, and the organic phase washed with 
water, dried over MgSO4 and the solvent removed in vacuo to yield 2-3 as a white powder 
(0.207 g, 0.268 mmol, 99%).  
1H NMR (500 MHz, CDCl3): δ 7.51 (s, 1H, H6), 7.50 (d, J = 7.3 Hz, 1H, H1’/8’), 7.33 (d, J = 7.0 Hz, 
1H, H1’/8’), 7.25-7.17 (m, 3H, Ar), 7.10-7.02 (m, 6H, Ar), 6.94 (d, J = 8.2 Hz, 2H, Ar), 6.85-6.60 
(m, 10H, Ar), 3.89 (d, J = 21.8 Hz, 1H, H9’), 3.82 (d, J = 21.8 Hz, 1H, H9’), 1.22 (s, 9H, C(CH3)3), 
1.17 (s, 9H, C(CH3)3), 1.10 (s, 9H, C(CH3)3), 1.03 (s, 9H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 148.77, 148.20, 147.87, 147.71, 143.80, 143.28, 142.70, 142.36, 
140.53, 139.95, 139.91, 139.55, 139.24, 139.02, 137.76, 137.47, 137.45, 137.03, 131.49, 
131.23, 130.87 (C6), 130.63, 129.72, 129.56, 126.52, 126.16, 125.68, 124.74 (C1’/8’), 124.32, 
123.60, 123.23, 123.11, 123.07 (C1’/8’), 37.04 (C9’), 34.42 (C(CH3)3), 34.32 (C(CH3)3), 34.20 
(C(CH3)3), 34.17 (C(CH3)3), 31.42 (C(CH3)3), 31.41 (C(CH3)3), 31.35 (C(CH3)3), 31.25 (C(CH3)3) 
ppm.  
HR-ESI-MS: m/z 793.478; calcd for C59H62Na, [M+Na]+ 793.474.  






A solution of 2-3 (52 mg, 68 μmol) in DCM (50 mL) was bubbled with N2 for 10 min, then FeCl3 
(0.417 g, 2.57 mmol) in nitromethane (1 mL) added dropwise. The resultant brown solution 
was stirred for 1 h with continuous N2 bubbling. The reaction was quenched with MeOH (100 
mL) and the orange precipitate was isolated by filtration. The solid residue was purified via 
column chromatography (SiO2, 50:50 DCM/CS2) to yield 2-4 as an orange solid (38 mg, 
50 μmol, 74%).  
1H NMR (500 MHz, 50:50 CS2/CDCl3): δ 9.30 (s, 2H, H11,12), 9.25 (s, 2H, H9,14), 9.13 (s, 2H, H8,15), 
8.84 (s, 2H, H6,17), 8.44 (d, J = 7.8 Hz, 2H, H1,5), 7.74 (d, J = 7.7 Hz, 2H, H2,4), 4.01 (s, 2H, H3), 1.93 
(s, 18H, C(CH3)3), 1.83 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, 50:50 CS2:CDCl3): δ 148.36 (C10,13), 148.32 (C7,16), 139.47 (C2a,3a), 136.37 
(C2a1,3a1), 130.90 (C8a,14b), 130.86 (C8b,14a), 130.49 (C11a,11b), 130.19 (C5b,17a), 127.54 (C5a,17b), 
124.48 (C5b1,14b1), 124.11 (C8b1,11b1), 122.54 (C2,4), 121.00 (C5a1,17b1), 119.97 
(C5a2,17b2/5b2,14b2/8b2,11b2), 119.91 (C1,5), 119.63 (C5a2,17b2/5b2,14b2/8b2,11b2), 119.26 
(C5a2,17b2/5b2,14b2/8b2,11b2), 119.04 (C9,14), 118.97 (C6,17), 118.81 (C11,12), 118.43 (C8,15), 39.38 (C3), 
35.74 (C(CH3)3), 35.60 (C(CH3)3), 32.22 (C(CH3)3), 32.16 (C(CH3)3) ppm.  
MALDI-TOF MS: m/z 758.37; calcd for C59H50, [M]+ 758.39.  
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2.5.9 1-(9-Methyl-9H-fluoren-4-yl)-2,3,4,5-tetra(4-tert-butylphenyl)benzene (2-20) 
 
A solution of 2-17 (0.500 g, 0.637 mmol) in dry THF (10 mL) was cooled to 0 °C. 
Methylmagnesium bromide (3 M in Et2O, 0.43 mL, 1.27 mmol) was added dropwise and the 
mixture stirred for 30 min. The stirred mixture was then allowed to warm to RT over 1 h, 
before water was added. The product was extracted into DCM, washed with sat. NH4Cl, water, 
dried over MgSO4 and the solvent removed in vacuo. The off-white residue and triethylsilane 
(0.39 mL, 2.5 mmol) in dry DCM (20 mL) was cooled to 0 °C. Boron trifluoride diethyl etherate 
(0.30 mL, 2.5 mmol) was added dropwise and the red solution stirred for 1 h at 0 °C. The 
reaction was quenched with sat. aq. NaHCO3, extracted with DCM, and the organic phase 
washed with water, dried over MgSO4 and the solvent removed in vacuo to yield 2-20 as a 
white powder (0.431 g, 0.549 mmol, 86% over two steps, ~50:50 mixture of the 
diastereoisomers).  
1H NMR (500 MHz, CDCl3): δ 7.57 (s, 0.5H, H6), 7.54 (s, 0.5H, H6), 7.47 (d, J = 7.4 Hz, 0.5H, Ar), 
7.42 (d, J = 7.5 Hz, 0.5H, Ar), 7.31-7.02 (m, 10H, Ar), 6.97-6.93 (m, 2H, Ar), 6.86-6.58 (m, 10H, 
Ar), 3.85 (m, 1H, H9’), 1.52 (d, J = 7.4 Hz, 1.5H, CH3), 1.36 (d, J = 7.4 Hz, 1.5H, CH3), 1.24 (s, 4.5H, 
C(CH3)3), 1.23 (s, 4.5H, C(CH3)3), 1.19 (s, 4.5H, C(CH3)3), 1.18 (s, 4.5H, C(CH3)3), 1.11 (s, 4.5H, 
C(CH3)3),  1.11 (s, 4.5H, C(CH3)3), 1.04 (s, 4.5H, C(CH3)3), 1.02 (s, 4.5H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 149.55, 149.50, 149.15, 149.09, 148.80, 148.77, 148.19, 148.18, 
147.85, 147.74, 147.72, 147.69, 142.66, 142.54, 141.18, 141.15, 140.58, 140.54, 140.07, 
140.00, 139.93, 139.90, 139.43, 139.25, 139.06, 139.05, 138.38, 138.33, 137.77, 137.75, 
137.49, 137.47, 137.39, 137.38, 137.01, 136.82, 131.50, 131.34 (br), 131.21 (br), 130.85, 
130.67 (br), 130.59, 129.76, 129.74, 129.72, 129.59, 126.73, 126.59, 126.39, 126.37, 125.92, 
125.89, 124.34, 124.33, 123.72, 123.60, 123.59, 123.21, 123.19, 123.08, 123.06, 122.96 (br), 
122.08, 122.05, 42.27 (C9’), 42.18 (C9’), 34.44 (C(CH3)3), 34.42 (C(CH3)3), 34.33 (x2; C(CH3)3), 
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34.20 (x2; C(CH3)3), 34.17 (C(CH3)3), 34.10 (C(CH3)3), 31.44 (C(CH3)3), 31.43 (C(CH3)3), 31.41 
(C(CH3)3), 31.36 (C(CH3)3), 31.35 (C(CH3)3), 31.26 (C(CH3)3), 31.25 (C(CH3)3), 18.98 (CH3), 18.75 
(CH3) ppm; not all 13C NMR signals could be resolved due to broadness.  




A solution of 2-20 (0.210 g, 0.267 mmol) in DCM (50 mL) was bubbled with N2 for 10 min. 
Bubbling was stopped and FeCl3 (2.63 g, 16.2 mmol) in nitromethane (7 mL) was added 
dropwise. The resultant dark red solution was stirred under N2 for 30 min. The reaction was 
quenched with MeOH (100 mL) and the yellow precipitate was isolated by filtration. The 
precipitate was purified via column chromatography (SiO2, DCM) to yield 2-36 as a yellow 
powder (0.161 g, 0.191 mmol, 72%).  
1H NMR (500 MHz, CDCl3): δ 9.97 (s, 2H, H6,17), 9.31 (s, 2H, H11,12), 9.20 (s, 2H, H9,14), 9.06 (s, 
2H, H8,15), 7.27 (s, 2H, H2,4), 3.66-3.60 (m, 1H, H3), 1.98 (s, 18H, C(CH3)3), 1.79 (s, 18H, C(CH3)3), 
1.27 (s, 3H, CH3) ppm.  
13C NMR (125 MHz, CDCl3): δ 148.67 (C7,16), 147.70 (C10,13), 144.12 (C2a,3a), 132.21 (C2a1,3a1), 
130.61 (C8b,14a), 130.35 (C11a,11b), 129.84 (C8a,14b), 128.84 (C1,5/5b,17a/5a1,17b1), 128.75 
(C1,5/5b,17a/5a1,17b1), 125.60 (C2,4), 124.55 (C5b1,14b1), 123.88 (C5a,17b), 123.45 (C6,17), 123.02 
(C8b1,11b1), 121.5 (C5a2,17b2/5b2,14b2/8b2,11b2), 119.74 (C5a2,17b2/5b2,14b2/8b2,11b2), 119.20 
(C5a2,17b2/5b2,14b2/8b2,11b2), 118.86 (C8,15), 118.82 (C9,14), 118.76 (C1,5/5b,17a/5a1,17b1), 118.72 (C11,12), 
44.76 (C3), 36.02 (C(CH3)3), 35.90 (C(CH3)3), 32.44 (C(CH3)3), 32.30 (C(CH3)3), 16.60 (CH3) ppm.  
MALDI-TOF MS: m/z 840.26; calcd for C60H5035Cl2, [M]+ 840.33. 
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2.5.11 1-(9,9-Dimethyl-9H-fluoren-4-yl)-2,3,4,5-tetra(4-tert-butylphenyl)benzene (2-18) 
 
A solution of 2-3 (91 mg, 0.13 mmol) in dry THF (10 mL) was bubbled with argon for 10 min. 
Potassium tert-butoxide (0.087 g, 0.778 mmol) was added and the mixture stirred for 10 min 
under an argon atmosphere. Iodomethane (0.05 mL, 0.8 mmol) was added dropwise and the 
mixture was stirred for 16 h. The reaction was quenched with water and extracted with DCM. 
The organic phase was dried over MgSO4 and the solvent removed in vacuo to yield 2-18 as a 
white powder (89 mg, 0.11 mmol, 98%).  
1H NMR (500 MHz, CDCl3): δ 7.59 (s, 1H, H6), 7.33 (ddd, J = 7.5, 1.2, 0.7 Hz, 1H, Ar), 7.21 (td, J 
= 7.3, 1.3 Hz, 2H, Ar), 7.17-7.04 (m, 8H, Ar), 6.94 (d, J = 8.3 Hz, 2H, Ar), 6.85-6.45 (m, 10H, Ar), 
1.46 (s, 3H, CH3), 1.26 (s, 3H, CH3), 1.24 (s, 9H, C(CH3)3), 1.18 (s, 9H, C(CH3)3), 1.10 (s, 9H, 
C(CH3)3), 1.00 (s, 9H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 153.99, 153.70, 148.82, 148.19, 147.72, 147.70, 142.48, 140.61, 
140.15, 139.92, 139.84, 139.49, 139.08, 137.74, 137.49, 137.47, 137.07, 136.79, 131.50, 
131.37, 131.18, 130.68, 130.44, 129.77, 129.52, 126.64, 126.57, 126.17, 124.35, 123.60, 
123.19, 122.89, 122.10, 120.58, 46.23 (C9’), 34.44 (C(CH3)3), 34.33 (C(CH3)3), 34.19 (C(CH3)3), 
34.08 (C(CH3)3), 31.44 (C(CH3)3), 31.41 (C(CH3)3), 31.34 (C(CH3)3), 31.23 (C(CH3)3), 28.10 (CH3), 
26.87 (CH3) ppm.  






A solution of 2-18 (0.130 g, 0.163 mmol) in DCM (50 mL) was bubbled with N2 for 10 min. 
Bubbling was stopped and FeCl3 (1.58 g, 9.76 mmol) in nitromethane (5 mL) was added 
dropwise. The resultant dark green solution was stirred under N2 for 30 min. The reaction was 
quenched with MeOH (100 mL) and the yellow precipitate was isolated by filtration. The solid 
residue was purified via column chromatography (SiO2, DCM) to yield 2-19 as a yellow powder 
(0.121 g, 0.141 mmol, 87%).  
1H NMR (500 MHz, CDCl3): δ 10.58 (d, J = 1.7 Hz, 2H, H6,17), 9.38 (dd, J = 1.7, 0.7 Hz, 2H, H8,15), 
9.36 (m, 2H, H9,14), 9.35 (m, 2H, H11,12), 8.24 (s, 2H, H2,4), 1.95 (s, 6H, CH3), 1.86 (s, 18H, 
C(CH3)3), 1.82 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 150.07 (C2a,3a), 149.48 (C10,13), 148.99 (C7,16), 132.47, 131.16, 
130.80, 130.59, 130.18, 129.87, 125.77, 125.75 (C2,4), 125.74, 124.50 (C6,17), 123.78, 123.66, 
121.40, 120.60, 120.55, 119.70 (C8,15), 119.37 (C9,14), 119.05 (C11,12), 52.91 (C3), 36.09 
(C(CH3)3), 36.01 (C(CH3)3), 32.24 (C(CH3)3), 32.16 (C(CH3)3), 25.97 (CH3) ppm.  
MALDI-TOF MS: m/z 854.33; calcd for C61H5235Cl2, [M]+ 854.35. 
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2.5.13 1-Bromo-2-[2-(trimethylsilyl)ethynyl]benzene (2-31) 
 
Triethylamine (20 mL) was bubbled with argon for 15 min. 2-Bromoiodobenzene (1.00 g, 3.53 
mmol), dichlorobis(triphenylphosphine)palladium(II) (25 mg, 36 μmol), copper(I) iodide (6 mg, 
30 μmol), and trimethylsilylacetylene (0.347 g, 0.353 mmol) were added and the resultant 
solution was stirred under an argon atmosphere for 18 h. The reaction mixture was diluted 
with DCM, washed with sat. aq. NH4Cl, dried over MgSO4 and the solvent removed in vacuo. 
Crude 2-31 was reacted further without additional purification. 
1H NMR (400 MHz, CDCl3):23 δ 7.54 (d, J = 7.7 Hz, 1H), 7.46 (dd, J = 7.7, 1.6 Hz, 1H), 7.22 (t, J = 
7.7 Hz, 1H), 7.13 (td, J = 7.7, 1.6 Hz, 1H), 0.25 (s, 9H) ppm. 
2.5.14 2-[2-(Trimethylsilyl)ethynyl]-1,1’-biphenyl (2-32) 
 
A mixture of toluene (10 mL), water (10 mL) and n-propanol (2 mL) was bubbled with argon 
for 10 min. Crude 2-31 (ca. 1.25 g, 3.53 mmol), dichlorobis(triphenylphosphine)palladium(II) 
(25 mg, 36 μmol), phenylboronic acid (0.473 g, 3.88 mmol) and potassium carbonate (0.976 g, 
7.06 mmol) were added and the resultant mixture was heated with rapid stirring at 80 °C 
under an argon atmosphere for 18 h. The black mixture was cooled, diluted with water and 
extracted with DCM (x3). The organic phases were combined, dried over MgSO4 and the 
solvent removed in vacuo. The residue was purified via column chromatography (SiO2, PE) to 
yield 2-32 as a colourless film (0.315 g, 1.26 mmol, 36 % over two steps).  




2.5.15 2-Ethynyl-1,1’-biphenyl (2-33) 
 
TMS-alkyne 2-32 (0.315 g, 1.26 mmol) and potassium carbonate (0.348 g, 2.52 mmol) were 
added to MeOH (20 mL) and the suspension stirred for 2 h. The mixture was diluted with DCM, 
washed with water, dried over MgSO4 and the solvent removed in vacuo. Crude 2-33 was 
reacted further without additional purification. 
1H NMR (400 MHz):25 δ 7.63 (d, J = 8.0 Hz, 1H), 7.61-7.58 (m, 2H), 7.47-7.35 (m, 5H), 7.31 (td, 
J = 7.7, 2.0 Hz, 1H), 3.04 (s, 1H) ppm. 
2.5.16 1-(2-(1,1’-biphenyl))-2,3,4,5-tetra(4-tert-butylphenyl)benzene (2-34) 
 
 
Alkyne 2-33 (ca. 0.210 g, 1.18 mmol) and 2-2 (0.789 g, 1.30 mmol) were added to o-xylene (2 
mL) under argon and heated at reflux for 18 h. The reaction mixture was cooled, diluted with 
EtOH and the precipitate isolated by filtration to yield 2-34 as a white powder (0.714 g, 0.941 
mmol, 75% over two steps).  
1H NMR (500 MHz, CDCl3): δ 7.53 (s, 1H, H6), 7.50-7.47 (m, 1H, Ar), 7.32-7.27 (m, 2H, Ar), 7.18-
7.08 (m, 6H, Ar), 7.02 (d, J = 8.4 Hz, 2H, H2’’’’’), 6.92-6.82 (m, 4H, Ar), 6.77-6.44 (m, 9H, Ar), 1.27 
(s, 9H, C(CH3)3), 1.15 (s, 9H, C(CH3)3), 1.13 (s, 9H, C(CH3)3), 1.07 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 148.79 (C4’’’’’), 148.04 (C4’’/ C4’’’/ C4’’’’), 147.53 (C4’’/ C4’’’/ C4’’’’), 
147.36 (C4’’/ C4’’’/ C4’’’’), 141.98, 141.45, 140.93, 140.74, 140.04 (C5), 139.98, 139.80, 139.57, 
139.11, 137.78, 137.50, 136.40, 132.42 (C6), 132.17, 131.45, 131.34, 131.02, 129.85, 129.77 
(C2’’’’’), 129.72, 127.52, 127.22, 126.67, 126.19, 124.32, 123.46, 123.07, 122.94, 34.46 
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(C(CH3)3), 34.27 (C(CH3)3), 34.17 (C(CH3)3), 34.13 (C(CH3)3), 31.47 (C(CH3)3), 31.38 (C(CH3)3), 
31.35 (C(CH3)3), 31.32 (C(CH3)3) ppm.  
MALDI-TOF MS: m/z 758.49; calcd for C58H62, [M]+ 758.49. 
2.5.17 2,5,8,11-Tetra(tert-butyl)-hexa-peri-hexabenzocoronene (2-35) 
 
A solution of 2-34 (0.200 g, 0.263 mmol) in DCM (50 mL) was bubbled with N2 for 10 min. FeCl3 
(1.02 g, 6.31 mmol) in nitromethane (2 mL) was added dropwise and the resultant dark red 
solution stirred with N2 bubbling for 30 min. The reaction was quenched with MeOH (100 mL), 
and the yellow precipitate was filtered to yield 2-35 as a yellow powder (0.129 g, 0.173 mmol, 
65 %).  
1H NMR (500 MHz, 50:50 CS2/CDCl3): δ 9.27 (s, 2H, H4,9/6,7), 9.25 (s, 2H, H4,9/6,7), 9.22 (s, 2H, 
H3,10), 9.15 (s, 2H, H1,12), 9.07 (d, J = 7.8 Hz, 2H, H13,18), 8.98 (d, J = 7.8 Hz, 2H, H15,16), 8.06 (t, J 
= 7.8 Hz, 2H, H14,17), 1.87 (s, 18H, C(CH3)3), 1.83 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, 50:50 CS2/CDCl3): δ 148.71 (C5,8), 148.66 (C2,11), 130.56 (x2; C3a,9b/3b,9a/6a,6b), 
130.50 (C12b,18a), 130.35 (C3a,9b/3b,9a/6a,6b), 130.33 (C15a,15b), 130.10 (C12a,18b), 126.46 (C14,17), 
125.51 (C12b1,15b1), 123.88 (C3b1,6b1), 123.68 (C3a1,9b1), 121.76 (C13,18), 121.73 (C15,16), 120.67 
(C3a2,9b2/3b2,6b2/12b2,15b2), 120.64 (C3a2,9b2/3b2,6b2/12b2,15b2), 120.60 (C3a2,9b2/3b2,6b2/12b2,15b2), 119.11 
(C1,12), 118.96 (C3,10), 118.93 (C4,9/6,7), 118.90 (C4,9/6,7), 35.58 (C(CH3)3), 35.56 (C(CH3)3), 32.04 
(C(CH3)3), 32.03 (C(CH3)3) ppm. 






Cerium(III) chloride heptahydrate (0.199 g, 0.534 mmol) was heated at 140 °C under high 
vacuum for 2 h. After cooling, 2-36 (0.150 g, 0.178 mmol) and dry THF (15 ml) were added 
before LiAlH4 (1 M in THF, 1.6 mL, 1.6 mmol) was added dropwise under an argon atmosphere. 
The resultant dark green mixture was heated at reflux for 20 h. After cooling, the reaction was 
quenched by dropwise addition of water. The mixture was extracted with DCM, washed with 
sat. aq. NH4Cl, water, then dried over MgSO4 and the solvent removed in vacuo. The product 
was purified via column chromatography (SiO2, 50:50 DCM/PE) to yield 2-21 as a yellow 
powder (0.102 g, 0.132 mmol, 74%).  
1H NMR (500 MHz, CDCl3): δ 9.28 (s, 2H, H11,12), 9.22 (s, 2H, H9,14), 9.07 (s, 2H, H8,15), 8.81 (s, 
2H, H6,17), 8.39 (d, J = 7.7 Hz, 2H, H1,5), 7.71 (d, J = 7.7 Hz, 2H, H2,4), 4.04 (q, J = 7.9 Hz, 1H, H3), 
1.93 (s, 18H, C(CH3)3), 1.82 (s, 18H, C(CH3)3), 1.62 (d, J = 7.9 Hz, 3H, CH3) ppm.  
13C NMR (125 MHz, CDCl3): δ 148.55 (C10,13), 148.45 (C7,16), 145.36 (C2a,3a), 134.91 (C2a1,3a1), 
130.90 (C8b,14a), 130.84 (C8a,14b), 130.52 (C11a,11b), 130.21 (C5b,17a), 127.73 (C5a,17b), 124.46 
(C5b1,14b1), 124.04 (C8b1,11b1), 121.40 (C2,4), 120.95 (C5a1,17b1), 119.89 (C1,5/5a2,17b1/5b2,14b2/8b2,11b2), 
119.88 (C1,5/5a2,17b1/5b2,14b2/8b2,11b2), 119.47 (C5a2,17b1/5b2,14b2/8b2,11b2), 119.21 
(C5a2,17b1/5b2,14b2/8b2,11b2), 118.96 (x2; C6,9,14,17), 118.72 (C11,12), 118.35 (C8,15), 47.05 (C3), 36.00 
(C(CH3)3), 35.83 (C(CH3)3), 32.41 (C(CH3)3), 32.31 (C(CH3)3), 16.93 (CH3) ppm.  






Cerium(III) chloride heptahydrate (0.158 g, 0.424 mmol) was heated at 140 °C under high 
vacuum for 2 h. After cooling, 2-19 (0.121 g, 0.141 mmol) and dry THF (10 ml) were added 
before LiAlH4 (1 M in THF, 1.27 mL, 1.27 mmol) was added dropwise under an argon 
atmosphere. The resultant dark green mixture was heated at reflux for 20 h. After cooling, the 
reaction was quenched by dropwise addition of water. The mixture was extracted with DCM, 
washed with sat. aq. NH4Cl, water, then dried over MgSO4 and the solvent removed in vacuo. 
The product was purified via column chromatography (SiO2, 50:50 DCM/PE) to yield 2-37 as a 
yellow powder (0.051 g, 0.065 mmol, 46%).  
1H NMR (500 MHz, CDCl3): δ 9.35 (s, 2H, H9,14/11,12), 9.33 (s, 2H, H9,14/11,12), 9.32 (s, 2H, H8,15), 
9.24 (s, 2H, H6,17), 9.04 (d, J = 7.8 Hz, 2H, H1,5), 8.20 (d, J = 7.8 Hz, 2H, H2,4), 2.01 (s, 6H, CH3), 
1.86 (s, 18H, C(CH3)3), 1.84 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 150.57 (C2a,3a), 149.40 (C7,16), 149.09 (C10,13), 134.53 (C2a1,3a1), 
131.42, 131.09, 130.79 (C5b,17a), 130.68, 128.91 (C5a,17b), 125.11 (C5b1,14b1), 124.34, 122.24, 
120.97 (C1,5), 120.90 (C2,4), 120.81 (C5a2,17b2/5b2,14b2/8b2,11b2), 120.31 (C5a2,17b2/5b2,14b2/8b2,11b2), 
120.29 (C5a2,17b2/5b2,14b2/8b2,11b2), 119.52 (C6,17), 119.37, 119.10, 118.93 (C8,15), 54.80 (C3), 35.98 
(C(CH3)3), 35.95 (C(CH3)3), 32.26 (C(CH3)3), 32.23 (C(CH3)3), 26.04 (CH3) ppm.  







A solution of 2-37 (30 mg, 38 μmol) in DCM (5 mL) was cooled to -20 °C. Bromine (0.120 g, 
0.38 mmol) dissolved DCM (2 mL) was added dropwise, and the mixture stirred for 1 h. The 
excess bromine was quenched with sat. aq. Na2S2O3 and the organic phase was washed with 
water. The organic phase was dried over MgSO4 and the solvent removed in vacuo to yield 2-
39 as a yellow powder (33 mg, 35 μmol, 92%).  
1H NMR (500 MHz, CDCl3): δ 10.72 (s, 2H, H6,17), 9.38 (s, 2H, H8,15), 9.36 (s, 2H, H9,14/11,12), 9.35 
(s, 2H, H9,14/11,12), 8.51 (s, 2H, H2,4), 1.96 (s, 6H, CH3), 1.85 (s, 18H, C(CH3)3), 1.82 (s, 18 H, 
C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 150.43 (C2a,3a), 149.60 (C10,13), 148.70 (C7,16), 133.04 (C2a1,3a1), 
132.98, 131.18 (C8b,14a), 130.85 (C8a,14b/11a,11b), 130.61 (C8a,14b/11a,11b), 129.82, 129.48 (C2,4), 
127.00 (C5a,17b), 125.80 (C5b1,14b1), 124.07 (C6,17), 123.65 (C8b1,11b1), 121.36, 120.71, 120.62, 
120.43, 119.93 (C8,15), 119.46 (C9,14/11,12), 119.06 (C9,14/11,12), 118.39, 52.80 (C3), 36.21 (C(CH3)3), 
36.02 (C(CH3)3), 32.22 (C(CH3)3), 32.19 (C(CH3)3), 25.95 (CH3) ppm; one more carbon signal than 
expected was found, the source of which could not be identified. 






A solution of 2-39 (33 mg, 0.042 mmol) in toluene (1 mL), water (1 mL) and n-propanol (0.5 
mL) was bubbled with argon for 10 min. 4-tert-Butylphenylboronic acid (75 mg, 0.42 mmol), 
potassium carbonate (66 mg, 0.67 mmol), tris(dibenzylideneacetone)dipalladium(0) (10 mg, 
0.011 mmol) and tri-tert-butylphosphonium tetrafluoroborate (12 mg, 0.041 mmol) were 
added, and the mixture rapidly stirred at reflux under an argon atmosphere for 16 h. The 
solution was allowed to cool, extracted with DCM, the organic phase washed with brine, 
water, then dried over MgSO4 and the solvent removed in vacuo. The residue was purified via 
preparative thin layer chromatography (SiO2, 25:75 DCM/PE) to yield 2-40 as a yellow powder 
(6 mg, 6 μmol, 14%).  
1H NMR (500 MHz, CDCl3): δ 9.33 (s, 2H, H11,12), 9.30 (s, 2H, H9,14), 9.16 (s, 2H, H8,15), 8.69 (s, 
2H, H6,17), 8.01 (s, 2H, H2,4), 7.79-7.70 (m, 8H, H2’,3’), 1.96 (s, 6H, CH3), 1.81 (s, 18H, C(CH3)3), 
1.52 (s, 18H, C(CH3)3), 1.36 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 150.00 (C4’), 149.68 (C2a,3a), 149.16 (C10,13), 148.12 (C7,16), 143.85 
(C1’), 139.61 (C1,5), 133.72 (C2a1,3a1/5a,17b), 131.35 (C8b,14a), 131.03, 130.87 (C8a,14b), 130.57 
(C11a,11b), 129.52 (C2’), 126.75 (C2a1,3a1/5a,17b), 126.68 (C3’), 126.14, 125.96 (C6,17), 125.70 (C2,4), 
124.08 (C8b1,11b1), 123.09, 121.53, 121.42, 120.24, 119.35 (C9,14), 118.81 (C11,12), 118.42 (C8,15), 
53.63 (C3), 35.95 (C(CH3)3), 35.37 (C(CH3)3), 34.93 (C(CH3)3), 32.22 (C(CH3)3), 31.71 (C(CH3)3), 
31.67 (C(CH3)3), 26.21 (CH3) ppm. 
MALDI-TOF MS: m/z 1050.58; calcd for C81H78, [M]+ 1050.61. 
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A solution of 2-40 (22 mg, 21 μmol) in DCM (5 mL) was bubbled with N2 for 10 min. FeCl3 (27 
mg, 0.167 mmol) in nitromethane (0.5 mL) was added dropwise and the resultant purple 
solution stirred with N2 bubbling for 30 min. The reaction was quenched with MeOH (20 mL), 
and the reddish orange precipitate was isolated by filtration to yield a mixture of 2-40 and 
trace amounts of a partially fused product (one new C-C bond formed) by MALDI-TOF.  
2.5.23 Bromination of 9,9-dimethylfluorene 
A solution of 9,9-dimethylfluorene (74 mg, 38 μmol) in DCM (5 mL) was cooled to -20 °C. 
Bromine (0.120 g, 0.38 mmol) dissolved DCM (2 mL) was added dropwise, and the mixture 
stirred for 1 h. The excess bromine was quenched with sat. aq. Na2S2O3 and the organic phase 
was washed with water. The organic phase was dried over MgSO4 and the solvent removed in 
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This chapter describes the extension of the methodology of Chapter 2 towards multi-bridged 
HBCs utilising fluorene as a pre-formed source of five-membered rings. A number of different 





3.1 Synthetic Approach 
Following the resolution of oxidative cyclodehydrogenation conditions required for forming a 
monobridged HBC, a tribridged example was chosen as the next logical step as it would from 
the most highly bridged HBC possible utilising fluorene as a pre-formed bridge. Two key steps 
were envisioned towards synthesising this HBC: coupling of a fluorene moiety to a benzene 
core to give the key intermediate trifluorenoyl benzene 3-1 (the functional equivalent of a 
HPB) and cyclodehydrogenation of the trifluorenylbenzene to form the desired multi-bridged 
HBC.  
 
Scheme 3.1: Synthetic approach showing the key intermediate 3-1 towards a tribridged HBC. 
3.2 Trifluorenylbenzene Precursor Synthesis 
Two possible strategies to form trifluorenyl benzene can be envisioned (Scheme 3.2): either a 
convergent route involving the attachment of the fluorenyl moiety to a benzene core by a 
palladium-catalysed cross-coupling reaction, or alternatively a divergent method consisting of 
the sequential build-up of aromatic rings around a benzene core, followed by the formation 
of the multiple methylene bridges once all rings are attached. After initial test reactions, a 
divergent synthesis was outright discarded due to the required Suzuki coupling and 
intramolecular Friedel-Crafts steps being poorly yielding on a single-fold system, let alone on 
the three-fold reactions required in this investigation. Additionally, an advantage in using the 
convergent approach is that it would utilise the functionalised fluorenone precursors 
previously used to prepare the monobridged HBC 2-37. Ketone functionality was desired at 
the methylene bridge initially as the polar group should allow for chromatographic separation 




Scheme 3.2: Divergent versus convergent approach towards trifluorenoylbenzene 3-1. 
3.2.1 Pd-catalysed Cross-Coupling Approach 
The first investigation towards trifluorenoyl 3-1 utilised a Suzuki-Miyaura cross-coupling of a 
boryl fluorenone to 1,3,5-tribromobenzene 3-6. Boryl fluorenone 3-2 was synthesised via 
Miyaura borylation of bromofluorenone 2-25 with bis(pinacolato)diboron in modest yields 
(Scheme 3.3). A Suzuki-Miyaura cross-coupling between boryl fluorenone 3-2 and 
tribromobenzene 3-6 then proceeded to afford a sparingly-soluble yellow solid once purified 
via column chromatography. 
 
Scheme 3.3: Synthesis of 3-1 via Suzuki-Miyaura cross-coupling of 3-2 and 3-6. 
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Examination of the yellow solid by 1H NMR revealed several broad peaks, consistent with the 
restricted rotation expected for desired trifluorenoyl benzene 3-1 (Figure 3.1). The broad 
features observed in the 1H NMR spectrum were also encountered in the 13C NMR spectrum, 
with the broadened proton and carbon environments corresponding to those on the benzene 
core and the ring on the fluorenone moiety not attached to the core.  
 
Figure 3.1: 1H (top) and 13C (bottom) NMR spectra of 3-1. 
Surprisingly, the ESI-MS spectrum was found to not exhibit the desired product but instead a 
complex mixture of oligomeric and fragmented products, despite the polarisable functionality 
present in the compound. It was presumed that these measurements were unsuccessful due 
to the poor solubility of the compound in most solvents. Further examination by MALDI-TOF 
MS revealed a single species at 612.10 m/z that agreed with the assigned mass of the product. 
Additional confirmation of the desired structure was obtained via x-ray crystallography with a 




Figure 3.2: Crystal structure of 3-1, Top down view (top left), side on view (bottom left) and long range stacking 
of one fluorenone moiety (right). 
Due to the poor yields obtained, modifications in the method were investigated. Improving 
the activity of the catalyst through adjustment of the phosphine ligand from 
triphenylphosphine or 1,1’-bis(diphenylphosphino)ferrocene to the more reactive tri(tert-
butyl)phosphine resulted in an increase in yield. Furthermore, the mixture of phosphine, 
deborylated fluorenone and partially coupled intermediates proved more readily separable 
by column chromatography, particularly the partially coupled intermediates, which were 
present in smaller quantities when utilising tri(tert-butyl)phosphine. In further efforts to 
improve yields, the functionality of the coupling partners was swapped, with coupling 
between bromofluorenone 2-25 and boryl benzene 3-7 investigated (Scheme 3.4). Again, 
similarly modest yields were obtained; however, this approach was found to be much more 
efficient in the use of bromo 2-25, a major limiting reagent in terms of scale and time required 




Scheme 3.4: Synthesis of 3-1 via Suzuki-Miyaura cross-coupling of triboronic ester 3-7 and bromo 2-25. 
3.2.2 Trimerisation Approaches 
As yields from Suzuki-Miyuara cross-couplings were consistently low, alternative trimerisation 
approaches were investigated. The first trimerisation investigated was an acid mediated 
condensation of an acetophenone, such as the often utilised condensation of 2’-
bromoacetophenone to form 1,3,5-tris(2-bromophenyl)benzene.1 Instead of acetophenone, 
4-acetylfluorene 3-8 was utilised in this investigation (Scheme 3.5). Synthesis of acetyl 
fluorene was acheived via Friedel-Crafts acylation of di(tert-butyl)fluorene 2-6 in modest 
yields, with functionalisation at the accessible 4 position guaranteed by the steric bulk of the 
appended tert-butyl groups; the tert-butyl groups were removed via a retro Friedel-Crafts 
alkylation. Initial attempts utilising a slight excess of AlCl3 (1.3 eq.) were found to return 
starting material; however, the reaction proceeded cleanly once three or more than 
equivalents of AlCl3 were used, presumably due to an interaction between the carbonyl groups 
and AlCl3. Acid-catalysed trimerisation using TfOH was then attempted which yielded an 




Scheme 3.5: Attempted synthesis of a trifluorene system 3-10 via cyclotrimerisation of acetyl 3-8. 
A further trimerisation method which became increasingly relevant as other methods 
remained poorly yielding was a cyclotrimerisation of an acetylene catalysed by Co2(CO)8. 
Although two isomers would be obtained as a mixture, with the preferred symmetrical isomer 
having a statistical yield of ca. 25%, the unsymmetrical 1,2,4 substituted product, if 
cyclodehydrogenation was possible, could also afford the same bridged symmetrical HBC 
(Scheme 3.6). For ease of analysis in further new reactions, only the symmetrical isomer was 
considered for these initial studies. Cyclotrimerisation proceeded cleanly, with the isomeric 
mixture obtained in yields ca. 70%; however, despite the polar carbonyl groups present, the 
two isomers were not separable via column chromatography. Despite the inseparability, this 




Scheme 3.6: Putative formation of a tribridged HBC from either the symmetrical (left) or unsymmetrical (right) 
isomer of trifluorenoylbenzene. New bonds formed represented in red. 
3.2.3 Methylene-bridge Functionalisation 
Functionalisation of the methylene bridge was then undertaken in the same manner as the 
singly bridged 2-37, with nucleophilic addition of alkyl Grignard or organolithium reagents to 
the carbonyl carbon, yielding a tertiary alcohol as a mixture of isomers (Scheme 3.7). The 
alcoholic functionality was then removed using Et3SiH/BF3·Et2O to give a singly alkyl 
substituted bridge, before deprotonation with n-BuLi and addition of an alkyl iodide to afford 
the doubly substituted bridge. Initially, hydrogen or methyl substitutions were investigated; 
however, these compounds were found to be very poorly soluble in most organic solvents. To 
circumvent this, butyl functionality was utilised, as it would both increase solubility in organic 





Scheme 3.7: Three-fold functionalisation of the methylene carbon of trifluorenoyl benzene 3-1 
Examination of 3-13 by 1H NMR revealed a series of broad aryl peaks with many overlapping 
signals at 7.35 ppm along with the expected butyl peaks (Figure 3.3). Due to the number of 
signals overlapping, the peaks could not be assigned, even with the assistance of 2D NMR 
experiments; however, due to the presence of a number of peaks with an integral of one, the 
molecule is not as symmetrical as expected, possibly with one fluorene moiety in a different 
magnetic environment to the other two. Formation of 3-13 was confirmed by MALDI-TOF MS, 
with the major species consistent with the loss of a butyl group (Figure 3.4). 
 




Figure 3.4: MALDI-TOF spectrum of 3-13. 
3.3 Trifluorenylbenzene Cyclodehydrogenation Studies 
From the newly formed butyl substituted 3-13, cyclodehydrogenation was then attempted. 
Three key aspects were investigated: firstly, whether cyclodehydrogenative conditions would 
yield a HBC at all. Secondly, whether regioselective chlorination would occur under the 
conditions, as observed in the monobridged system. Finally, if chlorination does occur, at what 
positions? Regioselective chlorination at the 2 or 7 positions of the fluorenyl moiety allows for 
further functionalisation post-cyclodehydrogenation, towards the main goal of a hexabridged 




Scheme 3.8: Ideal outcomes after cyclodehydrogenation with no chlorination (top) or regioselective 
chlorination and further functionalisation (bottom). 
After treatment of 3-13 with 48 eq. of FeCl3 under oxidative cyclodehydrogenation conditions, 
followed by passing through a short silica plug to remove any remaining iron salts, a yellow 
film was obtained that was found to be soluble in CHCl3. The 1H NMR spectrum of the film 
contained few, faint broad aromatic signals along with broad butyl peaks. In an attempt to 
improve the intensity of the 1H signals, the sample was re-measured in a mixture of 50:50 





Figure 3.5: 1H NMR spectrum of butyl substituted trifluorenyl benzene 3-13 after subjected to 
cyclodehydrogenative conditions. 
Examination by MALDI-TOF MS returned a spectrum with several species and a broadened 
baseline (Figure 3.6). Only one species could be identified, that at 836.38 Da, consistent with 
the loss of a butyl group from the starting material; the rest of the species are observed at 
higher molecular weights than expected, none of which were consistent with chlorinated 
products, with or without partial alkyl group decomposition, suggesting none of the target 




Figure 3.6: MALDI-TOF spectrum of 3-13 after treatment with FeCl3. 
A series of modifications to the cyclodehydrogenation conditions were then investigated 
(Table 3.1). Firstly, a reduction from 48 eq. to 24 or 36 eq. of FeCl3 was attempted and was 
found to afford the same broad product distribution (entries 2 and 3). Treatments at higher 
temperatures, up to 100 °C, were also investigated, in case restricted rotation about the 
benzene-fluorene bond could be hindering fusion; however, in all cases at raised 
temperatures broad peaks in the MALDI-TOF spectra were observed with no identifiable single 








Oxidant Eq. Solvent Time Temp Observation 
1  FeCl3 FeCl3 48 DCM 30 min RT 
Soluble polymeric 
mixture 
2 FeCl3 FeCl3 24 DCM 30 min RT 
Soluble polymeric 
mixture 
3  FeCl3 FeCl3 36 DCM RT 1 h 
Unidentifiable 
mixture 
4  FeCl3 FeCl3 24 DCE 4 h 60 
Soluble polymeric 
mixture 
5  FeCl3 FeCl3 48 DCE 27 h 80 
Soluble polymeric 
mixture 
6  FeCl3 FeCl3 24 TCE 3 h 100 
Soluble polymeric 
mixture 
7  TfOH DDQ 12 DCM 1h -78 SM 
8 MeSO3H DDQ 6 DCM 3 h 0 SM 





Figure 3.7: Representative MALDI-TOF spectrum after FeCl3 mediated cyclodehydrogenation of 3-13 (entry 6). 
Cyclodehydrogenative conditions utilising different oxidant/acid combinations were also 
investigated. Utilising DDQ with either methanesulfonic acid or triflic acid, was found to return 
starting material without any signs of fusion or decomposition. An alternate method using 
AlCl3 and copper(II) triflate was also attempted; however, loss of butyl groups was observed, 
along with the broad peaks seen in the FeCl3 examples. 
The broad peaks observed in the MALDI-TOF spectra were postulated to be due to oligomeric 
products formed under cyclodehydrogenative conditions, instead of the desired discrete HBC. 
MALDI-TOF spectra of polydisperse oligomers were found to contain these broad peaks, with 
few distinguishing features, albeit found at much higher m/z.2 This agrees with the broad 1H 
NMR spectra seen, with very broad, convoluted environments being observed, but in very 
small quantities, resulting in no distinctive peaks.  
Due to the persistent difficulties in studying these compounds either by 1H NMR or MALDI-
TOF MS, as well as the low overall yields in the synthesis of the alkylated precursors, attention 
was turned to alternate topologies containing fluorene, to see if the proposed oligomerisation 
is influenced by the fluorene moiety, or if another mitigating factor could be occurring. 
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3.4 Alternate Topologies 
As cyclodehydrogenation of 3-13 had proven troublesome, efforts were turned towards 
synthesising alternate PAHs containing fluorene to see if multi-bridged systems could be 
made. 
3.4.1 Cyclopenta[def]triphenylene Core 
One alternate pathway to a tribridged HBC could be from a cyclopentatriphenylene core 
previously synthesised by Hoggard et al.3-4 Structurally, a difluorenyl-appended 
cyclopentatriphenylene 3-16 contains an additional aryl-aryl bond compared to the previously 
investigated trifluorenylbenzene 3-13 (Figure 3.8). This more pre-organised compound was 
thought to potentially undergo cyclodehydrogenation more readily than the 
trifluorenylbenzene 3-13; the first bond formed during cyclodehydrogenation is usually the 
most difficult, therefore introducing an additional pre-existing bond from the beginning might 
facilitate further bond formation.  
 
Figure 3.8: Proposed cyclopentatriphenylene based scaffold (left) and trifluorenyl benzene (right). The 
additional aryl-aryl bond is depicted in red. 
Synthesis proceeded to the ditriflate as reported (Scheme 3.9), however cross-coupling to the 
triflates proved troublesome. Initial attempts at Suzuki-Miyaura cross-coupling of fluorenone 
3-2 to ditrifyloxy cyclopentatriphenylene 3-17 resulted in formation of a mixture of 
inseparable products containing a mostly mono-coupled product, with triflate functionality 




Scheme 3.9: Synthetic methodology based on Hoggard et al. undertaken towards tribridged HBC from 
cyclopentatriphenylene 3-17.3-4 
Utilising a more active catalyst (tri(tert-butyl)phosphine instead of triphenylphosphine as the 
ligand) also resulted in the formation of a mono-coupled product, along with the loss of triflate 
functionality, with no signs of dicoupled product being observed (Figure 3.9). This resistance 
to undergoing two-fold coupling was ascribed to steric hindrance with no conditions found 




Figure 3.9: MALDI-TOF spectra of partially isolated singly-coupled cyclopentatriphenylenes. 
3.4.2 Bifluorene System Towards Pinakene 
Due to other fluorene-containing intermediates either being unable to be formed, or failing 
to form discrete compounds upon cyclodehydrogenation, a simpler test system for subjecting 
a fluorene moiety to cyclodehydrogenative conditions was proposed, consisting of two 
fluorenes coupled together (Scheme 3.10). Upon cyclodehydrogenation, ideally two new 
carbon-carbon bonds would form to yield a dibridged dibenzotetracene system 3-23. This 
system could be further utilised towards the rational synthesis of pinakene, a tetrabridged 
dibenzotetracene, the successful synthesis of which has yet to be reported.  
 
Scheme 3.10: Desired product of bifluorene fusion and its more highly bridged example, pinakene (blue core). 
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A number of theoretical studies on pinakene have been reported,5-8 as it has been considered 
a rational building block towards C70, in a manner similar to sumanene and corannulene which 
are considered to be building blocks, or fragments of, C60. In a study by Jemmis et al.,5 the 
energy levels of many plausible intermediate products towards pinakene were calculated in 
an attempt to highlight the most promising synthetic pathways to pinakene. As expected, 
adding bridges sequentially resulted in an increase in energy; however, for the three possible 
dibridged isomers, the isomer containing bridges diagonal to each other was found to be 
significantly lower in energy, and therefore easier to form. This diagonal arrangement could 
be accessed by the fusion of two fluorene moieties. From this fused dibridged system, 
additional bridges could then be incorporated after small modifications of the fluorenes used 
to give additional functionality.  
Bifluorenone 3-22 was accessed from the Suzuki coupling of bromo 2-25 and boronic ester 3-2 
previously synthesised (Scheme 3.11). Coupling was straightforward, with a sharp 1H NMR 
spectrum obtained for the coupled product. Slow evaporation from CDCl3 also resulted in 
crystalline compound forming, allowing for X-ray crystallography which further confirmed the 
structure (Figure 3.10). Bridge functionalisation then proceeded as outlined for 3-13 but with 
potassium tert-butoxide utilised as the base for the second alkylation.  
 




Figure 3.10: Crystal structure of bifluorenone 3-22. 
Cyclodehydrogenation of butyl 3-24 was attempted using either FeCl3 or DDQ/TfOH; however, 
similar results to 3-13 were obtained, with broad peaks observed in the 1H NMR spectrum. 
Further investigation by MALDI-TOF MS also revealed similar patterns to 3-13, with broad 
signals, presumably oligomeric species observed, along with unidentifiable, lower mass 
decomposition species and higher mass species which could not be matched to chlorinated 




Figure 3.11: MALDI-TOF MS spectrum after cyclodehydrogenation of 3-24. 
If the proposed oligomerisation was occurring, it was most likely to be occurring at the reactive 
2 and 7 positions of fluorene which are sterically unhindered. In an effort to mitigate the effect 
of this potentially reacting site, a methylated bromofluorene 3-25 was designed to block one 
of the two sites, functionality that could be utilised further to form pinakene (Scheme 3.12). 
Application of 3-25 to form dimethylated bifluorenone 3-26 proceeded as per non-methylated 
3-22, in similar yields, with further butyl functionalisation requiring n-BuLi as a base instead of 




Scheme 3.12: Attempted synthesis of dimethyl 3-29. 
Despite the additional steric bulk, cyclodehydrogenative conditions again presumably resulted 
in oligomeric products formed by 1H NMR, with the disappearance of the peaks corresponding 
to 3-28 without any additional peaks appearing. Further examination by MALDI-TOF revealed 
two species consistent with a dimer with one bond formed (m/z 1162.83) and trimer with two 
bonds formed (m/z 1743.24) along with decomposition products (Figure 3.12), giving 




Figure 3.12: MALDI-TOF spectrum of 3-28 after treatment with FeCl3. 
3.5 Conclusions 
The synthesis of a number of multi-fluorene-based PAHs were investigated. Issues in 
cross-coupling fluorenone moieties to triflate functionality were encountered, with coupling 
only occurring under conditions where the triflate functionality would also be lost. Those 
fluorene-based PAHs that were able to be synthesised were subjected to oxidative 
cyclodehydrogenation conditions and were found to undergo oligomerisation rather than 
planarization. As this fluorene-based methodology cannot solely be used to directly install all 
bridges of the ultimate hexabridged HBC, attention was instead turned towards post-
cyclodehydrogenative bridging approaches, which have the potential to facilitate six bridges.  
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3.6 Experimental Section 
3.6.1 General Experimental 
For general experimental details see §2.5.1.  
Triboronic ester 3-7,9 2,7-di(tert-butyl)fluorene 2-6,10 4-acetyl-2,7-di(tert-butyl)fluorene 3-9,10 
4-bromo-2,7-di(tert-butyl)fluorene 2-7,10 dimethoxyphenyl fluorene 3-18,4 dimethoxy 
cyclopentatriphenylene 3-19,4  dihydroxy cyclopentatriphenylene 3-204 and ditriflyloxy 
cyclopentatriphenylene 3-174 were synthesised as reported without significant modification. 
3.6.2 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-fluorenone (3-2) 
 
A solution of 2-25 (0.650 g, 2.51 mmol) in 1,4-dioxane (40 mL) was bubbled with argon for 10 
min. Bis(pinacolato)diboron (0.955 g, 3.77 mmol), [1,1’-bis(diphenylphosphino)- 
ferrocene]dichloropalladium(II) (0.055 g, 0.075 mmol) and potassium acetate (1.48 g, 15.1 
mmol) were added and the resultant solution heated at 90 °C for 18 h under argon. The 
reaction mixture was cooled and the solvent removed in vacuo. The residue was extracted 
with DCM, and the organic phase washed with aq. sat. NaCl, water, dried over MgSO4 and the 
solvent removed in vacuo. The solid residue was purified via column chromatography (SiO2, 
10:90 acetone/PE) to yield 3-2 as a yellow powder (0.420 g, 1.37 mmol, 55%).  
1H NMR (500 MHz, CDCl3): δ 8.52 (d, J = 7.7 Hz, 1H, H5), 7.94 (dd, J = 7.5, 1.3 Hz, 1H, H3), 7.75 
(dd, J = 7.3, 1.4 Hz, 1H, H1), 7.66 (d, J = 7.2 Hz, 1H, H8), 7.49 (td, J = 7.6, 1.2 Hz, 1H, H6), 7.30-
7.25 (m, 2H, H2, H7), 1.44 (s, 12H, H2’) ppm. 
13C NMR (125 MHz, CDCl3): δ 194.43 (C9), 149.87 (C4a), 145.91 (C4b), 142.60 (C3), 134.91 (C6), 
134.59 (C8a/9a), 134.48 (C8a/9a), 129.03 (C2/7), 128.03 (C2/7), 126.62 (C1), 124.78 (C5), 123.93 (C8), 
84.58 (C1’), 25.12 (C2’) ppm. C4 could not be observed.  
HR-ESI-MS: m/z 329.131; calcd for C19H19BO3Na, [M+Na]+ 329.132. 
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3.6.3 1,3,5-Tri(4-9H-fluorenoyl)benzene (3-1) 
 
Method 1: A solution of toluene (10 mL), water (10 mL) and n-propanol (3 mL) was bubbled 
with argon for 15 min. Boronic ester 3-2 (0.200 g, 0.653 mmol), tribromobenzene 3-6 (52 mg, 
82 μmol), dichlorobis(triphenylphosphine)palladium(II) (34 mg, 49 μmol) and potassium 
carbonate (0.273 g, 1.99 mmol) were added and the resultant mixture was heated at 80 °C for 
18 h under argon. The reaction mixture was cooled and diluted with toluene. The organic 
phase was washed with water, dried over MgSO4 and the solvent removed in vacuo. The 
organic residue was purified via column chromatography (SiO2, DCM) to yield 3-1 as a pale 
yellow solid (17 mg, 28 μmol, 17%). 
Method 2: A solution of toluene (10 mL), water (5 mL) and n-propanol (1 mL) was bubbled 
with argon for 15 min. Triboronic ester 3-7 (0.384 g, 0.842 mmol), bromofluorenone 2-25 (1.00 
g, 3.86 mmol), tris(dibenzylideneacetone)dipalladium(0) (26 mg, 29 μmol), tri-tert-
butylphosphonium tetrafluoroborate (34 mg, 0.12 mmol) and potassium carbonate (1.6 g, 12 
mmol) were added and the resultant solution was heated at 80 °C for 18 h under argon. The 
reaction mixture was cooled and diluted with toluene. The organic phase was washed with 
water, dried over MgSO4 and the solvent removed in vacuo. The residue was purified via 
column chromatography (SiO2, DCM) to yield 3-1 as a pale yellow solid (0.286 g, 0.467 mmol, 
48%). 
Method 3: Ethynyl fluorenone 2-16 (1.00 g, 4.91 mmol) in 1,4-dioxane (30 mL) was bubbled 
with argon for 15 min. Dicobaltoctacarbonyl (0.167 g, 0.488 mmol) was added and the 
resulting dark solution was heated at reflux for 18 h. The mixture was cooled and the solvent 
removed in vacuo. The organic residue was purified via column chromatography (SiO2, DCM) 
to yield a mixture of 3-1 and 1,2,4-trifluorenoylbenzene that could not be separated 
chromatographically (0.683 g, 1.11 mmol, 68%). 
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1H NMR (500 MHz, CDCl3): δ 7.74 (s, 3H, H2), 7.73 (dd, J = 7.5, 1.0 Hz, 3H, H1’), 7.70 (d, J = 7.5 
Hz, 3H, H8’), 7.47 (d, J = 7.5 Hz, 3H, H3’), 7.37 (t, J = 7.5 Hz, 3H, H2’), 7.24 (br s, 3H, H7’), 7.10 (br 
s, 6H, H5’, H6’) ppm. 
13C NMR (125 MHz, CDCl3): δ 193.45 (C9’), 144.46 (C4b’), 141.21 (C4a’), 140.95 (C1), 136.96 (C4’), 
136.52 (C3’), 135.04 (C9a’), 134.77 (C8a’), 134.33 (C6’), 129.37 (C2), 129.25 (C7’), 129.23 (C2’), 
124.80 (C8’), 124.05 (C1’), 122.76 (C5’) ppm. 
MALDI-TOF MS: m/z 612.10; calcd for C45H24O3, [M]+ 612.17. 
3.6.4 4-Acetyl-9H-fluorene (3-8) 
 
Benzene (25 mL) was bubbled with argon for 15 min. Aluminium(III) chloride (0.463 g, 3.47 
mmol) and 3-9 (0.371 g, 1.16 mmol) was added and the resultant mixture was heated at 60 °C 
for 5 h under argon. The mixture was cooled to RT and poured into ice-cold water. The mixture 
was extracted with ether and the organic phase washed with aq. HCl (2 M), water, dried over 
MgSO4 and the solvent removed in vacuo. The residue was purified via column 
chromatography (SiO2, 50:50 DCM/PE) to yield 3-8 as a colourless oil (0.112 g, 0.538 mmol, 
46%). 
1H NMR (500 MHz, CDCl3): δ 8.07-8.03 (m, 1H, H5), 7.64 (d, J = 7.5 HZ, 1H, H1), 7.57-7.54 (m, 
2H, H3,8), 7.37-7.31 (m, 3H, H2,6,7), 3.92 (s, 2H, H9), 2.73 (s, 3H, COCH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 203.35 (COCH3), 145.28 (C9a), 144.11 (C8a), 140.17 (C4b), 138.83 
(C4a), 135.90 (C4), 127.81 (C1), 127.58 (C7), 126.91 (C6), 126.60 (C3), 126.10 (C2), 124.86 (C8), 
124.26 (C5), 37.03 (C9), 30.36 (COCH3) ppm. 
HR-ESI-MS: m/z 231.077; calcd for C15H12ONa, [M+Na]+ 231.078. 
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3.6.5 Attempted synthesis of 1,3,5-tri(4-9H-fluorenyl)benzene (3-10) 
 
Triflic acid (1 mL) and 3-8 (55 mg, 0.264 mmol) were combined and heated at 120 °C for 20 h. 
The black mixture was cooled to RT, extracted with DCM and the organic phase washed with 
aq. NaOH (2 M), water, dried over MgSO4 and the solvent removed in vacuo to yield a black 
mixture of unidentifiable products by 1H NMR and MALDI-TOF MS.  
3.6.6 1,3,5-Tri(4-(9,9-dibutyl-9H-fluorenyl))benzene (3-13) 
 
A solution of 3-1 (96 mg, 0.16 mmol) in dry THF (20 mL) was cooled to -78 °C under argon. n-
BuLi (2 M in cyclohexane, 0.80 mL, 1.6 mmol) was added dropwise and the solution was 
allowed to warm to RT over 18 h. The reaction was quenched with water and extracted with 
DCM. The organic phase was washed with water, dried over MgSO4 and the solvent removed 
in vacuo. The organic residue was dissolved in dry DCM (20 mL) and cooled to 0 °C under 
argon. Triethylsilane (0.20 mL, 0.15 g, 1.3 mmol) and BF3·Et2O (0.20 mL, 0.23 g, 1.6 mmol) 
were added and the solution was stirred for 2 h. The reaction was quenched with sat. aq. 
sodium bicarbonate, extracted with DCM and the organic phase washed with water, dried 
over MgSO4, the solvent removed in vacuo. The residue was purified via column 
chromatography (SiO2, 25:75 DCM:PE) to yield a colourless film. The film was dissolved in dry 
THF (10 mL) and n-BuLi (2 M in cyclohexane, 0.80 mL, 1.6 mmol) was added dropwise under 
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argon. The dark purple solution was stirred for 5 min before iodobutane (0.20 mL, 0.32 g, 1.7 
mmol) was added dropwise. The pale red solution was stirred for 2 h under argon. The 
reaction was quenched with water and extracted with DCM. The organic phase was washed 
with water, dried over MgSO4 and the solvent removed in vacuo. The colourless residue was 
purified via column chromatography (SiO2, PE) to yield 3-13 as a white powder (17 mg, 19 
μmol, 12%). 
1H NMR (500 MHz, CDCl3): δ 7.76-7.70 (m, 3H, Ar), 7.69-7.62 (s, 1H, Ar), 7.45-7.28 (m, 13H, 
Ar), 7.21-7.12 (m, 4H, Ar), 6.93 (t, J = 7.4 Hz, 2H, Ar), 6.77 (s, 1H, Ar), 1.99-1.94 (m, 12H, 
CH2CH2CH2CH3), 1.07 (sext, J = 7.4 Hz, 12H, CH2CH2CH2CH3), 0.69-0.57 (m, 30H, CH2CH2CH2CH3) 
ppm. 
13C NMR (125 MHz, CDCl3): δ 151.68 (C8a’/9a’), 151.31 (C8a’/9a’), 141.75 (C4a’/4b’), 141.13 (C4a’/4b’), 
138.29 (C1/4’), 137.28 (C1/4’), 129.38, 128.91, 126.79, 126.59, 126.36, 123.03, 122.78, 121.98, 
54.46 (C9’), 40.58 (CH2CH2CH2CH3), 26.04 (CH2CH2CH2CH3), 23.22 (CH2CH2CH2CH3), 13.92 
(CH2CH2CH2CH3) ppm. 
MALDI-TOF MS: 849.54 m/z; calcd for C65H69, [M-Bu]+ 849.54. 
3.6.7 Attempted synthesis of 3,3,8,8,13,13-hexa(n-butyl)trifluoreno[3,4,5,6-
efghi:3’,4’,5’,6’-klmno:3’’,4’’,5’’6,’’-qrabc]coronene (3-14) 
 
A solution of 3-13 (17 mg, 19 μmol) in DCM (10 mL) was bubbled with N2 for 10 min. FeCl3 
(0.146 g, 0.899 mmol) in nitromethane (1 mL) was added dropwise and the resultant black 
solution was stirred with slow bubbling for 30 min. The reaction was quenched with MeOH 
(10 mL), extracted with DCM and washed with water. The organic phase was dried over MgSO4 
and the solvent removed in vacuo. The yellow residue was passed through a short plug (SiO2, 
DCM) to afford a mixture of products by MALDI-TOF MS. 
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3.6.8 Attempted synthesis of 2,6-di(tert-butyl)-9,10-di(4-9H-fluorenoyl)-4H-
cyclopenta[def]triphenylene (3-21) 
 
A solution of 3-17 (91 mg, 0.14 mmol), boronic ester 3-2 (0.150 g, 0.490 mmol) and potassium 
carbonate (0.135 g, 0.977 mmol) in toluene (6 mL), water (3 mL) and n-propanol (1 mL) was 
bubbled with argon for 15 min. Tris(dibenzylideneacetone)dipalladium(0) (5 mg, 5 μmol) and 
tri-tert-butylphosphonium tetrafluoroborate (6 mg, 20 μmol) were added and the resultant 
mixture was heated at 70 °C for 2 d under argon. The reaction was cooled and extracted with 
DCM. The organic phase was washed with water, dried over MgSO4 and the solvent removed 
in vacuo. The residue was purified via column chromatography (SiO2, 50:50 DCM/PE) to yield 
a number of singly-coupled products by MALDI-TOF MS and 1H NMR. 
3.6.9 4,4’-Bifluorenone (3-22) 
 
A mixture of 2-25 (0.200 g, 0.772 mmol), 3-2 (0.285 g, 0.931 mmol), potassium carbonate 
(0.426 g, 3.09 mmol), toluene (10 mL), water (5 mL) and propanol (1 mL) was bubbled with 
argon for 15 min. Dichlorobis(triphenylphosphine)palladium(II) (58 mg, 79 μmol) was added 
and the resultant mixture was heated at 80 °C for 18 h under argon. The mixture was cooled 
to RT, extracted with DCM and the organic phase washed with water, dried over MgSO4 and 
the solvent removed in vacuo. The residue was purified via column chromatography (SiO2, 
50:50 DCM/PE) to yield 3-22 as a yellow powder (0.140 g, 0.391 mmol, 51%). 
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1H NMR (500 MHz, CDCl3): δ 7.83 (dd, J = 6.8, 1.6 Hz, 1H, H1), 7.65 (ddd, J = 7.1, 1.4, 0.7 Hz, 1H, 
H8), 7.47-7.41 (m, 2H, H2, H3), 7.18 (td, J = 7.5, 1.0 Hz, 1H, H7), 7.14 (td, J = 7.5, 1.4 Hz, 1H, H6), 
6.61-6.58 (m, 1H, H5) ppm. 
13C NMR (125 MHz, CDCl3): δ 193.70 (C9), 143.98 (C4b), 141.88 (C4a), 136.15 (C3), 135.07 (C4/9a), 
135.04 (C6), 134.53 (C4/9a), 134.38 (C8a), 129.58 (C2), 129.24 (C7), 124.50 (C8), 124.42 (C1), 
122.79 (C5) ppm. 
HR-ESI-MS: m/z 381.086; calcd for C26H14O2Na, [M+Na]+ 381.089. 
3.6.10 9,9,9’,9’-Tetra(n-butyl)-4,4’-bifluorene (3-24) 
 
A solution of 3-22 (0.120 g, 0.335 mmol) in dry THF (10 mL) was cooled to -78 °C under argon. 
n-BuLi (2 M in cyclohexane, 0.70 mL, 1.4 mmol) was added dropwise and the red solution was 
allowed to warm to RT over 18 h. The reaction was quenched with water and extracted with 
DCM. The organic phase was washed with water, dried over MgSO4 and the solvent removed 
in vacuo. The residue was dissolved in dry DCM (10 mL) and cooled to 0 °C under argon. 
Triethysilane (0.21 mL, 0.16 g, 1.3 mmol) and BF3·Et2O (0.17 mL, 0.19 g, 1.3 mmol) were added 
then stirred for 2 h. The reaction was quenched with sat. aq. sodium bicarbonate, extracted 
with DCM and washed with water. The organic phase was dried over MgSO4, the solvent 
removed in vacuo and the residue purified via column chromatography (SiO2, 25:75 DCM:PE) 
to yield a colourless film. The film was dissolved in dry THF (10 mL) and cooled to -78 °C under 
argon. Potassium tert-butoxide (0.200 g, 3.1 mmol) was added and the red solution was stirred 
for 5 min. Iodobutane (0.20 mL, 0.32 g, 1.7 mmol) was added dropwise and the solution was 
allowed to warm to RT over 18 h. The reaction was quenched with water and extracted with 
DCM. The organic phase was washed with water, dried over MgSO4 and the solvent removed 
in vacuo. The colourless residue was purified via column chromatography (SiO2, PE) to yield 3-
24 as a colourless film (37 mg, 66 μmol, 20%). 
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1H NMR (500 MHz, CDCl3): δ 7.47-7.41 (m, 4H, H1,2), 7.26 (dd, J = 6.9, 1.4 Hz, 2H, H3), 7.23 (d, J 
= 7.4 Hz, 2H, H8), 7.07 (t, J = 7.5 Hz, 2H, H7), 6.74 (t, J = 7.8 Hz, 2H, H6), 6.44 (d, J = 7.8 Hz, 2H, 
H5), 2.14-1.94 (m, 8H, CH2CH2CH2CH3), 1.20-1.07 (m, 8H, CH2CH2CH2CH3), 0.80-0.55 (m, 8H, 
CH2CH2CH2CH3), 0.77 (t, J = 7.3 Hz, 6H, CH2CH2CH2CH3), 0.71 (t, J = 7.3 Hz, 6H, CH2CH2CH2CH3) 
ppm. 
13C NMR (125 MHz, CDCl3): δ 151.25 (C9a), 150.78 (C8a), 141.24 (C4b), 138.95 (C4a), 135.86 (C4), 
128.32 (C3), 127.09 (C2), 126.65 (C7), 126.35 (C6), 122.54 (C5), 122.31 (C8), 122.16 (C1), 54.60 
(C9), 40.90 (CH2CH2CH2CH3), 40.73 (CH2CH2CH2CH3), 26.25 (CH2CH2CH2CH3), 26.06 
(CH2CH2CH2CH3), 23.39 (CH2CH2CH2CH3), 23.26 (CH2CH2CH2CH3), 14.21 (CH2CH2CH2CH3), 13.98 
(CH2CH2CH2CH3) ppm. 
MALDI-TOF MS: 497.30 m/z; calcd for C38H41, [M-Bu]+ 497.32. 
3.6.11 Attempted synthesis of 1,1,7,7-tetra(n-butyl)-1,7-dihydrodiindeno- 
[3,4-fghi:3’,4’-opqr]tetracene (3-23) 
 
A solution of 3-24 (19 mg, 33 μmol) in DCM (15 mL) was bubbled with N2 for 10 min. FeCl3 (44 
mg, 0.27 mmol) in nitromethane (1 mL) was added dropwise and the resultant dark red 
solution was stirred with bubbling for 30 min. The reaction was quenched with MeOH (10 mL), 
extracted with DCM and washed with water. The organic phase was dried over MgSO4 and the 
solvent removed in vacuo. The pale yellow residue was passed through a short plug (SiO2, 




3.6.12 2-Bromo-2’-ethoxycarbonyl-4-methylbiphenyl (3-30) 
 
Toluene (20 mL) was bubbled with argon for 10 min. 2-Bromo-1-iodo-4-methylbenzene (1.19 
g, 4.00 mmol), 2-(ethoxycarbonyl)phenylboronic acid (1.00 g, 5.15 mmol), 
dichlorobis(triphenylphosphine)palladium(II) (0.088 g, 0.12 mmol) and potassium carbonate 
(2.71 g, 19.6 mmol) were added and the resultant suspension was heated at 100 °C for 18 h. 
The tan suspension was cooled, water added and extracted with DCM three times. The orange 
organic phase was dried over MgSO4 and the solvent removed in vacuo. The residue was 
purified via column chromatography (SiO2, 50:50 DCM/PE) to yield 3-30 as a pale yellow oil 
(0.842 g, 2.64 mmol, 66%). 
1H NMR (500 MHz, CDCl3): δ 8.02 (dd, J = 7.8, 1.3 Hz, 1H, H3’), 7.55 (td, J = 7.5, 1.5 Hz, 1H, H5’), 
7.48-7.44 (m, 2H, H3,4’), 7.24 (dd, J = 7.6, 1.2 Hz, 1H, H6’), 7.17-7.14 (m, 1H, H5), 7.12 (d, J = 7.7 
Hz, 1H, H6), 4.17-4.08 (m, 2H, OCH2CH3), 2.38 (s, 3H, CH3), 1.06 (t, J = 7.1 Hz, 3H, OCH2CH3) 
ppm. 
13C NMR (125 MHz, CDCl3): δ 167.16 (COOEt), 142.19 (C1’), 139.99 (C1), 138.79 (C4), 132.66 (C3), 
131.71 (C5’), 131.24 (C6’), 130.79 (C2’), 130.21 (C3’), 129.94 (C6), 127.86 (C5/4’), 127.85 (C5/4’), 
122.83 (C2), 60.95 (OCH2CH3), 20.96 (CH3), 13.86 (OCH2CH3) ppm. 




3.6.13 4-Bromo-2-methylfluorenone (3-25) 
 
Biphenyl 3-30 (0.30 g, 0.94 mmol) was dissolved in methanesulfonic acid (5 mL) and heated at 
100 °C for 18 h. The hot mixture was poured into ice-cold water, extracted with DCM and the 
organic phase washed with aq. NaOH (2M), dried over MgSO4 and the solvent removed in 
vacuo. The residue was recrystallised from EtOH to yield 3-25 as a yellow microcrystalline solid 
(0.173 g, 0.63 mmol, 67%). 
1H NMR (500 MHz, CDCl3): δ 8.29 (d, J = 7.6 Hz, 1H, H5), 7.68 (ddd, J = 7.4, 1.2, 0.8 Hz, 1H, H8), 
7.52 (ddd, J = 7.6, 7.6, 1.3 Hz, 1H, H6), 7.45-7.42 (m, 2H, H1,3), 7.32 (ddd, J = 7.5, 7.5, 0.8 Hz, 
1H, H7), 2.36 (s, 3H, CH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 192.91 (C9), 144.10 (C4b), 140.93 (C2), 139.92 (C4a), 139.62 (C3), 
136.97 (C9a), 134.87 (C6), 134.36 (C8a), 129.23 (C7), 124.52 (C8), 124.22 (C1), 123.25 (C5), 117.35 
(C4), 21.02 (CH3) ppm. 
HR-ESI-MS: m/z 294.970; calcd for C14H9BrONa, [M+Na]+ 294.970.  




3.6.14 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)fluorenone (3-27) 
 
A mixture of 3-25 (0.686 g, 2.51 mmol), bis(pinacolato)diboron (0.955 g, 3.77 mmol) and 
potassium acetate (1.48 g, 15.1 mmol) in 1,4-dioxane (20 mL) was bubbled with argon for 15 
min. Dichloro[1,1’-bis(diphenylphosphino)ferrocene]palladium(II) (55 mg, 75 μmol) was 
added and the resultant suspension was heated at 90 °C for 18 h under argon. The mixture 
was cooled to RT and the solvent removed in vacuo. The residue was extracted with DCM, 
washed with brine, then water. The organic phase was dried over MgSO4 and the solvent 
removed in vacuo. The residue was purified via column chromatography (SiO2, 50:50 DCM/PE) 
to yield 3-27 as a yellow powder (0.343 g, 1.07 mmol, 43%). 
1H NMR (500 MHz, CDCl3): δ 8.46 (d, J = 7.7 Hz, 1H, H5), 7.74-7.73 (m, 1H, H3), 7.62 (d, J = 7.4 
Hz, 1H, H8), 7.56-7.55 (m, 1H, H1), 7.46 (td, J = 7.5, 1.1 Hz, 1H, H6), 7.24 (t, J = 7.3 Hz, 1H, H7), 
2.37 (s, 3H, CH3), 1.44 (s, 12H, H2’) ppm. 
13C NMR (125 MHz, CDCl3): δ 194.69 (C9), 147.31 (C4a), 146.07 (C4b), 142.86 (C3), 138.03 (C9a), 
134.87 (C6), 134.73 (C8a), 128.58 (C7), 127.38 (C1), 124.42 (C5), 123.84 (C8), 84.52 (C1’), 25.11 
(C2’), 21.19 (CH3) ppm. C2 and C4 could not be observed. 




3.6.15 2,2’-Dimethyl-4,4’-bifluorenone (3-26) 
 
A mixture of 3-25 (0.250 g, 0.915 mmol), 3-27 (0.343 g, 1.07 mmol), potassium carbonate 
(0.608 g, 4.4 mmol), toluene (10 mL), water (5 mL) and propanol (1 mL) was bubbled with 
argon for 15 min. Dichlorobis(triphenylphosphine)palladium(II) (0.077 g, 0.110 mmol) was 
added and the resultant mixture was heated at 80 °C for 18 h under argon. The mixture was 
cooled to RT, extracted with DCM and the organic phase washed with water, dried over MgSO4 
and the solvent removed in vacuo. The residue was purified via column chromatography (SiO2, 
50:50 DCM/PE) to yield 3-26 as a yellow powder (0.259 g, 0.670 mmol, 73%).   
1H NMR (500 MHz, CDCl3): δ 7.63-7.60 (m, 4H, H1, H8), 7.22-7.21 (m, 2H, H3), 7.14 (td, J = 7.5, 
1.3 Hz, 2H, H7), 7.12 (td, J = 7.5, 1.5 Hz, 2H, H6), 6.62-6.58 (m, 2H, H5), 2.44 (s, 6H, CH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 193.94 (C9), 144.28 (C4b), 139.92 (C4), 139.23 (C4a), 136.42 (C3), 
135.24 (C9a), 135.02 (C6), 134.48 (C8a), 128.73 (C7), 125.08 (C1), 124.37 (C8), 122.39 (C5), 21.42 
(CH3) ppm. C2 could not be observed. 




3.6.16 9,9,9’,9’-Tetra(n-butyl)-2,2’-dimethyl-4,4’-bifluorene (3-28) 
 
A solution of 3-26 (0.120 g, 0.31 mmol) in dry THF (20 mL) was cooled to -78 °C under argon. 
n-BuLi (2 M in cyclohexane, 0.62 mL, 2.7 mmol) was added dropwise and the red solution was 
allowed to warm to RT over 18 h. The reaction was quenched with water and extracted with 
DCM. The organic phase was washed with water, dried over MgSO4 and the solvent removed 
in vacuo. The organic residue was dissolved in dry DCM (20 mL) and cooled to 0 °C under 
argon. Triethylsilane (0.20 mL, 0.15 g, 1.3 mmol) and BF3·Et2O (0.20 mL, 0.23 g, 1.6 mmol) 
were added and the resultant solution was stirred for 2 h. The reaction was quenched with 
sat. aq. sodium bicarbonate, extracted with DCM and the organic phase washed with water, 
dried over MgSO4 and the solvent removed in vacuo. The residue purified via column 
chromatography (SiO2, PE) to yield a colourless film. The film was dissolved in dry THF (5 mL) 
and n-BuLi (2 M in cyclohexane, 0.12 mL, 0.24 mmol) was added dropwise under argon. The 
dark red solution was stirred for 5 min before iodobutane (0.20 mL, 0.32 g, 1.7 mmol) was 
added dropwise. The pale yellow solution was stirred for 2 h under argon. The reaction was 
quenched with water and extracted with DCM. The organic phase was washed with water, 
dried over MgSO4 and the solvent removed in vacuo. The colourless residue was purified via 
column chromatography (SiO2, PE) to yield 3-28 as a white powder (16 mg, 27 μmol, 15%). 
1H NMR (500 MHz, CDCl3): δ 7.23-7.19 (m, 4H, H1,8), 7.06-7.00 (m, 4H, H3,7), 6.72 (td, J = 7.8, 
1.1 Hz, 2H, H6), 6.46 (d, J = 7.7 Hz, 2H, H5), 2.49 (s, 6H, CH3), 2.09-1.95 (m, 8H, CH2CH2CH2CH3), 
1.20-1.08 (m, 8H, CH2CH2CH2CH3), 0.80-0.53 (m, 20H, CH2CH2CH2CH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 151.39 (C9a), 150.63 (C8a), 141.41(C4b), 136.90 (C2/4), 136.32 (C4a), 
135.62 (C2/4), 129.10 (C3), 126.26 (C6), 126.12 (C7), 122.71 (C1), 122.21 (C8), 122.17 (C5), 54.41 
(C9), 40.96 (CH2CH2CH2CH3), 40.89 (CH2CH2CH2CH3), 26.27 (CH2CH2CH2CH3), 26.05 
(CH2CH2CH2CH3), 23.42 (CH2CH2CH2CH3), 23.30 (CH2CH2CH2CH3), 21.89 (CH3), 14.24 
(CH2CH2CH2CH3), 13.99 (CH2CH2CH2CH3) ppm. 
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MALDI-TOF MS: 582.42 m/z; calcd for C44H54, [M]+ 582.42. 
3.6.17 Attempted synthesis of 1,1,7,7-tetrabutyl5,11-dimethyl-1,7-dihydro-diindeno[3,4-
fghi:3’,4’-opqr]tetracene (3-29) 
 
A solution of 3-28 (17 mg, 29 μmol) in DCM (10 mL) was bubbled with N2 for 10 min. FeCl3 (38 
mg, 0.233 mmol) in nitromethane (0.5 mL) was added dropwise and the resultant dark brown 
solution was stirred with bubbling for 30 min. The reaction was quenched with MeOH (10 mL), 
extracted with DCM and washed with water. The organic phase was dried over MgSO4 and the 
solvent removed in vacuo. The pale yellow residue was passed through a short plug (SiO2, 
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This chapter describes the synthesis and reactivity of bay-functionalised hexa-peri-
hexabenzocoronenes. Due to a limited number of examples of post-cyclodehydrogenation bay 
functionalisation of HBCs in the literature, none of which are regioselective, the development 





Following the unsuccessful attempts at pre-cyclodehydrogenative incorporation of multiple 
peripheral rings onto an HBC core (Chapter 3), attention turned to the formation of a suitable 
HBC core from which further functionality could be added post-cyclodehydrogenation 
(Scheme 4.1). This synthetic strategy posed two initial issues: the low functional group 
tolerance of oxidative cyclodehydrogenation reactions, and limited established methods for 
bay-region functionalisation of HBCs.  
 
Scheme 4.1: General methodology investigated to methylene bridge incorporation. 
A handful of single-step post-cyclodehydrogenation functionalisations have been reported at 
the 2 position. The first report, by Ito et al. investigated a number of Pd- or Cu-mediated cross-
coupling reactions to a bromo-substituted HBC (Figure 4.1).1 A number of functional groups 
were successfully installed including amino, ether, ester and nitrile groups. Further 
cross-coupling reactions upon bromo HBCs have since been reported, including Sonogashira2 




Figure 4.1: Post-cyclodehydrogenative functionalisation of bromo HBCs reported via cross-coupling reactions.1-
3 Coupled functionality depicted in red. 
An additional notable study is the first multi-step post-cyclodehydrogenative functionalisation 
of an HBC by Yamaguchi et al., investigating the formation of a stable HBC-based 
benzoquinone (Scheme 4.2).4 Ir-catalysed direct borylation was demonstrated, allowing for 
addition of boronic ester functionality to the unsubstituted rings of the HBC. The boryl groups 
were then oxidised with H2O2, giving a diol which upon further oxidation did not give the 




Scheme 4.2: Synthesis of a tetraoxo HBC by Yamaguchi et al.4 
A study by Li et al. further extended upon the synthesis towards a HBC-based benzoquinone, 
where additional methyl functionality was appended to circumvent the over oxidation 
observed (Scheme 4.3).5 Instead of direct borylation, selective bromination followed by 
Miyaura borylation was utilised, before oxidation to the alcohol. Upon oxidation with PbO2, 




Scheme 4.3: Synthesis of a dioxo HBC by Li et al.5 Desired benzoquinone-like functionality depicted in red. 
Despite these known functionalisations possible upon a HBC, they all occur at the least 
sterically-hindered 2 position. For the purposes of this project, selective functionalisation 
must occur in the more hindered bay sites (1 or 3 position; Figure 1.5). One example of bay 
functionalisation is two sulfur appended HBCs reported by Tan et al (Scheme 4.4).6 In this 
study, a perchlorinated HBC was appended with phenylthio substitutents, with unexpected 
thioether bridging occurring at two or three bay sites. Despite the efficiency of this method, 
with multiple 5-membered rings formed simultaneously, this method does not provide regio-




Scheme 4.4: Bay-functionalised HBCs reported by Tan et al.6 
For the purposes of this research, two functional groups were proposed to be incorporated 
onto an HBC before an investigation into post-cyclodehydrogenative functionalisation was 
undertaken: methyl and bromo groups. These were chosen for their synthetic utility as well 
as their known tolerance to oxidative cyclodehydrogenative conditions.1, 7 Of the possible 
arrangements to have these functional groups, a 1,3-disubstituted HBC was chosen for a 
number of reasons. Firstly, the simplicity of the starting materials required, with the readily 
available 1,3,5-substituted benzenes being a varied and often cheap precursor. Secondly, only 
three well established steps are required to get to a HBC, namely a Sonogashira cross-
coupling, a Diels-Alder reaction and a cyclodehydrogenation (Scheme 4.5). Thirdly, up to five 
solubilising tert-butyl groups can be appended to the periphery, thereby minimizing potential 
solubility issues from aggregation. Finally, the system contains a mirror plane, giving a simpler 




Scheme 4.5: General synthetic strategy towards 1,3-disubstituted hexa-peri-hexabenzocoronenes. X = halogen, 
R = Me or Br. 
Both sites of interest on the same ring could also give insights for application on more highly 
substituted derivatives. Predominantly of interest is whether multiple simultaneous reactions 
on the same ring are able to be achieved, a potential issue, which would have to be mitigated 
before more highly-bridged derivatives could be synthesised, which would require this 
substitution pattern (Figure 4.2).  
 
Figure 4.2: Proposed test HBC scaffold (left) and proposed extension HBC scaffold (right). 
One concern when undertaking this method was the steric bulk of the substituents in the bay 
region. If the added groups are too bulky, complete fusion to form the HBC core may be slow 
or even prevented. Additionally, the crucial solubilising bulky tert-butyl groups present on the 
neighbouring ring (5 and 17 positions) may be too bulky for certain reactions to occur on 
neighbouring rings.  
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4.2 Methyl-Substituted HBC 
The first 1,3-disubstituted target investigated was dimethyl HBC 4-4. Hexaphenylbenzene 4-3 
was able to be synthesised in high yields over two steps from iodoxylene 4-1 utilising a 
Sonogashira cross-coupling with 4-tert-butylphenylacetylene, followed by a Diels-Alder 
reaction with cyclopentadienone 2-2 (Scheme 4.6). Iodoxylene was chosen as the starting 
material over bromoxylene due to formation of chromatographically inseparable by-products 
from the desired acetylene 4-2 in test reactions.  
 
Scheme 4.6: Synthesis of methyl HBC 4-4 from 4-1. 
Cyclodehydrogenation of 4-3 with the standard 4 eq. of FeCl3 per bond formed (24 eq. in total) 
for 30 min, then quenching with MeOH, gave a yellow precipitate. Comparison of the product 
1H NMR with the HPB showed the distinctive shift of the aromatic protons from the shielded 
HPB to the deshielded HBC, as well as a reduction in multiplicity from many overlapping 
multiplets to distinct singlets and finely split doublets (Figure 4.3). MALDI-TOF MS of the 
product was consistent with 6 bonds being formed and the loss of 12 hydrogens, with the 




Figure 4.3: 1H NMR spectrum of 4-4. 
 
Figure 4.4: MALDI spectra of 4-3 (top) and 4-4 (bottom). 
Following this success, HBC 4-4 was treated under oxidative conditions in an effort to obtain 
a dicarboxylic acid 4-5 (Scheme 4.7). This would then be used in an intramolecular Friedel-
Crafts acylation to give diketone 4-6 in a manner similar to Hoggard’s method to fluorenone, 




Potassium permanganate was used in a refluxing mixture of H2O/t-BuOH or H2O/pyridine 
mixture; however, starting material was recovered with trace amounts of decomposed 
products which were unable to be identified by 1H NMR or MALDI-TOF MS. Due to previous 
difficulties in oxidising methyl HBCs, not reported in this thesis, oxidation was not pursued 
further in favour of a more promising method recently reported by Liu et al.12  
 
Scheme 4.7: Initial synthetic route towards dibridged 4-6 via benzylic oxidation. 
In this study (Scheme 4.8), methyl PAH 4-7 underwent a radical bromination with 
N-bromosuccinimide to form the analogous benzyl bromide 4-8, providing a mixture of 
brominated products that then underwent nucleophilic substitution with potassium acetate. 
The mixture was then able to be separated by column chromatography before the desired 
diacetate 4-9 could be hydrolysed to form a benzyl alcohol. Diol 4-10 could then be oxidised 
to the corresponding aldehyde 4-11 with pyridinium chlorochromate in a yield of 32% over 
the four steps. The aldehyde 4-11 was susceptible to addition in the presence of strong 
nucleophiles such as alkyllithium or Grignard reagents, to produce a number of secondary 
alcohols 4-12. The alcohols could then undergo an intramolecular Friedel-Crafts alkylation, 




Scheme 4.8: Synthetic route to 4-14 taken by Liu et al.12 
Applying similar reaction conditions to dimethyl 4-4 proved fruitful, with synthesis of the 
dialdehyde 4-18 being achieved in comparable yields (Scheme 4.9). The structures of 4-16 and 
4-18 were confirmed by MALDI-TOF MS (Figure 4.5), 1H (Figure 4.6) and 13C NMR. The 1H NMR 
spectrum of 4-18 exhibited a distinctive aldehyde peak at ca 10 ppm, confirming the formation 
of the desired functionality along with a 13C NMR carbonyl signal at 192.00 ppm. Comparison 
between the spectra of 4-4 and 4-18 showed the addition of an aldehyde to the HBC resulted 
in a notable downfield shift of 0.5 ppm for H2 as well as a shielding effect upon adjacent bay 
protons H4 and H18, giving an upfield shift of 1 ppm. The protons further away from the 








Figure 4.5: MALDI-TOF MS spectra of acetate 4-16 and formyl 4-18. 
 
Figure 4.6: Aromatic region of the 1H NMR spectrum of 4-18. 
Treatment of formyl 4-18 with strong nucleophiles proved troublesome. Despite a number of 
attempts treating 4-18 with n-butyllithium or methylmagnesium bromide, no reaction was 
observed to occur, with the complete recovery of the starting material over a range of reaction 
temperatures from -78 °C to refluxing THF attempted. This inertness to nucleophilic addition 
is presumed to be due to the sterics of the system, with the approach required for the 
nucleophile hindered by the plane of the HBC. This is in contrast to the related compounds of 
Liu et al., many other carbonyl containing PAHs and even fluorenoylbenzene 2-17 which do 
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undergo these addition reactions. Following these efforts, attention was turned towards the 
alternate bromo functional group. 
4.3 Bromo-Substituted HBC 
A bay brominated HBC was then synthesised in the same manner as the methyl analogue, 
beginning with 4-21 in an overall yield of 48% (Scheme 4.10).  
 
Scheme 4.10: Synthesis of bromo HBC 4-24. 
The successful formation of 4-24 was confirmed by MALDI-TOF MS (Figure 4.7) and NMR (1H 
NMR, Figure 4.8). Distinctive shifts when compared to 4-4 were observed in the 1H NMR 
spectrum, with a downfield shift ca 0.75 ppm for both H4 and H18, which point towards the 




Figure 4.7: MALDI-TOF MS spectrum of 4-24. 
 
Figure 4.8: Aromatic region of the 1H NMR spectrum of 4-24 
The successful synthesis of this HBC was notable, due to the wide and varied chemistry that 
can be applied to aryl bromides; particularly of interest were lithium-halogen exchange, 
followed by quenching with an electrophile and the numerous Pd-catalysed cross-coupling 
reactions. 
Lithiation was chosen as a first test as to whether electrophiles could readily be incorporated 
into the bay of an HBC (Scheme 4.11). Lithiation proceeded by the dropwise addition of a 
solution of tert-butyllithium to bromo HBC 4-24 in dry THF at -78 °C. The solution changed 
124 
 
from yellow to an intense dark green colour, indicative of lithium-halogen exchange. tert-
Butyllithium was utilised as it was found to be sufficiently basic to form the phenyl dianion, 
whereas n-butyllithium could not.13 The newly formed organolithium was then quenched with 
an electrophile, in this case dry diethyl carbonate, to yield the diester 4-25 in a mixture with 
the dehalogenated HBC 4-27 and a trace amount of the mono substituted derivative 4-26. The 
diester was able to be separated from the other products by column chromatography to give 
clean 4-25 in a yield of 36%.  
 
Scheme 4.11: Test incorporation of electrophiles onto HBC 4-24 via lithiation. 
The loss of bromo substituents suggested that complete lithiation was achieved, with the 
following addition-elimination reaction being incomplete. Upon work up with water, the 
remaining organolithio species then protonates. Due to this incomplete reaction, subsequent 
reactions were left stirring under inert conditions at room temperature overnight after diethyl 
carbonate addition, instead of the hour previously used. This resulted in no appreciable 
increase in yield. Further reaction of the diester with methanesulfonic acid, as utilised in the 
formation of fluorenone 2-25, proved unsuccessful, with a mixture of products obtained that 
could not be identified by MALDI-TOF MS (Figure 4.9). Regardless, bay incorporation of an 
electrophile via lithiation proved viable, albeit in low yields, opening up a whole host of 
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chemistry at the periphery (Chapter 5). This is in contrast to the work of Ito et al. on a 2-bromo 
HBC where lithiation was noted to not proceed at all.1 Despite the success of the reaction, low 
yields on a two-fold system rules it out for more highly substituted HBCs, thus alternate 
methods of functionalisation were explored.  
 
Figure 4.9: MALDI-TOF MS spectra of diester 4-25 (top) and the resulting products from its acid treatment 
(bottom).  
The next approach was to install a cyano group. A number of methods exist to install the  cyano 
functionality onto an aryl halide, including those reported for HBCs,1 and then hydrolyse to 
the corresponding carboxylic acid (Scheme 4.12). Synthesis proceeded from 4-24 with zinc 
cyanide as the cyanide source in a modified Rosenmund-von Braun reaction. Upon 
precipitation by the addition of the DMF/HBC mixture to water, the bright orange precipitate 
obtained was found to be consistent with the formation of one HBC species by 1H and 13C 
NMR. Corroboration with the MALDI spectrum confirmed the desired product was formed in 
good yields. Hydrolysis was then attempted using acidic and basic conditions, with the most 
common conditions utilised occurring in polar solvents such as water or EtOH,14-16 both of 
which are very poor solvents for HBCs. Regardless, 4-28 was suspended and subjected to a 
number of these conditions, resulting in the isolation of the cyano starting material after work 
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up in every attempt. Treatment of the cyano HBC with a hydride source followed by acidic 
work up was found to form the dialdehyde 4-18, offering a quicker and higher yielding 
pathway.  
 
Scheme 4.12: Synthesis of cyano 4-28 and attempted transformation. 
Following the successful reduction of the dicyano group with a hydride source, a new pathway 
to an HBC with a secondary benzylic alcohol functionality was proposed (Scheme 4.13). This 
synthetic pathway would proceed via a Heck reaction with 4-24 to yield alkene 4-29 which 
upon treatment with acid yields diketone 4-30; this could then be treated with a hydride 




Scheme 4.13: Attempted dibridged synthesis via a Heck reaction. 
The synthesis proceeded in modest yields from dibromo 4-24 with the alkenyl intermediate 
4-29 not being isolated due to the mixture of mono and disubstituted products being unable 
to be separated. Further reaction of the mixture afforded mono and diketone HBCs that were 
able to be separated by column chromatography due to the large difference in polarity, 
isolating clean 4-30 in a yield of 53% over the two steps. Treatment of this dicarbonyl HBC 
with methylmagnesium bromide yet again was found to result in no reaction, with complete 
recovery of starting material; however, treatment with a hydride source, as with cyano 4-28, 
was found to give the diol 4-20 in high yields. As expected, with the formation of two 
stereocentres, two isomers were observed by 1H NMR, with attempts to assign the signals for 
each isomer unable to be achieved due to the number of overlapping signals (Figure 4.10). 
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Using the relative integrations of the quartets at 6.33 and 6.25 ppm, belonging to the methine 
protons, the ratio between the two isomers was found to be 1:1.4. The assignment was further 
supported by MALDI-TOF MS with a species observed at the expected 890.48 m/z (Figure 
4.11).  
 
Figure 4.10: Aromatic region of the 1H NMR spectrum of 4-20. 
  
Figure 4.11: MALDI-TOF MS spectrum of 4-20. 
Acid-mediated intramolecular Friedel-Crafts was then attempted on diol 4-20, but no 
identifiable products were observed including the desired dibridged 4-31; the starting material 
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or elimination of water when subjected with a range of acids including commonly used 
BF3·Et2O and H2SO4. Due to the extensive use of this methodology in the literature,12, 17-19 the 
failure of the desired bridging in this example was postulated to be due to the tert-butyl 
groups sterically blocking the reaction from proceeding. To test this, a new HBC was targeted 
which did not have tert-butyl groups on the neighbouring ring. 
4.4 Less Sterically-Hindered System 
Monosubstituted HBC 4-40 was chosen to test if steric hindrance was preventing bay position 
bridging, with the added advantage that the final product 2-21 had previously been 
synthesised, allowing for quick comparison by 1H NMR. Synthesis proceeded as outlined in the 
previous example, starting from 2-bromoiodobenzene (Scheme 4.14).  
Characterisation of bromo 4-37 and acetyl 4-39 by 13C NMR proved troublesome. This was due 
to the limited solubility of the compounds, even in 50:50 CDCl3/CS2 mixtures, and a lack of 
symmetry in the molecule resulting in insufficient signal intensity for aromatic carbons signals 
to be distinguished even after 48 h collections.   
Additionally, a sample of 4-40 examined by MALDI-TOF MS gave a major species at 772.42 m/z 
instead of the expected 790.42 m/z for the formula C60H54O, along with dimeric and trace 
trimeric products (Figure 4.12). This major species observed was consistent with the 
elimination of water, which is plausible under the oxidising and high energy conditions the 








Figure 4.12: MALDI-TOF MS spectrum of alcohol 4-40. 
Initial attempts for the acid-mediated Friedel-Crafts proved troublesome, where treatment 
with boron trifluoride etherate yielded a mixture of unidentifiable products by MALDI-TOF. A 
method by Sarkar et al. using iron chloride as a Lewis acid was found to yield a product with 
higher order symmetry than the unsymmetrical starting material.20 Comparison of the 1H NMR 
spectrum with that of 2-21 synthesised via the fluorenone route confirmed the successful 
bridging (Figure 4.13), albeit with small differences in chemical shift, thought to be due to 
concentration effects. Subsequent examination by MALDI-TOF MS further confirmed the 
formation of the bridged product. Treatment of diol 4-20 was then investigated using the 
same conditions, but was found to still yield a mixture of unidentifiable products, suggesting 




Figure 4.13: Bridging of 4-40 crude (top) and genuine sample of 2-21 (bottom) 
4.5 Hexa-Substituted system 
Using the knowledge gained on the singly substituted system, design of a synthesis towards a 
hexabromo HBC was then explored, without the previously problematic tert-butyl groups 
present. This HBC was predicted to be insoluble once formed, with post-cyclodehydrogenative 
Heck reactions expected to improve solubility enough for further functionalisation to be 
achievable. Synthesis from acetylene 4-41 proceeded via Co2(CO)8 catalysed 
cyclotrimerisation, providing the expected mixture of isomers in good yield (Scheme 4.15). 
Separation of the symmetrical 4-42a and unsymmetrical 4-42b isomers by chromatography or 




Scheme 4.15: Attempted synthesis of Hexabromo HBC 4-43a. 
The isomeric mixture was then reacted on as the less peripherally hindered 4-43a was 
expected to be more readily formed under oxidative cyclodehydrogenation conditions, and 
ideally would crash out of solution upon quenching with MeOH, leaving the partially-fused or 
non-fused unsymmetrical isomer in solution. If separation could not be achieved, 
modifications incorporating polar functionality were expected to facilitate separation, such as 
hexaacetyl HBCs that are expected to have differing polarities. 
Initial cyclodehydrogenation attempts of the isomeric mixture with 24 eq. of FeCl3 resulted in 
no reaction occurring, with the starting material isolated with no additional peaks observed in 
the 1H NMR spectrum. Further cyclodehydrogenation attempts were made with DDQ/TfOH 
and Cu(OTf)2/AlCl3, but to no avail, with no fusion observed. This was suspected to be due to 
unfavourable electronics, with two bromo groups on one ring and no substituents on the other 
thought to be too electron-deficient for cyclodehydrogenation to occur. This result contrasts 
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with other hexahalo HBCs, with one halogen substitutent per ring, which do undergo 
successful cyclodehydrogenation.21-23 
A tert-butyl appended analogue was then attempted, where the added tertiary alkyl 
functionality increasing the electron density of the rings, hopefully enough for 
cyclodehydrogenation to occur, as in the formation of 4-24. If required, the tert-butyl 
functionality could later be removed after cyclodehydrogenation via a retro Friedel-Crafts 
alkylation (Scheme 4.16).  
 
Scheme 4.16: Attempted synthesis of hexabromo HBC 4-45a. 
This time, instead of no HBC forming, an HBC with 9 aromatic protons was observed in an 
inseparable mixture with a HPB. Two possibilities could result in this observation: either the 
unsymmetrical HBC formed and the symmetrical didn’t, or an unsymmetrical HBC formed 
from the symmetrical HPB with some sort of aryl shift occurring. Analysis of the MALDI-TOF 
MS spectrum revealed that the mixture contained two species consistent with both a HBC and 
the HPB starting material. Attempts at crystallising the product resulted in the crystallisation 
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of some of the symmetrical HPB 4-44a from this mixture (Figure 4.14), suggesting that the 
unsymmetrical isomer formed the HBC, whilst the unsymmetrical did not.  
 
Figure 4.14: Crystal structure of 4-44a which was obtained from the cyclodehydrogenation mixture. 
1H ROESY NMR experiments were undertaken on the product mixture, in an attempt to 
observe any through space interactions between aromatic protons, with the symmetrical HBC 
expected to have none and the unsymmetrical having one; however, no cross peaks could be 
observed. A 13C NMR spectrum of the mixture revealed 42 aromatic signals, consistent with 




Figure 4.15: Aromatic region of the 1H (top) and 13C (bottom) NMR spectra of 4-45b. The peaks between 7.25 
and 6.5 ppm in the 1H NMR spectrum are consistent with HPB 4-44a. 
A potential reason for these observed results is a mixture of electronics and topology. 
Assuming the cyclodehydrogenation behaves in the typical manner, the formation of the first 
carbon-carbon bond is the most difficult step, with the formation of further carbon-carbon 
bonds proceeding more readily after.24 Additionally, bond formation is more favourable 
between two electron rich rings. In the case of 4-44a there is only one combination of rings to 
form new bonds, between an electron rich tert-butyl substituted ring and an electron deficient 
brominated ring. Presumably as this HBC is not formed, the brominated ring is deficient 
enough to prevent cyclodehydrogenation from occurring. In the case of 4-44b there are three 
possible ring combinations for the formation of the first bond; between two tert-butyl 
substituted rings, between two brominated rings or between one of each. The most 
electronically favoured bond formation is between the two electron rich tert-butyl appended 
rings, which upon formation facilitates further bond formation, leading to the formation of 




Scheme 4.17: Proposed rate determining step of the unsymmetrical (left) and symmetrical HBCs undergoing 
cyclodehydrogenation. First bond formed depicted in red, additional bonds formed depicted in blue. 
Further attempts at formation of the symmetrical HBC proved unfruitful, with longer reaction 
times resulting in no additional HBCs forming. Due to the inability to form the symmetrical 
hexabromo HBC, the incorporation of more electron-donating groups or a re-think of potential 
scaffolds is required to obtain a hexabridged HBC, beyond the scope of this thesis. 
4.6 Conclusions 
Methods to bay-functionalise a substituted HBC following cyclodehydrogenation were 
developed. Nucleophilic addition to carbonyl groups in a bay position were found to be 
unsuccessful, with steric hindrance likely to be the cause. An intramolecular Friedel-Crafts 
138 
 
reaction was able to be achieved with an alcoholic HBC, yielding the previously synthesised 
monobridged 2-21, but with steric hindrance from neighbouring tert-butyl groups preventing 
a dibridged example. Attempts to develop a route to a hexabridged example were made; 
however, a suitable hexabromo HBC was unable to be synthesised.  
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4.7 Experimental Section 
4.7.1 General experimental 
For general experimental details see §2.5.1.  
2-Bromoiodobiphenyl 4-3325 was synthesised as reported without significant modification. 
4.7.2 4-tert-Butyl-3’,5’-dimethyldiphenylacetylene (4-2) 
 
Triethylamine (5 mL) was bubbled with argon for 10 min. 1-Iodo-3,5-dimethylbenzene (1.00 
g, 4.31 mmol, 1 eq.), 4-tert-butylphenylacetylene (0.75 g, 4.74 mmol, 1.1 eq.), 
dichlorobis(triphenylphosphine)palladium(II) (75 mg, 0.11 mmol, 0.025 eq.) and copper(I) 
iodide (41 mg, 0.11 mmol, 0.025 eq.) were added and the mixture stirred under an argon 
atmosphere at 60 °C for 2 h. The solvent was removed in vacuo and the residue purified via 
column chromatography (SiO2, 25:75 DCM/PE) to give 4-2 as a white solid (1.05 g, 4.01 mmol, 
97 %). 
1H NMR (500 MHz, CDCl3): δ 7.48 (d, J = 8.5 Hz, 2H, H2’’), 7.38 (d, J = 8.5 Hz, 2H, H3’’), 7.19 (s, 
2H, H2’), 6.98 (s, 1H, H4’), 2.33 (s, 6H, CH3), 1.35 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 151.46 (C4’’), 137.96 (C3’), 131.44 (C2’’), 130.14 (C4’), 129.34 (C2’), 
125.44 (C3’’), 123.24 (C1’), 120.58 (C1’’), 89.20 (C1), 88.99 (C2), 34.91 (C(CH3)3), 31.33 (C(CH3)3), 
21.26 (CH3) ppm.  




4.7.3 1-(3,5-Dimethylphenyl)-2,3,4,5,6-penta(4-tert-butylphenyl)benzene (4-3) 
 
Alkyne 4-2 (1.05 g, 4.01 mmol, 1 eq.), 2-2 (3.94 g, 6.46 mmol, 1.6 eq.) and diphenyl ether (5 
mL) were placed under an argon atmosphere and stirred at 260 °C for 18 h. The mixture was 
cooled to 30-40 °C and diluted with EtOH (30 mL). The white precipitate was isolated by 
filtration and washed with EtOH to yield 4-3 as an off-white powder (2.50 g, 2.97 mmol, 74 %). 
1H NMR (500 MHz, CDCl3): δ 6.85-6.78 (m, 10H, H3’’,3’’’,3’’’’), 6.71-6.65 (m, 10H, H2’’,2’’’,2’’’’), 6.42 
(s, 1H, H4’), 6.37 (s, 2H, H2’), 1.88 (s, 6H, CH3), 1.12 (s, 18H, C(CH3)3), 1.10 (s, 27H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 147.52 (C4’’/4’’’/4’’’’), 147.46 (C4’’/4’’’/4’’’’), 147.44 (C4’’/4’’’/4’’’’), 140.60, 
140.46, 140.40, 140.27, 140.08, 138.23 (x2), 138.17, 135.33, 131.34 (C2’’/2’’’/2’’’’), 131.29 
(C2’’/2’’’/2’’’’), 131.24 (C2’’/2’’’/2’’’’), 130.12 (C2’), 126.28 (C4’), 123.16 (C3’’/3’’’/3’’’’), 123.13 (x2; 
C3’’/3’’’/3’’’’), 34.26 (C(CH3)3), 34.19 (x2; C(CH3)3), 31.37 (C(CH3)3), 31.35 (x2; C(CH3)3), 21.05 (CH3) 
ppm. 




4.7.4 1,3-Dimethyl-5,8,11,14,17-penta(tert-butyl)hexa-peri-hexabenzocoronene (4-4) 
 
HPB 4-3 (1.00 g, 1.18 mmol, 1 eq.) in DCM (200 mL) was bubbled with nitrogen for 10 min. 
FeCl3 (4.62 g, 28.4 mmol, 24 eq.) in nitromethane (10 mL) was added over 5 min and the 
resultant dark red mixture was stirred with bubbling for 30 min. The reaction was quenched 
with MeOH (50 mL) and the mixture poured into stirred MeOH (200 mL). The yellow 
precipitate was isolated by filtration and washed with MeOH to yield 4-4 as a yellow powder 
(0.870 g, 1.05 mmol, 89 %).   
1H NMR (500 MHz, CDCl3): δ 9.34-9.32 (m, 6H, H7,9,10,12,13,15), 9.23 (d, J = 1.4 Hz, 2H, H6,16), 8.98 
(d, J = 1.4 Hz, 2H, H4,18), 7.85 (s, 1H, H2), 3.36 (s, 6H, CH3), 1.84 (x2 s, 27H, C(CH3)3), 1.78 (s, 
18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.27 (C11), 149.16 (C8,14), 147.39 (C5,17), 136.22 (C2), 133.45 
(C1,3), 130.75 (C3b,18a/6a,15b/9a,12b/9b,12a), 130.71 (C3b,18a/6a,15b/9a,12b/9b,12a), 130.62 (C6b,15a), 130.54 
(C3b,18a/6a,15b/9a,12b/9b,12a), 129.39 (C3b,18a/6a,15b/9a,12b/9b,12a), 129.18 (C3a1), 128.22 (C3a,18b), 125.41 
(C4,18), 124.55 (C3b1,15b1), 124.22 (C9b1), 123.93 (C6b1,12b1), 121.31 (C3a2,9b2), 120.72 (C3a2,9b2), 
120.50 (C3b2,15b2/6b2,12b2), 120.09 (C3b2,15b2/6b2,12b2), 119.10 (C7,15/9,13/10,12), 119.02 (C7,15/9,13/10,12), 
118.82 (C7,15/9,13/10,12), 117.97 (C6,16), 35.91 (x2; C(CH3)3), 35.82 (C(CH3)3), 32.21 (C(CH3)3), 32.20 
(C(CH3)3), 32.11 (C(CH3)3), 26.65 (CH3) ppm. 
MALDI-TOF MS: m/z 830.47; calcd for C64H62, [M]+ 830.49. 
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4.7.5 Attempted synthesis of 1,3-dicarboxy-5,8,11,14,17-penta(tert-butyl)hexa-peri-
hexabenzocoronene (4-5) 
 
Method 1: Dimethyl HBC 4-4 (0.100 g, 0.120 mmol) was added to water (5 mL) and tert-
butanol (5 mL) and the resultant suspension was heated to 70 °C. KMnO4 (0.380 g, 2.40 mmol) 
was added in 3 portions over 3 h and the dark purple solution was heated with vigorous stirring 
for 18 h. To the hot mixture, sat. aq. Na2S2O3 was added until the purple colour disappeared. 
The brown suspension was filtered and the residue washed with hot water. The filtrate was 
acidified with aq. HCl (5 M) and the yellow precipitate was isolated by filtration to return 4-4 
by 1H NMR. 
Method 2: Dimethyl HBC 4-4 (90 mg, 0.108 mmol) was added to water (3 mL) and pyridine (2 
mL) and the resultant suspension was heated to 90 °C. KMnO4 (0.380 g, 2.40 mmol) was added 
and the dark purple solution was heated with vigorous stirring for 18 h. To the hot mixture, 
sat. aq. Na2S2O3 was added until the purple colour disappeared. The brown suspension was 
filtered and the residue washed with hot water. The filtrate was acidified with aq. HCl (5 M) 
and the yellow precipitate was isolated by filtration to return 4-4 by 1H NMR. 
Method 3: Dicyano HBC 4-28 (80 mg, 94 μmol) and KOH (0.200 g, 3.56 mmol) were added to 
water (2 mL) and 1,4-dioxane (2 mL) and the resultant suspension was heated at reflux for 18 
h. The yellow suspension was cooled, aq. HCl (2 M) added and the precipitate was isolated by 
filtration to return 4-28 by 1H NMR. 
Method 4: Dicyano HBC 4-28 (80 mg, 94 μmol) was added to acetic acid (2 mL) and sulfuric 
acid (2 mL) and the resultant suspension was heated with vigorous stirring at 100 °C for 18 h. 
The red suspension was cooled, diluted with water and the precipitate isolated by filtration to 






Benzene (15 mL) was bubbled with argon for 15 min. Dimethyl HBC 4-4 (0.500 g, 0.602 mmol), 
N-bromosuccinimide (0.224 g, 1.26 mmol) and 2,2’-azobis(2-methylpropionitrile) (50 mg, 30 
μmol) were added and the mixture heated at 85 °C for 48 h under an argon atmosphere. The 
mixture was cooled, extracted with DCM and the DCM extract washed with water. The organic 
mixture was dried over MgSO4 and the solvent removed in vacuo. The crude product was 







Crude di(bromomethyl) HBC 4-15 (up to 0.595 g, 0.602 mmol), tetra-n-butylammonium 
bromide (0.194 g, 0.602 mmol) and potassium acetate (0.590 g, 6.02 mmol) were added to 
DMF (10 mL) then bubbled with argon for 10 min. The mixture was heated at 100 °C for 18 h 
then poured onto ice-cold water. The precipitate was isolated by filtration, washed with water 
then methanol. The crude was purified via column chromatography (SiO2, DCM) to yield 4-16 
as an orange solid (0.510 g, 0.538 mmol, 89% over two steps). 
1H NMR (500 MHz, CDCl3): δ 9.34 (d, J = 1.5 Hz, 2H, H7,15/9,13), 9.33 (s, 2H, H10,12), 9.32 (d, J = 
1.1 Hz, 2H, H7,15/9,13), 9.31 (d, J = 1.1 Hz, 2H, H6,16), 8.95 (d, J = 1.6 Hz, 2H, H4,18), 8.33 (s, 1H, H2), 
5.95 (s, 4H, CH2OAc), 2.39 (s, 6H, OCOCH3), 1.84 (s, 18H, C(CH3)3), 1.83 (s, 9H, C(CH3)3), 1.76 (s, 
18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 171.21 (OCOCH3), 149.62 (C11), 149.51 (C8,14), 148.49 (C5,17), 
135.40 (C2), 131.62 (C3a,18b), 130.80 (C6a,15b/9b,12a), 130.61 (C9a,12b), 130.43 (C6b,15a), 130.29 
(C1,3/3b,18a), 129.61 (C6a,15b/9b,12a), 128.86 (C1,3/3b,18a), 128.74 (C3a1), 125.64 (C4,18), 124.51 
(C3b1,15b1), 124.06 (C9b1), 123.79 (C6b1,12b1), 121.18 (C3a2/9b2), 120.44 (C3a2/9b2), 120.38 
(C3b2/15b2/6b2,12b2), 120.11 (C3b2,15b2/6b2,12b2), 119.51 (C6,16/7,15/9,13/10,12), 119.26 (C6,16/7,15/9,13/10,12), 
199.18 (C6,16/7,15/9,13/10,12), 119.13 (C6,16/7,15/9,13/10,12), 68.31 (CH2OAc), 35.96 (C(CH3)3), 35.95 
(C(CH3)3), 35.85 (C(CH3)3), 32.20 (C(CH3)3), 32.18 (C(CH3)3), 32.00 (C(CH3)3), 21.63 (OCOCH3) 
ppm. 






To a mixture of THF (40 mL), EtOH (40 mL) and aq. KOH (10% w/w, 15 mL) was added 4-16 
(0.500 g, 0.528 mmol) and the resultant suspension was bubbled with argon for 10 min. The 
mixture was heated at 80 °C for 24 h under an argon atmosphere. The reaction was cooled 
and the organic solvents removed in vacuo. The suspension was extracted with CHCl3, washed 
with brine then water. The organic mixture was dried over MgSO4 and the solvent removed in 




4.7.9 1,3-Diformyl-5,8,11,14,17-penta(tert-butyl)hexa-peri-hexabenzocoronene (4-18) 
 
Method 1: Crude di(hydroxymethyl) HBC 4-17 (up to 0.382 g, 0.443 mmol) was dissolved in 
dry DCM (40 mL) under an argon atmosphere. Pyridinium chlorochromate (0.228 g, 1.06 
mmol) was added and the resultant solution stirred for 2 h. The solvent was removed in vacuo 
and the residue was purified via column chromatography (SiO2, DCM) to yield 4-18 as a 
reddish-orange powder (0.105 g, 0.122 mmol, 23 % over two steps).   
Method 2: Benzene (10 mL) was bubbled with argon for 10 min and dicyano HBC 4-28 (50 mg, 
59 μmol) was added. DIBAL (1 M in cyclohexane, 0.59 mL, 0.59 mmol) was added dropwise 
and the resultant bright red solution was stirred for 18 h under an argon atmosphere. The 
reaction mixture was poured into aq. HCl (2 M, 40 mL) and extracted with DCM. The organic 
layer was washed with water, dried over MgSO4 and the solvent removed in vacuo. The 
organic residue was purified via column chromatography (SiO2, DCM) to yield 4-18 as a 
reddish-orange powder (45 mg, 52 μmol, 89 %). 
1H NMR (500 MHz, CDCl3): δ 9.99 (s, 2H, CHO), 9.27 (s, 2H, H10,12), 9.24 (s, 2H, H7,15/9,13), 9.10 
(s, 2H, H7,15/9,13), 9.08 (s, 2H, H6,16), 8.60 (s, 1H, H2), 7.96 (s, 2H, H4,18), 1.92 (s, 9H, C(CH3)3), 1.90 
(s, 18H, C(CH3)3), 1.69 (s, 18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 192.00 (CHO), 149.89 (C11), 149.64 (C8,14), 148.74 (C5,17), 134.11 
(C3a,18b), 132.23 (C1,3), 130.47 (C6a,15b/9b,12a), 130.27 (C9a,12b), 129.69 (C6b,15a), 129.55 
(C6a,15b/9b,12a), 128.40 (C4,18), 127.10 (C2), 126.83 (C3a1), 126.07 (C3b,18a), 123.94 (C3b1,15b1), 
123.31 (C9b1), 123.19 (C6b1,12b1), 121.03 (C6,16), 120.84 (C3a2/9b2), 120.37 (C3b2,15b2/6b2,12b2), 
119.38 (C10,12), 119.36 (C7,15/9,13), 119.23 (C3b2,15b2/6b2,12b2), 119.11 (C7,15/9,13), 117.95 (C3a2/9b2), 




MALDI-TOF MS: m/z 858.42; calcd for C64H58O2, [M]+ 858.44. 
4.7.10 4-tert-Butyl-3’,5’-dibromodiphenylacetylene (4-22) 
 
Triethylamine (40 mL) was bubbled with argon for 10 min. 1,3,5-Tribromobenzene (4.58 g, 
14.7 mmol), 4-tert-butylphenylacetlyene (1.55 g, 9.80 mmol), 
dichlorobis(triphenylphosphine)palladium(II) (69 mg, 98 μmol) and copper(I) iodide (19 mg, 
98 μmol) were added and the mixture stirred under an argon atmosphere at 90 °C for 18 h. 
The suspension was cooled and extracted with DCM. The organic phase was washed with aq. 
sat. NH4Cl, dried over MgSO4 and the solvent removed in vacuo to give a brown paste that was 
purified via column chromatography (SiO2, PE) to yield 4-22 as a colourless oil (3.80 g, 9.74 
mmol, 99 %). 
1H NMR (500 MHz, CDCl3): δ 7.63-7.59 (m, 3H, H2’,4’), 7.45 (d, J = 8.6 Hz, 2H, H2’’), 7.39 (d, J = 
8.6 Hz, 2H, H3’’), 1.33 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): 152.53 (C4’’), 133.81 (C4’), 133.08 (C2’), 131.64 (C2’’), 127.13 (C1’), 
125.63 (C3’’), 122.73 (C3’), 119.35 (C1’’), 92.37 (C2), 85.97 (C1), 35.04 (C(CH3)3), 31.30 (C(CH3)3) 
ppm. 




4.7.11 1-(3,5-Dibromophenyl)-2,3,4,5,6-penta(4-tert-butylphenyl)benzene (4-23) 
 
Acetylene 4-22 (1.51 g, 3.85 mmol), 2-2 (2.84 g, 4.62 mmol, 1.2 eq.) and diphenyl ether (5 mL) 
were placed under an argon atmosphere and stirred at 260 °C for 18 h. The mixture was cooled 
to 30-40 °C, diluted with EtOH (30 mL) then cooled to 0 °C. The resultant precipitate was 
isolated by filtration and washed with EtOH to yield 4-23 as an off-white powder (2.31 g, 2.38 
mmol, 62 %). 
1H NMR (500 MHz, CDCl3): δ 7.11 (t, J = 1.7 Hz, 1H, H4’), 6.91 (d, J = 8.2 Hz, 4H, H3’’/3’’’), 6.84 (d, 
J = 1.7 Hz, 2H, H2’), 6.83-8.70 (m, 6H, H3’’/3’’’,3’’’’), 6.70-6.64 (m, 10H, H2’,2’’,2’’’), 1.15 (s, 18H, 
C(CH3)3), 1.11-1.09 (m, 27H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 148.40 (C4’’/4’’’), 147.80 (C4’’/4’’’), 147.75 (C4’’’’), 144.78, 141.68, 
140.86, 140.13, 137.70, 137.60, 137.22, 137.15, 133.60, 131.12 (x2), 131.05, 130.47, 123.73, 
123.30, 123.26, 120.79, 34.37 (C(CH3)3), 34.22 (C(CH3)3), 34.21 (C(CH3)3), 31.33 (x3; C(CH3)3) 




4.7.12 1,3-Dibromo-5,8,11,14,17-penta(tert-butyl)hexa-peri-hexabenzocoronene (4-24) 
 
HPB 4-23 (0.550 g, 0.565 mmol) in DCM (100 mL) was bubbled with nitrogen for 10 min. FeCl3 
(2.23 g, 13.6 mmol) in nitromethane (5 mL) was added over 2 min and the resultant dark red 
mixture was stirred with bubbling for 30 min. The reaction was quenched with MeOH (50 mL) 
and the mixture slowly poured into stirred MeOH (200 mL). The yellow precipitate was 
isolated by filtration and washed with MeOH to yield 4-24 as a yellow powder (0.431 g, 4.49 
mmol, 79 %).  
1H NMR (500 MHz, CDCl3): δ 9.85 (d, J = 1.6 Hz, 2H, H4,18), 9.32 (s, 4H, H9,10,12,13), 9.29 (s, 2H, 
H7,15), 9.27 (s, 2H, H6,16), 8.72 (s, 1H, H2), 1.83 (s, 27H, C(CH3)3), 1.77 (s, 18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.86 (C11), 149.64 (C8,14), 147.52 (C5,17), 139.51 (C2), 131.13 
(C3a1), 130.91 (C9a,12b/9b,12a), 130.57 (C9a,12b/9b,12a), 130.42 (C6b,15a), 129.28 (C6a,15b), 128.57 
(C3a,18b), 128.21 (C1,3/3b,18a), 125.65 (C4,18), 124.40 (C3b1,15b1), 123.91 (C9b1), 123.61 (C6b1,12b1), 
121.66 (C3a2/9b2), 120.39 (C3b2,15b2/6b2,12b2), 120.23 (C3b2,15b2/6b2,12b2), 119.83 (C6,16), 119.46 
(C3a2/9b2), 119.28 (C7,15), 119.20 (C9,13/10,12), 119.08 (C9,13/10,12), 118.59 (C1,3/3b,18a), 35.96 (x2; 
C(CH3)3), 35.95 (C(CH3)3), 32.17 (C(CH3)3), 32.16 (C(CH3)3), 32.01 (C(CH3)3) ppm. 






A solution of 4-24 (0.150 g, 0.156 mmol) in dry THF (10 mL) was cooled to -78 °C under an 
argon atmosphere. tert-Butyllithium (1.6 M in pentane, 1.0 mL, 1.6 mmol) was added 
dropwise and the resultant dark green solution stirred for 15 min at -78 °C. Diethylcarbonate 
(0.921 g, 7.8 mmol) was added dropwise, the mixture taken out of the cooling bath and stirred 
for 30 min. The reaction was quenched with water and extracted with DCM. The organic phase 
was washed with water, dried over MgSO4 and the solvent removed in vacuo. The residue was 
purified via column chromatography (SiO2, 50:50 DCM/PE) to give 4-25 as a yellow film (53 
mg, 56 μmol, 36 %). 
1H NMR (500 MHz, CDCl3):  δ 9.36-9.34 (m, 4H, H7,15/9,13/10,12), 9.33 (d, J = 1.3 Hz, 2H, H6,16), 9.31 
(d, J = 1.2 Hz, 2H, H7,15/9,13/10,12), 8.85 (d, J = 1.6 Hz, 2H, H4,18), 8.50 (s, 1H, H2), 4.61 (q, J = 7.2 
Hz, 4H, OCH2CH3), 1.84 (s, 9H, C(CH3)3), 1.83 (s, 9H, C(CH3)3), 1.74 (s, 18H, C(CH3)3), 1.36 (t, J = 
7.2 Hz, 6H, OCH2CH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 172.00 (COOEt), 149.75 (C11), 149.63 (C8,14), 148.60 (C5,17), 131.13 
(C3a,18b), 130.85, 130.67, 130.47 (C6b,15a), 130.10, 128.81, 128.53 (C2), 128.07, 128.03, 125.59 
(C4,18), 124.59 (C3b1,15b1), 123.93 (C9b1), 123.84 (C6b1,12b1), 121.51 (C3a2/9b2), 120.87 
(C3b2,15b2/6b2,12b2), 120.79 (C6,16), 120.68 (C3b2,15b2/6b2,12b2), 119.40 (C3a2/9b2), 119.29 
(C7,15/9,13/10,12), 119.24 (x2; C7,15/9,13/10,12), 62.20 (OCH2CH3), 35.95 (x2; C(CH3)3), 35.86 (C(CH3)3), 
32.17 (x2; C(CH3)3), 32.08 (C(CH3)3), 14.36 (OCH2CH3) ppm. 
MALDI-TOF MS: m/z 946.48; calcd for C68H66O4, [M]+ 946.50. 
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4.7.14 1,3-Dicyano-5,8,11,14,17-penta(tert-butyl)hexa-peri-hexabenzocoronene (4-28) 
 
Dimethylformamide (5 mL) was bubbled with argon for 10 min. Dibromo HBC 4-24 (0.100 g, 
0.104 mmol), zinc(II) cyanide (29 mg, 0.25 mmol), and 
dichlorobis(triphenylphosphine)palladium(II) (7 mg, 10 μmol) were added and the mixture 
heated at 150 °C under argon for 48 h. The mixture was cooled, poured into water (150 mL) 
and the precipitate isolated by filtration. The orange precipitate was purified via column 
chromatography (SiO2, DCM) to give 4-28 as a bright orange powder (83 mg, 97 μmol, 93 %). 
1H NMR (500 MHz, CDCl3): δ 9.62 (d, J = 1.4 Hz, 2H, H4,18), 9.34 (s, 2H, H10,12), 9.30 (d, J = 1.2 
Hz, 2H, H9,13), 9.09 (s, 2H, H7,15), 9.08 (s, 2H, H6,16), 8.10 (s, 1H, H2), 1.93 (s, 9H, C(CH3)3), 1.91 
(s, 18H, C(CH3)3), 1.69 (s, 18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 150.08 (C11), 149.67 (C8,14), 149.14 (C5,17), 139.87 (C2), 134.77 
(C3a,18b), 130.49 (C9b,12a), 130.39 (C9a,12b), 129.56 (C6b,15a), 129.43 (C6a,15b), 126.45 (C3a1), 125.91 
(C3b,18a), 123.60 (C3b1,15b1), 123.54 (C4,18), 123.02 (C9b1), 122.91 (C6b1,12b1), 122.22 (C6,16), 121.44 
(C3a2/9b2), 120.78 (CN), 120.36 (C3b2,15b2/6b2,12b2), 119.71 (C10,12), 119.67 (C9,13), 119.45 
(C3b2,15b2/6b2,12b2), 119.06 (C7,15), 117.19 (C3a2/9b2), 104.80 (C1,3), 36.22 (C(CH3)3), 36.06 (C(CH3)3), 
35.99 (C(CH3)3), 32.25 (C(CH3)3), 32.19 (C(CH3)3), 31.97 (C(CH3)3) ppm. 






Dimethylformamide (16 mL) and triethylamine (8 mL) were bubbled with argon for 10 min. n-
Butyl vinyl ether (2.9 mL, 2.3 g, 22 mmol), 4-24 (0.431 g, 0.449 mmol), palladium(II) acetate 
(12 mg, 56 μmol) and 1,3-bis(diphenylphosphino)propane (69 mg, 0.168 mmol) were added 
and the resultant mixture heated at 120 °C for 48 h under an argon atmosphere. The mixture 
was cooled and extracted with DCM. The organic phase was washed with water, dried over 
MgSO4 and the solvent removed in vacuo. The residue was reacted on without 




4.7.16 1,3-Diacetyl-5,8,11,14,17-penta(tert-butyl)hexa-peri-hexabenzocoronene (4-30) 
 
Crude 4-29 (maximum of 0.448 g, 0.449 mmol) was dissolved in 1,4-dioxane (20 mL). H2SO4 
(conc., 1 mL) was added dropwise and the solution stirred overnight. The reaction mixture 
was neutralised with aq. NaOH (2 M) and extracted with DCM. The organic phase was washed 
with water, dried over MgSO4 and the solvent removed in vacuo. The residue was purified via 
column chromatography (SiO2, DCM) to yield 4-30 as a yellow powder (0.212 g, 0.239 mmol, 
53 % over two steps). 
1H NMR (500 MHz, CDCl3): δ 9.41 (s, 2H, H6,16), 9.40 (s, 2H, H9,13/10,12), 9.38 (s, 2H, H9,13/10,12), 
9.37 (s, 2H, H7,15), 8.69 (s, 2H, H4,18), 8.28 (s, 1H, H2), 2.58 (s, 6H, COCH3), 1.85 (s, 27H, C(CH3)3), 
1.76 (s, 18H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 206.33 (COCH3), 149.95 (C11), 149.85 (C8,14), 149.46 (C5,17), 138.38 
(C1,3), 130.88, 130.79, 130.44, 130.37 (C3a,18b), 130.34, 128.05, 127.61, 126.89 (C4,18), 125.35 
(C2), 124.54 (C3b1,15b1), 123.91, 123.89, 121.63 (C3b2/9b2), 121.07 (C3b2,15b2/6b2,12b2), 120.75 (C6,16), 
120.65 (C3b2,15b2/6b2,12b2), 119.49 (C9,13/10,12), 119.43 (C3a2/9b2), 119.40 (C9,13/10,12), 119.38 (C7,15), 
36.12 (C(CH3)3), 35.99 (x2; C(CH3)3), 32.17 (x2; C(CH3)3), 31.98 (C(CH3)3), 31.48 (COCH3) ppm. 






Diacetyl HBC 4-30 (57 mg, 56 μmol) was dissolved in THF (5 mL) and EtOH (2 mL). Sodium 
borohydride (21 mg, 0.56 mmol) was added slowly and the resultant suspension was stirred 
at RT overnight. Aq. sat. NH4Cl was added dropwise until effervescence subsided. The mixture 
was extracted with DCM, and the organic phase washed with water, dried over MgSO4 and 
the solvent removed in vacuo. The yellow residue was purified via column chromatography 
(SiO2, 5:95 MeOH/DCM) to yield 4-20 as a yellow film (43 mg, 48 μmol, 86 %).  
1H NMR (500 MHz, CDCl3): δ 9.37-9.28 (m, 5.4H, Ar), 9.28-9.24 (2.2H, Ar), 8.97 (d, J = 1.5 Hz, 
1.2H, isomer 2 Ar), 8.93 (s, 0.6H, isomer 1 Ar), 8.85 (s, 0.7H, isomer 2 Ar), 8.64 (s, 0.9H, isomer 
1 Ar), 6.33 (q, J = 6.3 Hz, 0.8H, isomer 1 CH(OH)CH3), 6.25 (q, J = 6.3 Hz, 1.2H, isomer 2 
CH(OH)CH3), 2.32 (d, J = 6.3 Hz, 2.3H, isomer 1 CH(OH)CH3), 2.13 (d, 6.3 Hz, 3.4H, isomer 2 
CH(OH)CH3), 1.85-1.81 (m, 27H, C(CH3)3), 1.79-1.76 (s, 18H, C(CH3)3) ppm. 




4.7.18 2-Bromo-2’-[2-(trimethylsilyl)ethynyl]-1,1’-biphenyl (4-34) 
 
Triethylamine (20 mL) was bubbled with argon for 10 min. Biphenyl 4-33 (2.00 g, 7.10 mmol), 
(trimethylsilyl)acetylene (0.696 g, 7.10 mmol), copper(I) iodide (14 mg, 74 μmol) and 
dichlorobis(triphenylphosphine)palladium(II) (50 mg, 71 μmol) were added and stirred at RT 
for 18 h under argon. The solvent was removed in vacuo and the residue purified via column 
chromatography (SiO2, PE) to yield 4-34 as a pale yellow oil (1.82 g, 5.47 mmol, 78 %). 
1H NMR (500 MHz, CDCl3): δ 7.66 (dd, J = 8.1, 1.1 Hz, 1H, H3), 7.56 (dd, J = 7.6, 1.4 Hz, 1H, H3’), 
7.38 (td, J = 7.6, 1.4 Hz, 1H, H5’), 7.37-7.31 (m, 3H, H5,6,4’), 7.28 (dd, J =7.4, 1.5 Hz, 1H, H6’), 7.23 
(ddd, J = 8.0, 7.0, 2.2 Hz, 1H, H4), 0.04 (s, 9H, CH3) ppm. 
13C NMR (125 MHz, CDCl3): δ 144.54 (C1’), 141.77 (C1), 132.52 (C3), 131.92 (C3’), 131.43 (C6), 
129.51 (C6’), 129.00 (C4), 128.27 (C5’), 127.71 (C4’), 126.88 (C5), 123.63 (C2), 122.96 (C2’), 103.90 
(C7’), 98.26 (C8’), -0.26 (CH3) ppm. 
4.7.19 2-Bromo-2’-ethynyl-1,1’-biphenyl (4-35) 
 
TMS-acetylene 4-34 (0.901 g, 2.74 mmol) was dissolved in MeOH (40 mL). Potassium 
carbonate (4.90 g, 35.5 mmol) was added and the resultant suspension was stirred at RT for 2 
h. The reaction mixture was extracted with DCM, washed with sat. aq. sodium bicarbonate 
and water. The organic phase was dried over MgSO4 and the solvent removed in vacuo. The 
colourless oil was purified via column chromatography (SiO2, PE) to yield 4-35 as a pale brown 
oil (0.654 g, 2.54 mmol, 93 %). 
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1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 7.9 Hz, 1H, H3), 7.62 (d, J = 7.6 Hz, 1H, H3’), 7.42 (t, J = 
7.5 Hz, 1H, H5’), 7.38-7.32 (m, 3H, H5,6,4’), 7.28 (d, J = 7.6 Hz, 1H, H6’), 7.26-7.22 (m, 1H, H4), 
2.95 (s, 1H, H8’) ppm. 
13C NMR (125 MHz, CDCl3): δ 144.21 (C1’), 141.51 (C1), 133.02 (C3’), 132.73 (C3), 131.36 (C6), 
129.90 (C6’), 129.28 (C4), 128.59 (C5’), 127.83 (C4’), 127.07 (C4), 123.48 (C2), 121.85 (C2’), 82.29 
(C7’), 80.50 (C8’) ppm. 
4.7.20 1-[2-(2-Bromophenyl)phenyl]-2,3,4,5-tetra(4-tert-butylphenyl)benzene (4-36) 
 
A solution of 4-35 (0.654 g, 2.54 mmol) and 2-2 (1.44 g, 2.36 mmol) in o-xylene (3 mL) was 
heated at reflux for 18 h under argon. The solution was allowed to cool to RT and the solvent 
removed in vacuo. The residue was purified via column chromatography (SiO2, 25:75 DCM/PE) 
to yield 4-36 as a white powder (1.61 g, 1.92 mmol, 91 %).   
1H NMR (500 MHz, CDCl3): δ 7.65-7.36 (m, 4H), 7.16-6.49 (m, 18H), 6.46-6.29 (m, 3H), 1.25 (s, 
9H, C(CH3)3), 1.15 (s, 9H, C(CH3)3), 1.13 (s, 9H, C(CH3)3), 1.07 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 148.85, 148.65, 148.01, 147.49, 139.42, 139.20, 139.05, 137.45, 
132.56, 132.12, 131.30, 129.72, 129.66, 128.26, 128.13, 127.04, 126.49, 125.40, 124.23, 
12341, 123.00, 34.44 (C(CH3)3), 34.27 (C(CH3)3), 34.26 (C(CH3)3), 34.14 (C(CH3)3), 31.46 
(C(CH3)3), 31.39 (C(CH3)3), 31.37 (C(CH3)3), 31.33 (C(CH3)3) ppm. Not all signals could be 
resolved due to broadness. 




4.7.21 1-Bromo-5,8,11,14-tetra(tert-butyl)hexa-peri-hexabenzocoronene (4-37) 
 
A solution of 4-36 (0.300 g, 0.358 mmol) in DCM (100 mL) was bubbled with nitrogen for 10 
min. FeCl3 (1.39 g, 8.59 mmol) in nitromethane (3 mL) was added over 2 min and the resultant 
dark red mixture was stirred with bubbling for 30 min. The reaction was quenched with MeOH 
(50 mL) and the mixture slowly poured into stirred MeOH (200 mL). The yellow precipitate 
was isolated by filtration and washed with MeOH to yield 4-37 as a yellow powder (0.210 g, 
0.254 mmol, 71 %).   
1H NMR (500 MHz, CDCl3): δ 9.68 (d, J = 8.1 Hz, 1H, H18), 9.28 (s, 2H, H9,10), 9.26 (s, 1H, H7/12), 
9.24 (s, 1H, H7/12), 9.21 (s, 2H, H6,13), 9.08 (s, 1H, H15), 9.01 (s, 1H, H4), 8.96 (d, J = 7.7 Hz, 1H, 
H16), 8.71 (d, J = 8.6 Hz, 1H, H3), 8.23 (d, J = 8.6 Hz, 1H, H2), 7.90 (t, J = 7.9 Hz, 1H, H17), 1.86 (s, 
9H, C(CH3)3), 1.85 (s, 9H, C(CH3)3), 1.80 (s, 9H, C(CH3)3), 1.79 (s, 9H, C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals. 







Dimethylformamide (4 mL) and triethylamine (2 mL) were bubbled with argon for 10 min. n-
Butyl vinyl ether (0.606 g, 6.05 mmol), 4-37 (0.100 g, 0.121 mmol), palladium(II) acetate (3 mg, 
15 μmol) and 1,3-bis(diphenylphosphino)propane (19 mg, 45 μmol) were added and the 
resultant mixture heated at 120 °C for 48 h under an argon atmosphere. The mixture was 
cooled, extracted with DCM and washed with water. The organic phase was dried over MgSO4 





4.7.23 1-Acetyl-5,8,11,14-tetra(tert-butyl)hexa-peri-hexabenzocoronene (4-39) 
 
Crude 4-38 (maximum of 0.102 g, 0.121 mmol) was dissolved in 1,4-dioxane (5 mL). H2SO4 
(conc., 0.5 mL) was added dropwise and the solution stirred for 18 h. The reaction was 
neutralised with aq. NaOH (2 M), washed with water, the organic mixture dried over MgSO4 
and the solvent removed in vacuo. The residue was purified via column chromatography (SiO2, 
DCM) to yield 4-39 as a yellow powder (43 mg, 51 μmol, 45 % over two steps). 
1H NMR (500 MHz, 50:50 CS2/CDCl3): δ 9.34 (s, 1H, H4/6/7/9/10/12/13/15), 9.31-9.27 (m, 6H, 
H4/6/7/9/10/12/13/15), 9.26-9.22 (m, 3H, H3,16,4/6/7/9/10/12/13/15), 8.44 (d, J = 7.5 Hz, 1H, H18), 8.17 (d, 
J = 8.0 Hz, 1H, H2), 8.13 (t, J = 7.8 Hz, 1H, H17), 2.49 (s, 3H, COCH3), 1.86 (s, 18H, C(CH3)3), 1.85 
(s, 9H, C(CH3)3), 1.84 (s, 9H, C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals. 







Acetyl HBC 4-39 (43 mg, 51 μmol) was dissolved in THF (10 mL) and EtOH (2 mL). Sodium 
borohydride (21 mg, 0.54 mmol) was added slowly and the resultant suspension was stirred 
at RT for 18 h. Aq. sat. NH4Cl was added dropwise until effervescence subsided and the mixture 
was extracted with DCM. The organic phase was washed with water, dried over MgSO4 and 
the solvent removed in vacuo. The yellow residue was purified via column chromatography 
(SiO2, 5:95 MeOH/DCM) to yield 4-40 as a yellow film (39 mg, 49 μmol, 91 %).  
1H NMR (500 MHz, CDCl3): δ 9.29 (s, 1H, H10), 9.27 (s, 1H, H7), 9.25 (s, 1H, H9), 9.20 (s, 1H, H6), 
9.14 (s, 1H, H12), 9.05 (s, 1H, H13), 9.03 (s, 1H, H4), 8.79 (d, J = 8.7 Hz, 1H, H3), 8.78 (s, 1H, H15), 
8.48 (d, J = 8.4 Hz, 1H, H16), 8.14 (d, J = 8.4 Hz, 1H, H2), 7.81 (d, J = 7.7 Hz, 1H, H18), 7.42 (t, J = 
7.7 Hz, 1H, H17), 5.76 (q, J = 6.1 Hz, 1H, CH(OH)CH3), 1.91 (s, 9H, C(CH3)3), 1.87 (s, 9H, C(CH3)3), 
1.86 (s, 9H, C(CH3)3), 1.76 (d, J = 6.1 Hz, 3H, CH(OH)CH3), 1.74 (s, 9H, C(CH3)3) ppm. 
13C (125 MHz, CDCl3): δ 148.98 (C5/8/11/14), 148.91 (C5/8/11/14), 148.71 (C5/8/11/14), 148.58 
(C5/8/11/14), 140.27 (C1), 130.62 (C9b), 130.49 (x2; C9a,6b), 130.40 (C12a), 130.01 (C6a), 129.85 (C12a), 
129.74 (C15a), 129.59 (C3b), 129.17 (C15b), 128.71 (C18b), 128.63 (C3a), 127.99 (C18a), 127.76 (C18), 
125.79 (C15b1), 125.58 (C3a1), 125.27 (C2), 124.79 (C17), 123.94 (C6b1/9b1), 123.77 (C6b1/9b1), 
123.10 (C3b1), 122.94 (C12b1), 121.74 (C3), 121.38 (C16), 120.46 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.26 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.06 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.02 (C3a2/3b2/6b2/9b2/12b2/15b2), 119.71 
(C3a2/3b2/6b2/9b2/12b2/15b2), 119.62 (C3a2/3b2/6b2/9b2/12b2/15b2), 118.99 (C4), 118.87 (C15), 118.81 (C10), 
118.79 (C7), 118.74 (C9), 118.72 (C6), 118.69 (C12), 118.39 (C13), 67.73 (CH(OH)CH3), 35.92 
(C(CH3)3), 35.89 (C(CH3)3), 35.87 (C(CH3)3), 35.76 (C(CH3)3), 32.30 (C(CH3)3), 32.28 (C(CH3)3), 
32.24 (C(CH3)3), 32.19 (C(CH3)3), 25.25 (CH(OH)CH3) ppm. 
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A solution of 4-40 (19 mg, 24 μmol) in DCM (5 mL) was bubbled with nitrogen for 10 min. FeCl3 
(4 mg, 20 μmol) was added and the resultant dark red solution was stirred under nitrogen for 
1 h. The reaction mixture was quenched with MeOH, diluted with DCM and washed with 
water. The organic phase was dried over MgSO4 and the solvent removed in vacuo to yield 
2-21 as a yellow film (7.1 mg, 9.2 μmol, 35%), with 1H NMR and MALDI-TOF MS spectra 
matching those reported in Chapter 2 (§2.5.22) via a different synthetic pathway. 
1H NMR (400 MHz, CDCl3): δ 9.26 (s, 2H), 9.18 (s, 2H), 9.00 (s, 2H), 8.25 (d, J = 7.4 Hz, 2H), 7.58 
(d, J = 7.4 Hz, 2H), 3.89-3.79 (m, 1H), 1.94 (s, 18H), 1.81 (s, 18H), 1.54 (d, J = 7.8 Hz, 3H) ppm. 




4.7.26 (3,5-Dibromophenyl)phenylacetylene (4-41) 
 
Triethylamine (40 mL) was bubbled with argon for 10 min. 1,3,5-Tribromobenzene (4.58 g, 
14.7 mmol), phenylacetylene (1.00 g, 9.80 mmol), 
dichlorobis(triphenylphosphine)palladium(II) (69 mg, 98 μmol) and copper(I) iodide (19 mg, 
98 μmol) were added and the mixture stirred under an argon atmosphere at 90 °C for 36 h. 
The suspension was cooled and extracted with DCM. The organic phase was washed with aq. 
sat. NH4Cl, dried over MgSO4 and the solvent removed in vacuo to give a brown paste that was 
purified via column chromatography (SiO2, PE) to afford 4-41 as a colourless oil (2.15 g, 6.44 
mmol, 66 %). 
1H NMR (400 MHz, CDCl3):26 δ 7.64-7.60 (m, 3H), 7.53-7.49 (m, 2H), 7.39-7.35 (m, 3H) ppm. 
4.7.27  Mixture of 1,3,5-tri(3,5-dibromophenyl)-2,4,6-triphenylbenzene (4-42a) and 
1,2,4-tri(3,5-dibromophenyl)-3,5,6-triphenylbenzene (4-42b) 
 
A solution of alkyne 4-41 (1.32 g, 3.93 mmol) in 1,4-dioxane (25 mL) was bubbled with argon 
for 15 min. Co2(CO)8 (0.134 g, 0.392 mmol) was added and the resultant dark solution was 
heated at reflux for 18 h. The mixture was cooled and the solvent removed in vacuo. The 
residue was purified via column chromatography (SiO2, 25:75 DCM/PE) to yield a mixture of 
4-42a and 4-42b as a white powder that could not be separated chromatographically (0.610 
g, 0.605 mmol, 46%).  
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1H NMR (400 MHz, CDCl3): 7.25-7.23 (m, 1.5H, Ar), 7.17-7.14 (m, 1.2H, Ar), 7.08-6.92 (m, 
12.6H, Ar), 6.91 (d, J = 1.8 Hz, 1H, Ar), 6.89 (d, J = 1.8 Hz, 1.6H, Ar), 6.86-6.78 (m, 6.1H, Ar) 
ppm. 
MALDI-TOF MS: m/z 1007.73; calcd for C42H2479Br381Br3, [M]+ 1007.69. 
4.7.28 Attempted synthesis of 1,3,7,9,13,15-hexabromohexa-peri-hexbenzocoronene (4-
43a) 
 
A mixture of 4-42a and 4-42b (0.100 g, 99 μmol) in DCM (25 mL) was bubbled with N2 for 10 
min. FeCl3 (0.386 g, 2.38 mmol) in nitromethane (2 mL) was added dropwise and the resultant 
yellow-brown solution was stirred with bubbling for 30 min. The reaction was quenched with 
MeOH (100 mL) and the orange precipitate was isolated by filtration, returning 4-42a and 
4-42b by 1H NMR and MALDI-TOF MS. 
4.7.29 Mixture of 1,3,5-tri(3,5-dibromophenyl)-2,4,6-tri(4-tert-butylphenyl)benzene (4-
44a) and 1,2,4-tri(3,5-dibromophenyl)-3,5,6-tri(4-tert-butylphenyl)benzene (4-
44b) 
 
A solution of alkyne 4-22 (3.00 g, 7.65 mmol) in 1,4-dioxane (50 mL) was bubbled with argon 
for 15 min. Co2(CO)8 (0.262 g, 0.765 mmol) was added and the resultant dark solution was 
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heated at reflux for 18 h. The mixture was cooled and the solvent removed in vacuo. The 
residue was dissolved in a minimum of DCM and precipitated by slow addition of MeOH. The 
white precipitate was isolated by filtration to yield a mixture of 4-44a and 4-44b as a white 
powder that could not be separated chromatographically (2.18 g, 1.85 mmol, 73%).  
1H NMR (400 MHz, CDCl3): δ 7.19-6.54 (m, 21H, Ar), 1.27-1.07 (m, 27H, C(CH3)3) ppm.  
MALDI-TOF MS: m/z 1175.88; calcd for C54H4879Br381Br3, [M]+ 1175.88. 
4.7.30  1,3,4,6,13,15-Hexabromo-8,11,17-tri(tert-butyl)hexa-peri-hexabenzocoronene 
(4-45b) 
 
A mixture of 4-44a and 4-44b (0.250 g, 0.213 mmol) in DCM (25 mL) was bubbled with N2 for 
10 min, then FeCl3 (0.828 g, 5.10 mmol) in nitromethane (2 mL) was added dropwise. The 
resultant dark red solution was stirred for 30 min with continuous N2 bubbling. The reaction 
was quenched with MeOH (100 mL), the yellow precipitate isolated by filtration and purified 
via column chromatography (SiO2, 25:75 DCM/PE) to yield 4-45b along with small amounts of 
4-44a that could not be separated via column chromatography (84 mg, 72 μmol, 34% based 
on the total mixture of reactants). 
1H NMR (500 MHz, CDCl3): δ 10.03 (d, J = 1.6 Hz, 1H), 9.98 (d, J = 1.3 Hz, 1H), 9.97 (d, J = 1.3 
Hz, 1H), 9.89 (d, J = 1.2 Hz, 1H), 9.31 (d, J = 1.3 Hz, 1H), 9.28 (d, J = 1.2 Hz, 1H), 8.73 (s, 1H), 
8.49 (s, 1H), 8.48 (s, 1H), 1.79 (s, 9H), 1.76 (s, 9H), 1.70 (s, 9H) ppm. 
13C NMR (125 MHz, CDCl3): δ 151.28, 151.11, 149.33, 143.18, 140.48, 140.26, 133.47, 132.89, 
132.46, 131.66, 131.62, 131.37, 131.01, 130.78, 130.42, 130.17, 130.02, 129.70, 129.38, 
129.24, 128.82, 128.24, 128.20, 127.89, 126.61, 126.05, 125.78, 124.41, 124.12, 123.79, 
122.83, 122.58, 122.56, 122.49, 122.33, 122.10, 121.92, 121.78, 121.18, 120.96, 120.67, 38.69, 
38.62, 38.60, 34.52, 34.49, 34.44 ppm. 
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This chapter describes the exploration of alternative annulation reactions at the periphery of 
HBC from the newly synthesised bromo HBC 4-37. Introduction of ethynyl or heteroatomic 
functionality was investigated via Pd-catalysed cross-coupling reactions or lithiation, followed 






Following the unsuccessful formation of a suitable hexabromo HBC for multiple bridging, the 
main focus of this thesis, alternate functionalisation approaches were investigated to test the 
scope of functionalisation possible using the newly synthesised bromo HBC 4-37. Two 
different annulations were explored: formation of additional six membered rings consisting 
entirely of carbon, or formation of five-membered rings containing a heteroatom bridging 
across a bay site, as opposed to the carbon bridge previously investigated (Scheme 5.1). 
 
Scheme 5.1: General routes investigated for bridging a bay site with acetylene (top) or heteroatoms (bottom). 
X = heteroatom. 
5.2 Ethenylene-Annulated HBCs 
Methods to ethynyl-annulated HBCs already exist in the literature, notably in a series of 
studies by the Müllen group where a number of bay-bridged HBCs with zigzag edges were 
synthesised (Scheme 5.2).1-4 Inclusion of these bridges began with a substituted phenanthrene 
which was then incorporated into the remaining carbon framework using established 




Scheme 5.2: Reported ethenylene annulated HBCs (top2 and middle3) and ethenylene annulated HBCs that are 
potential targets for post-cyclodehydrogenative synthesis (bottom). Peripheral groups omitted for clarity. 
The disadvantage of the methodologies used in these studies is the same as that of the 
fluorene-based HBCs previously discussed: a maximum of three bay sites are able to be 
bridged based on phenanthrene precursors. To get past this phenanthrene based limitation, 
a tetra-bridged example by Dumslaff et al. was synthesised from a more preorganised 
precursor.3 Using current methods, a limit of four bay annulations exists and without the 
possibility of three adjacent bays fused; more highly bridged examples require increasingly 
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complex precursors. Ideally, the hexabridged compound, with the trivial name 
circumcoronene, would be able to be synthesised. To date, circumcoronene has not been 
synthesised, but has had a number of computational studies published predicting its 
properties.5-8 Of particular interest is whether the π-electrons adopt a benzene within a 
[18]annulene within a [30]annulene behaviour, or continues to retain the more localised Clar 
sextet arrangement (Figure 5.1). A possible pathway to form this theorised compound is with 
post-cyclodehydrogenative functionalisation. As a synthetic proof of concept towards this 
goal, bromo HBC 4-37 was used as a test system, to see if this proposed methodology is viable.  
 
Figure 5.1: Two possible bonding arrangements of circumcoronene: concentric annulenes arrangement (left) 
and localised Clar sextet arrangement (right). 
5.2.1 Annulation Proof of Concept 
Annulation of ethenylene groups to PAHs smaller than HBC, has been established for many 
related molecules, where two methods are available, utilising either ICl or with PtCl2.3, 9-11 
Using ICl, an unsymmetrical alkene is formed with one side bearing added iodo functionality 
which can then be utilised for further reaction (Scheme 5.3). The other methodology utilises 
PtCl2 and an acetylene to yield the alkene through C-H activation.12-13 Both these methods 
were investigated towards an ethenylene-annulated HBC which, if successful, could allow 




Scheme 5.3: Biphenyl examples of ethynyl annulation mediated by ICl (top)10 or PtCl2 (bottom).11 
Synthesis here proceeded from 4-37 via a Sonogashira reaction with tert-
butylphenylacetylene in good yields. Initial tests were focussed on the ICl mediated method 
(Scheme 5.4), as the added iodo functionality formed would allow for further incorporation of 
sterically bulky groups onto the HBC. This additional steric bulk would allow for increased 
solubility compared to those reported by the Müllen group, which were noted to be sparingly 
soluble to the extent that a sufficiently intense 13C NMR spectrum could not be collected. 
Upon treatment with ICl, a mixture of inseparable products was obtained. Examination of the 
mixture by MALDI-TOF MS showed a number of signals that could not be attributed to any 




Scheme 5.4: ICl mediated annulation (top) and PtCl2 catalysed annulation (bottom) of ethyl-HBCs. 
 
Figure 5.2: MALDI TOF spectra of 5-1 (top) and product mixture of subsequent treatment with ICl (bottom). 
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Attention was then turned to terminal acetylene HBC 5-4, which was then synthesised and 
treated with PtCl2. Upon work-up, a single, more symmetrical HBC was observed in the 1H 
NMR spectrum, with peaks consistent with those reported by the Müllen group on their 
dodecyl example (Figure 5.3).2  MALDI-TOF MS corroborated the formation of the product 
(albeit with a near identical spectrum to that of the immediate precursor, Figure 5.4). Utilising 
a mixture of CDCl3 with CS2, a weak, but sufficiently intense 13C NMR spectrum was able to be 
collected, further confirming the structure of the product. 
 
Figure 5.3: Aromatic region of the 1H NMR spectrum of 5-5. 
 
Figure 5.4:  MALDI TOF spectra of 5-4 (top) and 5-5 (bottom). 
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5.2.2 Multiple Annulations 
To further extend upon this successful annulation, using the previously synthesised dibromo 
4-24, a dibridged system was also attempted. Of interest with this system was observing the 
steric requirements for this reaction, for instance, do the tert-butyl groups on the 
neighbouring ring prevent annulation as was observed with the attempted annulation of diol 
HBC 4-20. Synthesis proceeded identically to that of the mono-substituted version, with 
treatment of the diacetylene 5-6 with PtCl2 yielding 5-7 in modest yields (Scheme 5.5). After 
purification via column chromatography, some small additional peaks were observed in the 
1H NMR spectrum. Further purification via preparatory TLC afforded a clean 1H NMR spectrum, 
barring solvent peaks (Figure 5.5). The compound was then subjected to high vacuum for 6 
hours to remove the remaining solvent, then the spectrum measured again. Interestingly, 
additional peaks were observed in the 1H NMR spectrum suggesting decomposition had 
occurred, the product of which could not be identified by MALDI-TOF (Figure 5.6).  
 
Scheme 5.5: Synthesis of dibridged 5-7 from bromo 4-24. 
 




Figure 5.6: MALDI-TOF spectra of 5-6 (top) and 5-7 (bottom). 
Despite the decomposition occurring, successful annulation to form 5-7 has been achieved, 
overcoming the potential steric hindrance of the neighbouring tert-butyl groups. This success 
opens the pathway to future, more highly bridged examples including circumcoronenes. 
5.3 Heteroatomic Annulated HBCs 
Incorporation of heteroatoms instead of carbon provides opportunities to modulate the 
properties of a PAH by modification of the geometry, adding or removing electrons and 
opening up additional reactivity. All the syntheses described herein were envisioned in a two-
step process: incorporation of a heteroatom, followed by annulation using methods reported 
for the biphenyl analogue (Scheme 5.6). As the reactions undertaken were for proof of 




Scheme 5.6: Synthesis towards heteroatomic annulated HBCs. X = heteroatom. 
5.3.1 Sulfur Annulated 
Two sulfur annulated HBCs have previously been reported by the Müllen group (Scheme 
5.7).14 These were synthesised in a post-cyclodehydrogenative functionalisation of 
perchlorinated HBC via nucleophilic substitution, resulting in incorporation of thioether 
functionality along with either two or three bay positions being annulated. This annulation 
was proposed to occur after thioether formation, with the sulfur atom subsequently 
undergoing a second nucleophilic substitution with a chlorine atom on the neighbouring ring. 
This positively charged sulfur species then eliminates chlorobenzene to reform the neutral 
sulfur as a bridging thioether. An additional sulfur incorporated HBC was reported, with three 




Scheme 5.7: Sulfur incorporated HBCs reported.4, 14 
Despite the efficiency in the formation of multiple annulated heteroatomic rings by Tan et al., 
the method leaves much to be desired. Firstly, regioselective control is lacking, with a mixture 
of two and three bridges obtained. Additionally, all peripheral sites are substituted in this 
reaction, with no ability to functionalise the other, non-bridged peripheral sites later on.  
One method reported separately by Zhang et al. and Nishino et al. that could circumvent these 
disadvantages utilises annulation of pre-incorporated thiols catalysed by a PdCl2/DMSO 
system (Scheme 5.8).15-16 Crucially, this method was proven to accommodate the formation 
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of compounds with significant ring strain, with the demonstrated synthesis of trithiasumanene 
via this method, the non-pyrolytic synthesis of which had previously been reported by Li et al. 
and Tan et al. via an organolithium or hypervalent iodane intermediate.17-18 
 
Scheme 5.8: Methods to form sulfur bridged PAHs by Zhang et al. (top) and non-pyrolytic synthesis of 
trithiasumanene (bottom).15, 17-18 
Sulfur addition to HBC was achieved by lithiation of bromo HBC 4-37 followed by quenching 
with elemental sulfur. This was attempted despite the previously demonstrated low yields via 
lithiation methods, as it was quick and the expected side products would be readily separable 
such as debrominated HBC 2-35. Thiol 5-8 was able to be obtained in yields of 15% as a 
sparingly soluble yellow powder, with the 1H NMR spectrum containing the expected 13 
aromatic signals, along with a trace amount of other inseparable, unidentifiable aromatic 
products (Figure 5.7). Examination of the MALDI-TOF spectrum showed a single major peak, 




Scheme 5.9: Synthesis of sulfur bridged 5-9. 
Annulation was then investigated using the method outlined by Zhang et al. and Nishino et 
al.15-16 After 5-8 was treated under these conditions, the cooled reaction mixture was poured 
into water, forming a yellow precipitate which was isolated by filtration. Delightfully, the 1H 
NMR spectrum was consistent with a single, more symmetric major product containing four 
aromatic singlets and two aromatic doublets (Figure 5.7), as well as two tert-butyl signals as 
expected for 5-9. Corroboration with the MALDI-TOF MS spectrum confirmed the successful 
formation of the bridged product, with a single peak consistent with the desired compound 
(Figure 5.8).  
 




Figure 5.8: MALDI-TOF spectrum of 5-9. 
Attempts to crystallise the product proved unfruitful, with a propensity to powder out of 
solution, despite a number of attempts. To date, this is the third example of a HBC with a 
sulfur atom bridging a bay site, after the two by the Müllen group,14 but the first with 
regioselective control over bridging.  
5.3.2 Silicon-Annulated 
Silole-incorporated PAHs have recently garnered attention as a promising class for utilisation 
in organic electronics, due to their combination of attractive photophysical properties and 
favourable molecular packing allowing for high charge carrier mobilities.19-20 Although a 
number of silafluorene based PAHs have been reported,21-23 no examples of a silyl bridged 
HBC have been reported to date. A recently developed methodology towards silyl bridged 
PAHs first reported by Furukawa et al. utilises an intramolecular sila-Friedel-Crafts reaction to 
form a dibenzosilole moiety (Scheme 5.10).24 This methodology was further applied to form 




Scheme 5.10: Sila-Friedel-Crafts reaction developed by Furukawa et al.24 
In an attempt to obtain a silicon-bridged HBC, silicon addition was attempted via lithiation 
followed by chlorodiphenylsilane as utilised by Curless et al.;25 annulation followed using a 
sila-Friedel-Crafts reaction. It was hoped that the appended phenyl substituents would 
provide extra steric repulsion, ideally improving the solubility of the formed compound. 
 
Scheme 5.11: Synthesis of silicon bridged 5-11. 
Lithiation proceeded similarly to that of thiol 5-8, with a mixture of the desired hydrosilane 
5-10 and debrominated HBC 2-35 obtained. Separation of the mixture via column 
chromatography was attempted, with hydrosilane 5-10 able to be obtained with some minor 
additional phenyl peaks observed. A 1H signal corresponding to the hydrosilane proton was 
observed ca. 6.1 ppm, similar to that of a biphenyl analogue (2-(diphenylsilyl)biphenyl) with a 
shift of 5.16 ppm.25 Upon precipitation of the silane, from a minimum amount of CHCl3 with 
the addition of methanol in an effort to remove the minor aromatic impurities observed, a 
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mixture of products was obtained, with the minor impurity consistent with a more 
symmetrical HBC (Figure 5.9). Further purification via preparatory thin layer chromatography 
yielded hydrosilane 5-10 yet again, with the less soluble impurity remaining on the base line. 
A 1H NMR spectrum of the isolated impurity revealed the more symmetric HBC to be tetra 
tert-butyl 2-35, suggesting that under ambient conditions that the silyl functionality was 
eliminating. In an effort to prevent this, the re-purified silyl HBC was subjected to a high 
vacuum for an hour without the presence of light, to remove additional solvent signals, 
followed by storage overnight under as argon atmosphere in the dark. Despite these efforts, 
signs of elimination were observed the next morning.  
Stability issues were presumably due to the acid sensitivity of the silyl compounds, with 
potential sources of acid being the silica used during chromatography and the small amount 
of acid formed from the decomposition of CDCl3. In the original report by Furukawa et al. it 
was mentioned that the Sila-Friedel-Crafts reaction is reversible, resulting in the hydrosilane 
starting material being recovered.24 Plausibly this acts one step further in the case of 
hydrosilane 5-10, with 2-35 being recovered after a subsequent further reversible reaction 




Figure 5.9: Aromatic region of 1H NMR spectra displaying decomposition. Hydrosilane 5-10 peaks traced in red, 
2-35 traced in blue. 
184 
 
Bridging was then attempted using the methodology outlined by Furukawa et al. to no avail, 
with no reaction observed under the reported conditions. A further attempt using 
methodology by Murata et al. was then attempted, catalysed by PtCl2 and potassium 
trispyrazolylborate.26 Examination of the 1H NMR spectrum of the crude mixture showed 
additional HBC peaks, which upon separation via preparatory TLC yielded a more symmetrical 
HBC, consistent with the desired product (Figure 5.10). Additional phenyl-like peaks were 
observed, along with some solvent peaks. The compound was subjected to a high vacuum in 
the dark for 1 hour at RT, in an attempt to remove these impurities. After this treatment, 
decomposition was observed to have occurred with a reduction in the intensity of peaks in 
the 1H NMR spectrum, along with a broadening of the signals able to be observed. Analysis of 
the partially decomposed mixture by MALDI-TOF suggested the presence of the desired 
bridged HBC, along with a signal 33.95 m/z higher than that of 5-11 and another peak a further 
33.95 m/z higher (Figure 5.11). 
 





Figure 5.11: MALDI-TOF spectrum of partially decomposed 5-11. 
Stability issues, in the case of the silyl bridged 5-11, were not thought to be from acid 
sensitivity. This was concluded due to a lack of peaks consistent with either expected 
decomposition products hydrosilane 5-10 or tetra tert-butyl 2-35 observed by MALDI-TOF or 
1H NMR, suggesting that this reversible reaction is not occurring. From the MALDI-TOF 
spectrum, a potential decomposition product is the addition of two or four hydroxyl groups. 
Despite these issues, 5-11 is the first example of a silicon bridged HBC. 
5.3.3 Nitrogen-Annulated 
Nitrogen-substituted HBCs were first reported by Ito et al., in a study on an amino substituted 
HBC formed by Buchwald-Hartwig cross-coupling whilst studying the effect of amine 
functionality on mesophase formation (Figure 5.12).27 This methodology has more recently 
been utilised by Liu et al. to form donor-acceptor systems with an electron deficient 
chlorinated HBC.28 Another notable set of nitrogen containing HBCs are those first reported 
by Draper et al. where carbon atoms within the HBC framework were substituted with 
nitrogen atoms.29 The tetraaza HBCs were formed by cyclodehydrogenation of the 
corresponding nitrogen-substituted HPB in modest yields. More recently, in a study by 
Nagarajan et al., the corresponding diaza HBC was also synthesised; however, complete 
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cyclodehydrogenation was not able to be achieved until  an extra tert-butyl group ortho to the 
pyrimidine nitrogen atoms was included.30  
 
Figure 5.12: Nitrogen-containing HBCs reported.27-30 
To the best of the author’s knowledge, no nitrogen-bridged HBCs have been reported; 
however, a number of bridging methods exist for smaller PAHs, such as the recent 
developments in the formation of carbazoles via an amino or nitro functionalised biphenyls 
(Scheme 5.12).31-33 The methodology outlined by Sugahara et al. was first investigated towards 
a nitrogen-bridged HBC due to all required materials being readily at hand, and its utilisation 
of a secondary amine, allowing for incorporation of additional sterically bulky substituents to 




Scheme 5.12: Representative transformations from nitrogen containing biphenyls to carbazoles. 
Amine incorporation was attempted using a Buchwald-Hartwig cross-coupling with aniline 
(Scheme 5.13), as this methodology had previously demonstrated by the Müllen group on an 
HBC,27-28 and was found to provide 5-12 in good yields as a mixture, with a trace amount of an 
inseparable product also observed in the 1H NMR spectrum.  
 
Scheme 5.13: Synthesis of nitrogen bridged 5-13. 
N-Annulation of the mixture containing 5-12 was then attempted using Sugahara’s method 
over 18 h, with a separable mixture of starting material 5-12 and a collection of additional 
broad peaks by 1H NMR. Addition of CS2 to the sample resulted in a sharpening of the broad 
peaks, revealing a more symmetrical HBC product was formed.  
For the major, symmetrical product a MALDI-TOF spectrum consistent with the desired 
structure was able to be obtained (Figure 5.13); however, due to limited solubility, even with 
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the addition of CS2, only a low intensity 1H NMR spectrum could be obtained (Figure 5.14) but 
a 13C NMR spectrum of sufficient intensity could not be collected. 
 
Figure 5.13: MALDI-TOF spectra of 5-12 (top) and 5-13 (bottom). 
 
Figure 5.14: Aromatic region of the 1H NMR spectrum of 5-13. 
In an effort to reduce the amount of starting material obtained in the reaction, the reaction 
time was lengthened from 18 h to 42 h. This increased time did not result in any significant 
increase in yield, or decrease in the amount of the starting material recovered; however, an 
additional trace product was also formed that was an unsymmetrical HBC by 1H NMR (Figure 
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5.15). This product later crystallised out of a slowly evaporating solution of CDCl3 and single 
crystal X-ray crystallography determined this minor by-product to be another carbazole HBC, 
formed not through a desired C-N bond (like 5-13), but through a C-C bond between the 
phenyl substituent and one of the HBC rings (Figure 5.16). Attempts to further characterise 
this by-product with 2D 1H-1H, 1H-13C and 13C NMR experiments proved troublesome, with the 
remaining crystalline sample found to have decomposed upon further examination of the 
sample by 1H NMR.  
 
Figure 5.15: Aromatic region of the 1H NMR spectrum of isolated carbazole 5-14. 
 




5.3.4 Oxygen Annulated 
A number of oxygen incorporated HBCs have previously been reported, the bulk of which 
consist of peripheral alkoxy substituents as the solubilising group of choice. The first alkoxy 
HBC reported was by Wang et al. on their permethoxylated HBC which was synthesised from 
the corresponding HPB (Figure 5.17).34 A hexa-alkoxy HBC proved more troublesome to 
synthesise however, with aryl shifts occurring upon cyclodehydrogenation (§1.1.6), eventually 
circumvented by Wadumethridge et al. by proceeding from a tris(biphenyl)benzene precursor 
which did not undergo aryl shifts during oxidative cyclodehydrogenation.35  
 
Figure 5.17: Oxygen incorporated HBCs reported.34-38 
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Two other notable pairs of oxygen containing HBCs have been reported. The first is the study 
by Yamaguchi et al. towards a quinone-like HBC and a follow up study by Li et al.36-37 In the 
study by Yamaguchi et al., oxidation of an alcoholic HBC afforded a tetraone rather than the 
desired dione. To prevent this over oxidation, Li et al. blocked both sites ortho to the alcohol 
with methyl groups, which oxidised successfully to the desired dione. The other notable 
oxygen containing HBCs are those reported by Reger et al.38 In this study, a pair of HPBs were 
linked with an ether bridge and subjected to oxidative cyclodehydrogenation. Dependent on 
the conditions utilised, complete fusion could occur to give the corresponding ether linked 
HBCs (with FeCl3) or an additional bond could form to afford a HBC annulated furan ring, the 
first example of a furanyl annulated HBC.    
A number of intramolecular oxygen annulation reactions have been reported to form 
dibenzofuran, of which only three are through C-O bond formation. The first study by Xiao et 
al. found that dibenzofuran formation occurred with ligated Pd(OAc)2 with air as an oxidant in 
low yields.39 Improvements were made with the addition of a number of additives and the 
rate determining step was found to be C-O bond formation (Scheme 5.14). A study by Wei et 
al. reported after found similar results; however, kinetic studies found the rate determining 
step under these conditions was C-H cleavage.40 A later study by Schmidt et al. modified the 




Scheme 5.14: Intramolecular oxygen incorporation reactions reported.39-41 
Hydroxy incorporation was envisioned in a two-step process from 4-37 via a boronic ester 5-15 
followed by cleavage of the B-C bond with hydrogen peroxide to yield the alcoholic 5-16 




Scheme 5.15: Synthesis attempted towards 5-17 
Boronic ester 5-15 was synthesised in modest yields via a Miyaura cross-coupling with (Bpin)2, 
as previously used to synthesise boryl fluorenone 3-2. Cleavage of 5-15 with peroxide was 
then attempted, the product of which was found to be sparingly soluble in chlorinated 
solvents, with or without CS2, polar solvents such as acetone and THF, or aromatic solvents 
such as toluene or benzene. Attempts to measure the 1H NMR spectrum of the product proved 
troublesome, with few, weak peaks able to be observed (Figure 5.18). The most suggestive 
data to confirm the formation (other than the poorer solubility than the precursors) was 
MALDI-TOF MS which exhibited a peak consistent with the alcohol as well as an additional 
peak near in mass to a dimer (Figure 5.19). Bridging to form 5-17 was attempted using the 
method of Wei et al. utilised on biphenyls to dibenzofurans,40 even though it was a 
suspension. The resultant orange precipitate obtained from the reaction mixture was also 
found to be poorly soluble, with examination by MALDI-TOF yielding no observable signs of a 




Figure 5.18: 1H NMR spectra of 5-16 in 50:50 CS2/CDCl3 (top) and (CD3)2CO (bottom). 
 
Figure 5.19: MALDI-TOF spectra of 5-16 (top) and attempted bridging using the method of Wei et al.40 
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5.4 Conclusions and Future Directions 
A number of alternative bay-bridged HBCs have been synthesised using a two-step process 
from bromo HBC 4-37. A notable success was the incorporation of nitrogen and silicon atoms 
as bridging groups, the first reported for a HBC, and the formation of an additional sulfur 
bridged example, the first to provide regioselective bridging. 
5.4.1 Future Directions 
Successful annulation from alkyne precursors allows for a number of extensions to the HBC 
framework. Firstly, if formation of a hexabromo HBC is achieved, then formation of 
circumcoronene could be attempted (Scheme 5.16, top). Secondly, an investigation into 
utilising the APEX reaction, recently developed by the Itami group, where annulation of 
biphenyl to an alkene has been reported via a dibenzosilazole regent.42 An interesting reaction 
that could be attempted to test suitability of the APEX reaction upon HBCs would be reacting 
a dibenzosilazole with the reactive olefin 5-7 to make the extended 5-18 (Scheme 5.16, 
middle); this modification is expected to increase the solubility of these HBCs and, though 
steric crowding, provide a distorted saddle structure. Additional APEX reactions with 
silabridged 5-11 could also be investigated which, if successful, could provide a quick pathway 
for incorporation of HBCs into a wide range of aromatic structures containing the reactive 





Scheme 5.16: Formation of circumcoronene (top) and representative APEX reactions (middle, bottom). 
Furthermore, following the initial successes of heteroatomic bridging, further studies could be 
imagined. Firstly, improvements in synthetic methodology should be investigated in an effort 
to obtain larger quantities of hetero-bridged HBCs. Once this has been achieved, 
investigations into the stability of these compounds, namely the causes of decomposition 
observed in many of the new compounds and identification of the products produced. Further 
to these steps being completed, investigations into the optical and electronic properties of 
these hetero bridged compounds could be undertaken, as the small family synthesised could 
allow for the investigation of the individual heteroatoms effect on the HBC system. Finally, if 
a hexabromo HBC system is able to be synthesised, attempts towards a hexahetero-bridged 
HBC could be made. 
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5.5 Experimental Section 




Triethylamine (10 mL) was bubbled with argon for 10 min. 4-tert-Butylphenylacetylene (0.203 
g, 1.26 mmol), 4-37 (0.250 g, 0.300 mmol), copper(I) iodide (5 mg, 30 μmol) and 
dichlorobis(triphenylphosphine)palladium(II) (20 mg, 28 μmol) were added and heated at 
80 °C for 18 h under argon. The mixture was cooled and the solvent removed in vacuo. The 
residue was purified via column chromatography (SiO2, 25:75 DCM/PE) to yield 5-1 as a yellow 
solid (0.130 g, 0.144 mmol, 48%). 
1H NMR (500 MHz, 50:50 CS2/CDCl3): δ 10.55 (d, J = 8.2 Hz, 1H, H18), 9.27-9.22 (m, 6H, 
H6,7,9,10,12,13), 9.18 (s, 1H, H15), 9.15-9.12 (m, 2H, H4,16), 9.04 (d, J = 8.1 Hz, 1H, H3), 8.30 (d, J = 
8.2 Hz, 1H, H2), 8.07 (t, J = 7.8 Hz, 1H, H17), 7.68 (d, 8.4 Hz, 2H, H4’,8’), 7.51 (d, 8.4 Hz, 2H, H5’,7’), 
1.86 (s, 18H, C(CH3)3), 1.84 (s, 18H, C(CH3)3), 1.45 (s, 9H, C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals. 






Triethylamine (10 mL) was bubbled with argon for 15 min. (Triisopropylsilyl)acetylene (61 mg, 
0.33 mmol), 4-37 (0.250 g, 0.300 mmol), copper(I) iodide (6 mg, 30 μmol) and 
dichlorobis(triphenylphosphine)palladium(II) (42 mg, 60 μmol) were added and heated at 80 
°C for 18 h under argon. The yellow mixture was cooled and the solvent removed in vacuo. 
The residue was purified via column chromatography (SiO2, 25:75 DCM/PE) to yield 5-19 as a 
yellow film (0.210 g, 0.226 mmol, 75%). 
1H NMR (500 MHz, CDCl3): δ 10.49 (d, J = 8.0 Hz, 1H, H18), 9.24 (s, 1H, H9), 9.23 (s, 1H, H10), 
9.19 (s, 2H, H6,7), 9.18 (s, 1H, H12), 9.13 (s, 1H, H13), 9.04 (s, 1H, H4), 9.00 (s, 1H, H15), 8.92-8.87 
(m, 2H, H3,16), 8.22 (d, J = 8.4 Hz, 1H, H2), 7.78 (t, J = 8.0 Hz, 1H, H17), 1.85 (s, 9H, C(CH3)3), 1.84 
(s, 9H, C(CH3)3), 1.80 (s, 9H, C(CH3)3), 1.77 (s, 9H, C(CH3)3), 1.32-1.30 (m, 21H, CH(CH3)2, 
CH(CH3)2) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.00 (C8/11), 148.97 (C8/11), 148.89 (C5), 148.82 (C14), 135.10 
(C2), 131.21 (C18b), 130.57 (C9a/9b), 130.55 (C9a/9b), 130.51 (C12a), 130.46 (C3a), 130.34 (C6a/6b), 
130.15 (C15a), 130.12 (C6a/6b), 130.08 (C12b), 129.65 (C18a), 129.54 (C3b), 129.50 (C15b), 126.65 
(C18), 126.16 (C3a1), 125.82 (C15b1), 125.29 (C17), 123.89 (C6b1), 123.75 (C9b1), 123.50 (C3b1), 
123.21 (C12b1), 122.45 (C16), 120.94 (C3), 120.69 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.60 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.50 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.43 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.31 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.19 (C3a2/3b2/6b2/9b2/12b2/15b2), 119.42 (C4), 119.24 (C6/7), 118.98 (C9), 
118.85 (C10), 118.80 (C6/7), 118.78 (C12), 118.55 (C13), 117.68 (C1), 111.07 (C1’), 97.46 (C2’), 35.86 
(x2; C(CH3)3), 35.84 (C(CH3)3), 35.81 (C(CH3)3), 32.22 (x2; C(CH3)3), 32.18 (x2; C(CH3)3), 19.13 
(CH(CH3)2), 11.86 (CH(CH3)2) ppm.  
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MALDI-TOF MS: m/z 926.52; calcd for C69H70Si, [M]+ 926.53.  
5.5.3 5,8,11,14-Tetra(tert-butyl)-1-ethynylhexa-peri-hexabenzocoronene (5-4) 
 
Acetylene 5-19 (0.210 g, 0.266 mmol) was dissolved in DCM (20 mL), tetra(n-butyl)ammonium 
fluoride (1 M in THF, 0.45 mL, 0.45 mmol) was added dropwise and stirred for 18 h at RT. The 
mixture was washed with brine, water, dried over MgSO4 and the solvent removed in vacuo. 
The residue was purified via column chromatography (SiO2, 25:75 DCM/PE) to yield 5-4 as a 
yellow powder (0.193 g, 0.250 mmol, 83%). 
1H NMR (500 MHz, CDCl3): δ 10.03 (d, J = 8.0 Hz, 1H, H18), 9.26 (s, 2H, H9,10), 9.20 (s, 1H, H12), 
9.16 (s, 1H, H7), 9.12 (s, 1H, H13), 9.09 (s, 1H, H6), 8.92 (s, 1H, H15), 8.81 (s, 1H, H4), 8.74 (d, J = 
7.7 Hz, 1H, H16), 8.56 (d, J = 8.2 Hz, 1H, H3), 7.90 (d, J = 8.2 Hz, 1H, H2), 7.68 (t, J = 7.9 Hz, 1H, 
H17), 3.67 (s, 1H, H2’), 1.89 (2xs, 18H, C(CH3)3), 1.79 (s, 9H, C(CH3)3), 1.77 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 148.95 (C8/11), 148.84 (C8/11), 148.66 (C14), 148.56 (C5), 134.69 
(C2), 131.16 (C18b), 130.57 (x2; C9a,9b), 130.51 (C12a), 130.45 (C3a), 130.24 (C6b), 130.01 (C12b), 
129.96 (C6a), 129.93 (C15a), 129.27 (C15b), 129.14 (C3b), 129.12 (C18a), 125.68 (x2; C3a1,18), 125.05 
(C15b1), 123.74 (C6b1), 123.69 (C9b1), 123.21 (C3b1), 123.02 (C12b1), 122.27 (C16), 120.52 (C3), 
120.48 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.40 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.10 (C3a2/3b2/6b2/9b2/12b2/15b2), 
120.09 (x2; C3a2/3b2/6b2/9b2/12b2/15b2), 119.74 (C3a2/3b2/6b2/9b2/12b2/15b2), 119.25 (C6), 119.18 (C4), 
118.93 (C9), 118.87 (C15), 118.82 (C10), 118.79 (C12), 118.72 (C7), 118.52 (C13), 115.78 (C1), 87.73 
(C1’), 83.25 (C2’), 35.90 (C(CH3)3), 35.89 (C(CH3)3), 35.81 (C(CH3)3), 35.77 (C(CH3)3), 32.28 (x2; 
C(CH3)3), 32.23 (C(CH3)3), 32.20 (C(CH3)3) ppm. 
MALDI-TOF MS: m/z 770.39; calcd for C60H50, [M]+ 770.39. 
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5.5.4 2,5,8,11-Tetra(tert-butyl)tetrabenzo[bc,ef,hi,uv]ovalene (5-5) 
 
A solution of 5-4 (36 mg, 47 μmol) in toluene (5 mL) was bubbled with argon for 10 min. 
Platinum(II) chloride (4 mg, 20 μmol) was added and the resultant suspension was heated at 
80 °C for 16 h under argon. The dark yellow suspension was cooled to RT, diluted with DCM, 
filtered and the solvents removed in vacuo. The residue was dissolved in a mixture of DCM/CS2 
(50:50, 20 mL) and filtered. The organic filtrate was collected and the solvent removed in 
vacuo to afford 5-5 as an orange powder (34 mg, 44 μmol, 94%).   
1H NMR (500 MHz, 50:50 CS2/CDCl3): δ 9.36 (s, 2H, H6,7), 9.34 (s, 2H, H4,9), 9.31 (s, 2H, H3,10), 
9.24 (s, 2H, H1,12), 9.13 (d, J = 8.4 Hz, 2H, H13,18), 8.25 (d, J = 8.4 Hz, H14,17), 8.04 (s, 2H, H15,16), 
1.96 (s, 18H, C(CH3)3), 1.91 (s, 18H, C(CH3)3) ppm. 
13C NMR (125 MHz, 50:50 CS2/CDCl3): δ 148.66 (C5,8), 148.07 (C2,11), 130.79 (C3b,9a), 130.67 
(C6a,6b), 130.28 (C3a,9b), 129.26 (C12a,18b), 129.18 (C14a,16a), 126.55 (C12b,18a), 126.35 (C15,16), 
125.74 (C14,17), 124.12 (C3b1,6b1), 123.45 (C14a1,16a1), 123.09 (C12a1,18a1), 122.71 (C3a1,9b1), 120.57 
(C13,18), 120.25 (C3a2,9b2/3b2,6b2/12b2,18a2), 119.70 (C3a2,9b2/3b2,6b2/12b2,18a2), 119.59 
(C3a2,9b2/3b2,6b2/12b2,18a2), 118.97 (C4,9), 118.85 (C6,7), 118.64 (C1,12), 118.30 (C3,10), 35.76 (C(CH3)3), 
35.74 (C(CH3)3), 32.31 (C(CH3)3), 32.22 (C(CH3)3) ppm. 






Triethylamine (15 mL) was bubbled with argon for 15 min. (Triisopropylsilyl)acetylene (76 mg, 
0.42 mmol), 4-24 (0.100 g, 0.104 mmol), copper(I) iodide (6 mg, 30 μmol) and 
dichlorobis(triphenylphosphine)palladium(II) (28 mg, 40 μmol) were added and heated at 
80 °C for 18 h under argon. The yellow mixture was cooled and the solvent removed in vacuo. 
The residue was purified via column chromatography (SiO2, 10:90 DCM/PE) to yield 5-20 as a 
yellow film (80 mg, 69 μmol, 66%). 
1H NMR (500 MHz, CDCl3): δ 10.60 (d, J = 1.6 Hz, 2H, H4,18), 9.35-9.32 (m, 8H, H6,7,9,10,12,13,15,16), 
8.79 (s, 1H, H2), 1.85 (s, 27H, C(CH3)3), 1.81 (s, 18H, C(CH3)3), 1.30-1.26 (m, 42H, CH(CH3)2) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.57 (C11), 149.40 (C8,14), 148.66 (C5,17), 145.79 (C2), 131.09 
(C3a,18b), 130.83, 130.59, 130.57, 129.60, 129.55, 127.98, 124.92 (C4,18), 124.27 (C3b1,15b1), 
124.00 (C9b1), 123.82 (C6b1,12b1), 121.22 (C3a2/9b2), 120.83 (C3b2,15b2/6b2,12b2), 120.57 
(C3b2,15b2/6b2,12b2), 120.27 (C6b1,12b1), 120.25 (C6,16), 119.13 (C7,15/9,13/10,12), 119.10 (C7,15/9,13/10,12), 
118.98 (C7,15/9,13/10,12), 117.89 (C1,3), 111.15 (C1’), 98.43 (C2’), 36.26 (x2; C(CH3)3), 35.92 
(C(CH3)3), 32.41 (C(CH3)3), 32.19 (C(CH3)3), 32.18 (C(CH3)3), 19.17 (CH(CH3)2), 11.85 (CH(CH3)2) 
ppm. 
MALDI-TOF MS: m/z 1162.71; calcd for C84H98Si2, [M]+ 1162.72. 
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5.5.6 5,8,11,14,17-Penta(tert-butyl)-1,3-diethynylhexa-peri-hexabenzocoronene (5-6) 
 
Acetylene 5-20 (80 mg, 69 μmol) was dissolved in DCM (20 mL), tetra-n-butylammonium 
fluoride (1 M in THF, 0.2 mL, 0.2 mmol) was added dropwise and stirred at RT for 4 h under 
argon. The mixture was washed with brine, water, dried over MgSO4 and the solvent removed 
in vacuo to yield 5-6 as a yellow film (45 mg, 53 μmol, 78%). 
1H NMR (500 MHz, CDCl3): δ 10.54 (d, J = 1.6 Hz, 2H, H4,18), 9.34 (d, J = 1.4 Hz, 2H, H6,16), 9.33-
9.32 (m, 4H, H9,10,12,13), 9.31 (d, J = 1.4 Hz, 2H, H7,15), 8.67 (s, 1H, H2), 3.81 (s, 2H, H2’), 1.83 (s, 
27H, C(CH3)3), 1.79 (s, 18H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.64 (C11), 149.46 (C8,14), 148.52 (C5,17), 142.78 (C2), 132.61 
(C3a,18b), 130.83 (C6b,15a/9a,12b/9b,12a), 130.62 (C6b,15a/9a,12b/9b,12a), 130.52 (C6b,15a/9a,12b/9b,12a), 
129.56 (C6a,15b), 129.10 (C3b,18a), 127.98 (C3a1), 125.14 (C4,18), 124.36 (C3b1,15b1), 123.93 (C9b1), 
123.76 (C6b1,12b1), 121.35 (C3a2/9b2), 120.73 (C3b2,15b2/6b2,12b2), 120.61 (C3b2,15b2/6b2,12b2), 120.28 
(C6,16), 119.98 (C3a2/9b2), 119.14 (C7,15/9,13/10,12), 119.10 (C7,15/9,13/10,12), 119.05 (C7,15/9,13/10,12), 
116.43 (C1,3), 86.81 (C1’), 82.98 (C2’), 36.40 (C(CH3)3), 35.93 (x2; C(CH3)3), 32.18 (C(CH3)3), 32.17 
(C(CH3)3), 32.11 (C(CH3)3) ppm. 






A solution of 5-6 (45 mg, 53 μmol) in toluene (2 mL) was bubbled with argon for 10 min. 
Platinum(II) chloride (4 mg, 20 μmol) was added and the resultant suspension was heated at 
80 °C for 42 h under argon. The dark yellow suspension was cooled to RT, diluted with DCM, 
filtered and the solvents removed in vacuo. The residue was purified via column 
chromatography (SiO2, 25:75 DCM/PE) to give 5-7 as a mixture with an additional trace 
impurity powder (15 mg). The mixture was further purified via preparatory TLC (25:75 
DCM/PE) to yield clean 5-7 (ca 5 mg) which showed signs of further decomposition after 
subjection to high vacuum over 6 h. 
1H NMR (400 MHz, CDCl3): δ 10.14 (s, 2H, H1,9), 9.80 (s, 2H, H10,18), 9.58 (s, 2H, H12,16), 9.52 (s, 
2H, H13,15), 9.48-9.46 (m, 3H, H3,5,7), 8.88 (d, J = 9.5 Hz, 2H, H4,6), 2.23 (s, 18H, C(CH3)3), 1.95 (s, 
18H, C(CH3)3), 1.92 (s, 9H, C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals 
due to limited solubility. 




5.5.8 5,8,11,14-Tetra(tert-butyl)-1-mercaptohexa-peri-hexabenzocoronene (5-8) 
 
Bromo HBC 4-37 (0.100 g, 0.12 mmol) was dissolved in dry THF (15 mL) and cooled to -78 °C 
under argon. tert-Butyllithium (1.6 M in cyclohexane, 0.23 mL, 0.37 mmol) was added 
dropwise and the resulting dark solution was stirred for 15 min at -78 °C. Ground sulfur (8 mg, 
0.24 mmol) was added and the resultant suspension was stirred at RT for 48 h. The reaction 
was quenched with aq. HCl (2 M) dropwise, diluted with water and extracted with DCM. To 
the organic layer was added aq. NaOH (2 M) until a pH of 11 was obtained, washed with water, 
dried over MgSO4 and the solvent removed in vacuo. The yellow residue was purified via 
column chromatography (SiO2, 10:90 DCM/PE) to yield 5-8 as a yellow powder (11 mg, 14 
μmol, 15%).  
1H NMR (500 MHz, CDCl3): δ 9.30 (s, 1H, H9), 9.29 (s, 1H, H10), 9.26 (s, 1H, H7), 9.23 (s, 1H, H12), 
9.20 (s, 1H, H6), 9.17 (s, 1H, H13), 9.07 (s, 1H, H4), 9.00 (s, 1H, H15), 8.91 (d, J = 8.9 Hz, 1H, H3), 
8.83 (d, J = 7.6 Hz, 1H, H16), 8.69-8.65 (m, 2H, H2,18), 7.82 (t, J = 7.7 Hz, 1H, H17), 1.88 (s, 9H, 
C(CH3)3), 1.87 (s, 9H, C(CH3)3), 1.82 (s, 9H, C(CH3)3), 1.78 (s, 9H, C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals. 




[3,4,5,6-qrabc]coronene  (5-9) 
 
DMSO (2 mL) was bubbled with argon for 10 min. Palladium(II) chloride (1 mg, 6 μmol) and 
5-8 (11 mg, 14 μmol) were added and the resultant suspension was heated at 140 °C for 18 h 
under argon. The reaction mixture was cooled, poured into water and the precipitate isolated 
by filtration. The crude residue was purified via column chromatography (SiO2, 25:75 DCM/PE) 
to yield 5-9 as a yellow powder (4 mg, 5 μmol, 36%).  
1H NMR (500 MHz, CDCl3): δ 9.33 (s, 2H, H8,15/9,14/11,12), 9.32 (s, 2H, H8,15/9,14/11,12), 9.31 (s, 2H, 
H8,15/9,14/11,12), 9.26 (s, 2H, H6,17), 9.17 (d, J =8.4 Hz, 2H, H1,5), 8.51 (d, J = 8.4 Hz, 2H, H2,4), 1.90 
(s, 18 H, C(CH3)3), 1.88 (s, 18 H, C(CH3)3) ppm.  
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals. 
MALDI-TOF MS: m/z 776.35; calcd for C58H48S, [M]+ 776.35. 




Bromo HBC 4-37 (0.100 g, 0.12 mmol) was dissolved in dry THF (15 mL) and cooled to -78 °C 
under argon. tert-Butyllithium (1.6 M in cyclohexane, 0.23 mL, 0.37 mmol) was added 
dropwise and the resulting dark solution was stirred for 15 min at -78 °C. Chlorodiphenylsilane 
(53 mg, 0.24 mmol) was added and the resultant red solution was stirred at RT for 48 h. The 
bright orange reaction mixture was quenched with aq. sat. NH4Cl, diluted with water and 
extracted with DCM. The organic phase was dried over MgSO4 and the solvent removed in 
vacuo. The yellow residue was purified via column chromatography (SiO2, 25:75 DCM/PE) to 
yield 5-10 as a yellow powder (21 mg, 23 μmol, 19%).  
1H NMR (500 MHz, CDCl3): δ 9.35-9.31 (m, 6H, H6,7,9,10,12,13), 9.29 (s, 1H, H4/15), 9.27 (s, 1H, 
H4/15), 9.18-9.15 (m, 2H, H2,16), 8.92 (d, J = 7.8 Hz, 1H, H18), 8.34 (d, J = 8.0 Hz, 1H, H3), 7.93 (t, 
J = 7.8 Hz, 1H, H17), 7.76-7.72 (m, 4H, H2’), 7.49-7.39 (m, 6H, H3’,4’), 6.18 (s, 1H, SiH), 1.84 (s, 
9H, C(CH3)3), 1.83 (s, 9H, C(CH3)3), 1.81 (s, 9H, C(CH3)3), 1.79 (s, 9H, C(CH3)3) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.42 (C5/8/10/14), 149.40 (C5/8/10/14), 149.37 (C5/8/10/14), 149.36 
(C5/8/10/14), 139.13 (C1), 137.82 (C3), 136.32, 136.12 (C2’), 135.55 (C1’), 134.45, 131.65 (C18b), 
131.44, 130.78, 130.72, 130.60, 130.50, 130.43, 130.38, 129.99, 129.94, 129.87 (C4’), 128.89 
(C18), 128.59, 128.47, 128.37 (C3’), 128.23, 126.49, 126.37, 125.19 (C17), 124.13, 124.06, 
123.94, 123.69, 122.62 (C3), 121.73, 121.05 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.95 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.90 (C2), 120.81 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.74 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.70 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.63 (C3a2/3b2/6b2/9b2/12b2/15b2), 119.72 
(C4/15), 119.52 (C4/15), 119.19 (C6/7/9/10/12/13), 119.11 (C6/7/9/10/12/13), 119.06 (C6/7/9/10/12/13), 
118.99 (C6/7/9/10/12/13), 118.96 (x2; C6/7/9/10/12/13), 35.94 (C(CH3)3), 35.91 (x2; C(CH3)3), 35.90 
(C(CH3)3), 32.22 (C(CH3)3), 32.18 (x2; C(CH3)3), 32.15 (C(CH3)3) ppm. Four additional aromatic 
carbons were observed, which could not be distinguished from those of 5-10. 




tetrabenzo[ef,hi,kl,no]fluoreno[3,4,5,6-qrabc]coronene  (5-11) 
 
A solution of 5-10 (21 mg, 23 μmol) in THF (10 mL) was bubbled with argon for 10 min. PtCl2 
(3 mg, 10 μmol) and potassium trispyrazolylborate (13 mg, 52 μmol) were added and the 
reaction vessel sealed. The mixture was heated at 140 °C for 4 h, cooled to RT and the solvent 
removed in vacuo. The organic residue was purified via preparatory TLC (25:75 DCM/PE) to 
yield 5-11 in a mixture with an unidentified monoaromatic compound (ca 5 mg, observed by 
1H NMR). The mixture was subjected to high vacuum, after which 5-11 was observed to have 
partially decomposed by 1H NMR.   
1H NMR (400 MHz, CDCl3): 9.29 (s, 2H), 9.22 (s, 2H), 9.14 (s, 2H), 8.94 (s, 2H), 8.76 (d, J = 7.9 
Hz, 2H), 8.57 (d, J = 8.0 Hz, 2H), 7.77 (t, J = 7.7 Hz, 2H), 7.68-7.64 (m, 4H), 7.36-7.31 (m, 4H), 
1.89 (s, 18H), 1.79 (s, 18H) ppm.  
Satisfactory 13C or 2D 1H-1H NMR spectra could not be collected due to the low intensity of 
the signals due to limited solubility in combination with rapid decomposition. 




5.5.12 1-Anilino-5,8,11,14-tetra(tert-butyl)hexa-peri-hexabenzocoronene (5-12) 
 
Toluene (5 mL) was bubbled with argon for 10 min. Aniline (11 mg, 0.12 mmol), 4-37 (0.100 g, 
0.12 mmol), potassium tert-butoxide (20 mg, 0.18 mmol), tri(tert-butyl)phosphonium 
tetrafluoroborate (14 mg, 48 μmol), and tris(dibenzylidineacetone)dipalladium(0) (11 mg, 12 
μmol) were added and the mixture was stirred overnight under argon. The brown suspension 
was diluted with DCM and the solvent removed in vacuo. The crude mixture was purified by 
column chromatography (SiO2, 25:75 DCM/PE) to yield 5-12 as a yellow powder (79 mg, 94 
μmol, 78%).  
1H NMR (500 MHz, CDCl3): δ 9.29 (s, 1H, H10), 9.28 (s, 1H, H9), 9.25 (s, 1H, H12), 9.22-9.18 (m, 
3H, H7,13,18), 9.04 (s, 1H, H6), 8.99 (s, 1H, H15), 8.76-8.71 (m, 2H, H4,16), 8.48 (d, J = 8.7 Hz, 1H, 
H3), 7.62-7.56 (m, 2H, H2,17), 7.32 (t, J = 7.8 Hz, 2H, H3’), 7.07 (d, J = 7.8 Hz, 2H, H2’), 6.95 (t, J = 
7.5 Hz, 1H, H4’), 5.87 (s, 1H, NH), 1.87 (s, 9H, C(CH3)3), 1.86 (s, 9H, C(CH3)3), 1.79 (s, 9H, C(CH3)3), 
1.73 (s, 9H, C(CH3)3) ppm.  
13C NMR (125 MHz, CDCl3): δ 149.07 (C8/11), 148.94 (C8/11), 148.86 (C14), 148.71 (C5), 144.25 
(C1’), 138.36 (C1), 130.66, 130.54, 130.47, 130.13, 130.08, 130.04, 130.00, 129.94, 129.64 (C3’), 
129.47, 129.18, 128.37, 127.48, 126.13, 125.64, 125.41 (C2), 124.05 (C18), 123.93, 123.87, 
123.37, 122.86 (C17), 122.69, 122.31 (C3), 121.89, 121.41 (C16), 121.08, 120.63, 120.55, 120.47, 
120.24 (C4’), 119.85, 119.11 (C15), 118.92 (C9,10), 118.88 (C9,10), 118.82 (C12), 118.78 (C7,13), 
118.64 (C7,13), 118.43 (C4), 117.88 (C6), 116.33 (C2’), 35.90 (C(CH3)3), 35.88 (C(CH3)3), 35.84 
(C(CH3)3), 35.74 (C(CH3)3), 32.24 (x2; C(CH3)3), 32.21 (C(CH3)3), 32.18 (C(CH3)3) ppm. 







A solution of 5-12 (75 mg, 89 μmol) in DMF (5 mL) was bubbled with argon for 10 min. 
Palladium(II) acetate (10 mg, 45 μmol) and copper(II) acetate monohydrate (10 mg, 45 μmol) 
were added and the resultant suspension was heated at 140 °C for 42 h under argon. The 
mixture was cooled, poured into water and the precipitate was isolated by filtration. The crude 
was purified via column chromatography (SiO2, 25:75 DCM/PE) to yield 5-13 as a yellow 
powder (38 mg, ~50 %) as a mixture with trace amounts of 5-14 and another unidentified 
impurity. Further purification via preparatory TLC (SiO2, 50:50 DCM/PE) resulted in almost 
complete decomposition of the compound, with pure 5-13 isolated in yields <2 mg. 
1H NMR (500 MHz, CDCl3): δ 9.35 (s, 2H, H8,15/9,14/11,12), 9.32 (s, 2H, H8,15/9,14/11,12), 9.31 (s, 2H, 
H8,15/9,14/11,12), 9.27 (s, 2H, H6,17), 9.16 (d, J = 8.3 Hz, 2H, H1,5), 8.39 (d, J = 8.3 Hz, 2H, H2,4), 8.20 
(d, J = 7.6 Hz, 2H, H2’), 7.81 (t, J = 7.6 Hz, 2H, H3’), 7.52 (t, J = 7.7 Hz, 1H, H4’), 1.90 (2xs, 36H, 
C(CH3)3) ppm. 
A satisfactory 13C NMR spectrum could not be collected due to the low intensity of the signals 
due to limited solubility. 






Dioxane (10 mL) was bubbled with argon for 10 min. Bis(pinacolato)diboron (0.115 g, 0.454 
mmol), 4-37 (0.250 g, 0.303 mmol), dichlorobis(triphenylphosphine)palladium(II) (22 mg, 31 
μmol) and potassium acetate (0.178 g, 1.82 mmol) were added and the resultant solution 
heated at 90 °C for 18 h under argon. The mixture was cooled and the solvent removed in 
vacuo. The yellow residue was extracted with DCM, washed with brine, dried over MgSO4 and 
the solvent removed in vacuo. The organic residue was purified via column chromatography 
(SiO2, 50:50 DCM/PE) to yield 5-15 as a yellow powder (0.149 g, 0.171 mmol, 56%). 
1H NMR (500 MHz, CDCl3): δ 9.30-9.27 (m, 4H, H6,7,9,10), 9.27 (s, 1H, H12), 9.23 (s, 1H, H13), 9.21 
(s, 1H, H4), 9.14 (s, 1H, H15), 9.09 (d, J = 8.1 Hz, 1H, H3), 9.04 (d, J = 8.0 Hz, 1H, H16), 8.56 (d, J = 
7.7 Hz, 1H, H18), 8.26 (d, 7.8 Hz, 1H, H2), 7.93 (t, J = 7.8 Hz, 1H, H17), 1.85 (s, 9H, C(CH3)3), 1.84 
(s, 9H, C(CH3)3), 1.82 (s, 9H, C(CH3)3), 1.80 (s, 9H, C(CH3)3), 1.55 (s, 12H, H2’) ppm. 
13C NMR (125 MHz, CDCl3): δ 149.08 (x2; C5/8/11/14), 149.00 (C5/8/11/14), 148.98 (C5/8/11/14), 135.40 
(C18b), 132.23 (C2), 131.67 (C3a), 130.93 (C18a), 130.68 (C6a/6b/9a/9b), 130.63 (C6a/6b/9a/9b), 130.61 
(C12a), 130.58 (C6a/6b/9a/9b), 130.33 (x2; C12b,6a/6b/9a/9b), 130.23 (C15a), 130.06 (C15b), 129.94 (C3b), 
127.37 (C18), 126.01 (C15b1), 125.88 (C3a1), 125.33 (C17), 124.07 (C6b1), 124.00 (C9b1), 123.81 
(C3b1), 123.63 (C12b1), 122.16 (C16), 120.96 (C3), 120.77 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.65 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.63 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.54 (C3a2/3b2/6b2/9b2/12b2/15b2), 120.53 
(C3a2/3b2/6b2/9b2/12b2/15b2), 120.52 (C3a2/3b2/6b2/9b2/12b2/15b2), 119.50 (C4), 119.30 (C6), 119.26 (C15), 
118.98 (C12), 118.94 (x3; C7,9,10), 118.76 (C13), 84.35 (C1’), 35.89 (x2; C(CH3)3), 35.88 (C(CH3)3), 
35.86 (C(CH3)3), 32.21 (x3; C(CH3)3), 32.20 (C(CH3)3), 24.93 (C2’) ppm. C1 could not be observed. 
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MALDI-TOF MS: m/z 872.45; calcd for C64H61BO2, [M]+ 872.48. 
5.5.15 5,8,11,14-Tetra(tert-butyl)-1-hydroxyhexa-peri-hexabenzocoronene (5-16) 
 
To a mixture of 5-15 (70 mg, 80 μmol) in THF (5 mL) and H2O2 (5 mL) was added powdered 
NaOH (0.200 g, 5 mmol) and the resultant suspension was stirred at RT for 18 h. The reaction 
was slowly quenched with sat. aq. NH4Cl and extracted with DCM. The organic phase was 
washed with water, dried over MgSO4 and the solvent removed in vacuo to yield a poorly 
soluble, inseparable mixture containing 5-16 by MALDI-TOF MS (20 mg, up to 33%).  
Satisfactory 1H and 13C NMR spectra could not be collected due to the low intensity of the 
signals due to limited solubility. 
MALDI-TOF MS: m/z 762.36; calcd for C58H50O, [M]+ 762.39. 
5.5.16 Attempted synthesis of 7,10,13,16-Tetra(tert-butyl)-3-oxa-tetrabenzo- 
[ef,hi,kl,no]fluoreno[3,4,5,6-qrabc]coronene  (5-17) 
 
Toluene (5 mL) was bubbled with argon for 10 min. 3-Nitropyridine (2 mg, 10 μmol), tert-butyl 
peroxybenzoate (10 mg, 50 μmol), palladium(II) acetate (3 mg, 10 μmol) and crude 5-16 (ca 
20 mg) were added and the resultant suspension was heated at reflux for 4 h under an argon 
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atmosphere. The mixture was cooled to RT and diluted with MeOH. The orange precipitate 
was isolated by filtration to yield a mixture of products by MALDI-TOF MS; there were no peaks 
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